,aa_position,ref_aa,alt_aa,phosphorylation_site,methylation_site,ubiquitination_site,cleavage_site,s-nitrosylation_site,acetylation_site,sumoyylation_site,ogalnac_site,oglcnac_site,disorder_propensity,linear_motif,structure,sources,cancer_study,cancer_type,genomic_coordinates,genomic_mutation,REVEL_score,cancer_site,cancer_histology,gnomad_exome_af,gnomad_genome_af
0,1,M,L,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1,1,M,T,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2,2,A,S,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
3,3,A,T,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90747399-90747399","hg38,15:g.90747399G>A",0.088,"central_nervous_system, cerebellum","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
4,4,V,A,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","acc_2019, gbm_mayo_pdx_sarkaria_2019","Adrenocortical Carcinoma, Glioblastoma Multiforme","hg19,15:91290633-91290633, hg38,15:90747403-90747403","hg19,15:g.91290633T>C, hg38,15:g.90747403T>C",0.122,prostate,carcinoma,0.0011332599567894,0.0010191082802548
5,4,V,D,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
6,4,V,F,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,15:91290632-91290632, hg38,15:90747402-90747402","hg19,15:g.91290632G>T, hg38,15:g.90747402G>T",0.120,skin,malignant_melanoma,,
7,4,V,I,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
8,4,V,L,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
9,5,P,H,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,cBioPortal,"cellline_ccle_broad, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91290636-91290636","hg19,15:g.91290636C>A",0.528,,,,
10,5,P,L,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
11,5,P,S,,,,,,,,,,d,"IAP-binding motif (IBM), 1-5, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
12,6,Q,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
13,7,N,,,,,,,,,,,d,,,,,,,,,,,,
14,8,N,D,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90747414-90747414","hg38,15:g.90747414A>G",0.323,"skin, mucosal, anorectal",malignant_melanoma,,
15,8,N,K,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
16,9,L,I,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90747417-90747417","hg38,15:g.90747417C>A",0.293,stomach,"carcinoma, adenocarcinoma",,
17,9,L,V,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",msk_access_2021,Mixed Cancer Types,"hg19,15:91290647-91290647","hg19,15:g.91290647C>G",0.314,,,,
18,10,Q,,,,,,,,,,,d,,,,,,,,,,,,
19,11,E,Q,,,,,,,,,,d,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91290653-91290653, hg38,15:90747423-90747423","hg19,15:g.91290653G>C, hg38,15:g.90747423G>C",0.039,lung,"carcinoma, adenocarcinoma",,
20,12,Q,,,,,,,,,,,d,,,,,,,,,,,,
21,13,L,I,,,,,,,,,,d,,,"cBioPortal,COSMIC","lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub",Diffuse Glioma,"hg19,15:91290659-91290659, hg38,15:90747429-90747429","hg19,15:g.91290659C>A, hg38,15:g.90747429C>A",0.302,"central_nervous_system, brain",glioma,,
22,14,E,,,,,,,,,,,d,,,,,,,,,,,,
23,15,R,C,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","brca_tcga_pan_can_atlas_2018, lgg_tcga_pan_can_atlas_2018, msk_impact_2017, msk_met_2021","Diffuse Glioma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91290665-91290665, hg38,15:90747435-90747435","hg19,15:g.91290665C>T, hg38,15:g.90747435C>T",0.182,"breast, endometrium, penis","carcinoma, carcinoma, endometrioid_carcinoma, carcinoma, squamous_cell_carcinoma",0.0002380568108457,0.0002868983104877
24,15,R,H,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91290666-91290666","hg19,15:g.91290666G>A",0.208,,,0.0000282415214918,
25,15,R,L,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91290666-91290666","hg19,15:g.91290666G>T",0.097,,,,
26,15,R,S,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
27,16,H,D,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
28,17,S,L,P,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
29,18,A,,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,,,,,,,,,,
30,19,R,K,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
31,19,R,S,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
32,20,T,,P,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,,,,,,,,,,
33,21,L,V,,,,,,,,,,d,"14-3-3 binding phosphopeptide motif, 15-21, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
34,22,N,D,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
35,23,N,,,,,,,,,,,s,,,,,,,,,,,,
36,24,K,E,,,Ubq,,,,Sumo,,,s,,,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,15:91290692-91290692","hg19,15:g.91290692A>G",0.088,,,,
37,25,L,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
38,26,S,,P,,,,,,,,,s,,,,,,,,,,,,
39,27,L,F,,,,,,,,,,s,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91290701-91290701, hg38,15:90747471-90747471","hg19,15:g.91290701C>T, hg38,15:g.90747471C>T",0.068,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
40,28,S,L,P,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91290705-91290705","hg19,15:g.91290705C>T",0.039,,,,
41,29,K,E,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90747477-90747477","hg38,15:g.90747477A>G",0.203,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
42,29,K,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
43,30,P,L,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, hcc_inserm_fr_2015, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,15:91290711-91290711, hg38,15:90747481-90747481","hg19,15:g.91290711C>T, hg38,15:g.90747481C>T",0.218,"haematopoietic_and_lymphoid_tissue, liver, urinary_tract, bladder","carcinoma, carcinoma, hepatocellular_carcinoma, lymphoid_neoplasm, Hodgkin_lymphoma",,
44,30,P,R,,,,,,,,,,s,,,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,15:91290711-91290711, hg38,15:90747481-90747481","hg19,15:g.91290711C>G, hg38,15:g.90747481C>G",0.251,ovary,"carcinoma, serous_carcinoma",,
45,31,K,N,,,,,,,Sumo,,,s,,,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91290715-91290715, hg38,15:90747485-90747485","hg19,15:g.91290715A>C, hg38,15:g.90747485A>C",0.257,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
46,31,K,T,,,,,,,Sumo,,,s,,,cBioPortal,mel_ucla_2016,Melanoma,"hg19,15:91290714-91290714","hg19,15:g.91290714A>C",0.429,,,,
47,32,F,C,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91290717-91290717","hg19,15:g.91290717T>G",0.051,,,,
48,32,F,I,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,COSMIC,,,"hg38,15:90747486-90747486","hg38,15:g.90747486T>A",0.080,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,
49,33,S,L,P,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, coadread_tcga_pan_can_atlas_2018, mel_mskimpact_2020, msk_met_2021, pancan_pcawg_2020, sarcoma_mskcc_2022, skcm_tcga_pan_can_atlas_2018, tmb_mskcc_2018","Colorectal Adenocarcinoma, Cutaneous Melanoma, Mixed Cancer Types, Soft Tissue","hg19,15:91290720-91290720, hg38,15:90747490-90747490","hg19,15:g.91290720C>T, hg38,15:g.90747490C>T",0.027,"large_intestine, caecum, lung, skin","carcinoid-endocrine_tumour, carcinoma, adenocarcinoma, malignant_melanoma",0.0000173032832980,0.0000955535737037
50,34,G,,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,,,,,,,,,,
51,35,F,L,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,cBioPortal,breast_ink4_msk_2021,Breast,"hg19,15:91292603-91292603","hg19,15:g.91292603C>A",0.433,,,,
52,35,F,Y,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91292602-91292602, hg38,15:90749372-90749372","hg19,15:g.91292602T>A, hg38,15:g.90749372T>A",0.347,skin,"carcinoma, basal_cell_carcinoma",,
53,36,T,A,P,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
54,36,T,S,P,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
55,37,F,Y,,,,,,,,,,s,"AGC Kinase docking motif, 32-37, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91292608-91292608, hg38,15:90749378-90749378","hg19,15:g.91292608T>A, hg38,15:g.90749378T>A",0.387,skin,"adnexal_tumour, malignant_adnexal_tumour",,
56,38,K,R,,Me,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
57,38,K,T,,Me,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
58,39,K,N,,Me,,,,,,,,s,"FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91292615-91292615, hg38,15:90749385-90749385","hg19,15:g.91292615G>T, hg38,15:g.90749385G>T",0.356,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",,
59,40,K,,,,,,,,Sumo,,,s,"FHA phosphopeptide ligands, 39-45, ELM",,,,,,,,,,,
60,41,T,A,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91292619-91292619, hg38,15:90749389-90749389","hg19,15:g.91292619A>G, hg38,15:g.90749389A>G",0.032,large_intestine,"carcinoma, adenocarcinoma",,
61,41,T,I,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
62,42,S,F,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
63,42,S,P,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
64,42,S,Y,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91292623-91292623, hg38,15:90749393-90749393","hg19,15:g.91292623C>A, hg38,15:g.90749393C>A",0.098,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000040164836489,
65,43,S,L,P,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91292626-91292626","hg19,15:g.91292626C>T",0.050,,,,
66,44,D,G,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
67,44,D,Y,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91292628-91292628","hg19,15:g.91292628G>T",0.085,,,0.0000040092051350,
68,45,N,K,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,cBioPortal,lung_msk_mind_2020,Lung,"hg19,15:91292633-91292633","hg19,15:g.91292633C>A",0.046,,,,
69,45,N,S,,,,,,,,,,s,"Caspase cleavage motif, 41-45, ELM|FHA phosphopeptide ligands, 39-45, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_mskcc_2017","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91292632-91292632, hg38,15:90749402-90749402","hg19,15:g.91292632A>G, hg38,15:g.90749402A>G",0.030,prostate,"carcinoma, adenocarcinoma",,
70,46,N,K,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
71,46,N,S,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292635-91292635","hg19,15:g.91292635A>G",0.058,,,,
72,47,V,E,,,,,,,,,,s,,,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91292638-91292638","hg19,15:g.91292638T>A",0.095,,,,
73,47,V,L,,,,,,,,,,s,,,cBioPortal,cscc_ucsf_2021,Cutaneous Squamous Cell Carcinoma,"hg19,15:91292637-91292637","hg19,15:g.91292637G>T",0.044,,,,
74,48,S,C,P,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020",Bladder Urothelial Carcinoma,"hg19,15:91292641-91292641, hg38,15:90749411-90749411","hg19,15:g.91292641C>G, hg38,15:g.90749411C>G",0.104,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
75,48,S,F,P,,,,,,,,,s,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,15:91292641-91292641, hg38,15:90749411-90749411","hg19,15:g.91292641C>T, hg38,15:g.90749411C>T",0.174,skin,malignant_melanoma,,
76,48,S,T,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
77,49,V,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
78,49,V,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
79,50,T,S,P,,,,,,,,,s,,,COSMIC,,,"hg38,15:90749417-90749417","hg38,15:g.90749417C>G",0.115,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
80,51,N,,,,,,,,,,,s,,,,,,,,,,,,
81,52,V,M,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
82,53,S,L,P,,,,,,,,,s,,,cBioPortal,utuc_cornell_baylor_mdacc_2019,Upper Tract Urothelial Carcinoma,"hg19,15:91292656-91292656","hg19,15:g.91292656C>T",0.185,,,,
83,53,S,T,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
84,54,V,I,,,,,,,,,,s,"WW domain ligands, 54-59, ELM",,"cBioPortal,COSMIC","prad_p1000, prad_su2c_2015, prad_su2c_2019",Prostate Adenocarcinoma,"hg19,15:91292658-91292658, hg38,15:90749428-90749428","hg19,15:g.91292658G>A, hg38,15:g.90749428G>A",0.184,prostate,carcinoma,,
85,55,A,G,,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
86,55,A,V,,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
87,56,K,,,,,,,,Sumo,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,,,,,,,,,,
88,57,T,,P,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,,,,,,,,,,
89,58,P,S,,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
90,58,P,T,,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
91,59,V,,,,,,,,,,,s,"WW domain ligands, 54-59, ELM|FHA phosphopeptide ligands, 55-61, ELM",,,,,,,,,,,
92,60,L,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 55-61, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749446-90749446","hg38,15:g.90749446T>A",0.099,haematopoietic_and_lymphoid_tissue,"haematopoietic_neoplasm, chronic_myeloid_leukaemia",0.0002635719591384,0.0000318410494810
93,61,R,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 55-61, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91292680-91292680, hg38,15:90749450-90749450","hg19,15:g.91292680G>T, hg38,15:g.90749450G>T",0.011,large_intestine,"carcinoma, adenocarcinoma",,
94,61,R,K,,,,,,,,,,s,"FHA phosphopeptide ligands, 55-61, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91292680-91292680, hg38,15:90749450-90749450","hg19,15:g.91292680G>A, hg38,15:g.90749450G>A",0.023,"urinary_tract, bladder",carcinoma,,
95,61,R,T,,,,,,,,,,s,"FHA phosphopeptide ligands, 55-61, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
96,62,N,K,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
97,63,K,,,,,,,,,,,s,,,,,,,,,,,,
98,64,D,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
99,64,D,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
100,64,D,H,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91292688-91292688, hg38,15:90749458-90749458","hg19,15:g.91292688G>C, hg38,15:g.90749458G>C",0.178,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
101,64,D,V,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","acc_2019, breast_msk_2018, cellline_ccle_broad","Adrenocortical Carcinoma, Breast, Mixed Cancer Types","hg19,15:91292689-91292689, hg38,15:90749459-90749459","hg19,15:g.91292689A>T, hg38,15:g.90749459A>T",0.306,breast,"carcinoma, lobular_carcinoma",0.0002392306342802,0.0003821169277799
102,64,D,Y,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292688-91292688","hg19,15:g.91292688G>T",0.265,,,,
103,65,V,G,,,,,,,,,,s,,,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,15:91292692-91292692","hg19,15:g.91292692T>G",0.348,,,,
104,65,V,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
105,66,N,,,,,,,,,,,s,,,,,,,,,,,,
106,67,V,D,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
107,67,V,I,,,,,,,,,,s,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749467-90749467","hg38,15:g.90749467G>A",0.050,prostate,"carcinoma, adenocarcinoma",,
108,68,T,A,P,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292700-91292700","hg19,15:g.91292700A>G",0.024,,,,
109,68,T,N,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
110,69,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91292703-91292703, hg38,15:90749473-90749473","hg19,15:g.91292703G>A, hg38,15:g.90749473G>A",0.037,"endometrium, large_intestine, colon, sigmoid","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0001075328771815,
111,70,D,G,,,,,,,,,,s,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749477-90749477","hg38,15:g.90749477A>G",0.024,lung,"other, pneumocytoma_(sclerosing_haemangioma)",,
112,70,D,N,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
113,70,D,Y,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91292706-91292706","hg19,15:g.91292706G>T",0.016,,,0.0000039818745072,
114,71,F,L,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
115,72,S,A,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
116,72,S,F,P,,,,,,,,,s,,,"cBioPortal,COSMIC","bcc_unige_2016, mel_dfci_2019, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Basal Cell Carcinoma, Cutaneous Melanoma, Melanoma, Mixed Cancer Types","hg19,15:91292713-91292713, hg19,15:91292713-91292714, hg38,15:90749483-90749483","hg19,15:g.91292713C>T, hg19,15:g.91292713_91292714delinsTT, hg38,15:g.90749483C>T",0.120,", skin","carcinoma, basal_cell_carcinoma, malignant_melanoma",,
117,72,S,L,P,,,,,,,,,s,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91292713-91292714","hg19,15:g.91292713_91292714delinsTA",,,,,
118,73,F,,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,,,,,,,,,,
119,74,S,G,P,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
120,75,E,K,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,"cBioPortal,COSMIC","brca_tcga_pan_can_atlas_2018, esca_tcga, esca_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma, Invasive Breast Carcinoma","hg19,15:91292721-91292721, hg38,15:90749491-90749491","hg19,15:g.91292721G>A, hg38,15:g.90749491G>A",0.041,breast,carcinoma,,
121,75,E,Q,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
122,76,P,L,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
123,76,P,S,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
124,76,P,T,,,,,,,,,,s,"PP4 EVH1-binding docking motifs, 73-76, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
125,77,L,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
126,78,P,Q,,,,,,,,,,s,,,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91292731-91292732","hg19,15:g.91292731_91292732delinsAA",,,,,
127,78,P,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
128,79,N,,,,,,,,,,,s,,,,,,,,,,,,
129,80,T,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
130,80,T,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
131,81,T,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
132,81,T,K,,,,,,,,,,s,,,cBioPortal,"egc_mskcc_2020, msk_met_2021","Esophagus/Stomach, Mixed Cancer Types","hg19,15:91292740-91292740","hg19,15:g.91292740C>A",0.016,,,,
133,81,T,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
134,82,N,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
135,82,N,Y,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
136,83,Q,R,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM",,"cBioPortal,Manual annotations from clinvar.csv",acc_2019,Adrenocortical Carcinoma,"hg19,15:91292746-91292746","hg19,15:g.91292746A>G",0.068,,,0.0000000000000000,
137,84,Q,H,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
138,85,R,S,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM",,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,15:91292753-91292753, hg38,15:90749523-90749523","hg19,15:g.91292753G>T, hg38,15:g.90749523G>T",0.120,ovary,"carcinoma, serous_carcinoma",,
139,85,R,T,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749522-90749522","hg38,15:g.90749522G>C",0.017,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, Burkitt_lymphoma",0.0005052996785180,0.0015923566878981
140,86,V,L,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
141,87,K,,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,,,,,,,,,,
142,88,D,E,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, mm_broad","Mixed Cancer Types, Plasma Cell Myeloma","hg19,15:91292762-91292762","hg19,15:g.91292762C>A, hg19,15:g.91292762C>G",0.043,,,0.0000198932132314,
143,88,D,H,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
144,89,F,I,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
145,89,F,L,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91292763-91292763, hg38,15:90749533-90749533","hg19,15:g.91292763T>C, hg38,15:g.90749533T>C",0.035,lung,"carcinoma, adenocarcinoma",,
146,90,F,,,,,,,,,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,,,,,,,,,,
147,91,K,,,,Ubq,,,,Sumo,,,s,"PCSK cleavage site, 87-91, ELM|USP7 binding motif, 87-91, ELM|PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,,,,,,,,,,
148,92,N,D,,,,,,,,,,s,"PCNA binding PIP Box, 83-92, ELM|RIR motif, 87-93, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",lung_msk_pdx,Lung,"hg19,15:91292772-91292772, hg38,15:90749542-90749542","hg19,15:g.91292772A>G, hg38,15:g.90749542A>G",0.034,lung,"carcinoma, adenocarcinoma",0.0001352706208126,0.0000636983247341
149,93,A,D,,,,,,,,,,s,"RIR motif, 87-93, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91292776-91292776, hg38,15:90749546-90749546","hg19,15:g.91292776C>A, hg38,15:g.90749546C>A",0.026,endometrium,"carcinoma, endometrioid_carcinoma",,
150,94,P,S,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91292778-91292778","hg19,15:g.91292778C>T",0.045,,,,
151,95,A,E,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
152,95,A,T,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
153,95,A,V,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
154,96,G,E,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91292785-91292785","hg19,15:g.91292785G>A",0.049,,,,
155,96,G,V,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91292785-91292785, hg38,15:90749555-90749555","hg19,15:g.91292785G>T, hg38,15:g.90749555G>T",0.074,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
156,97,Q,H,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91292789-91292789, hg38,15:90749559-90749559","hg19,15:g.91292789G>T, hg38,15:g.90749559G>T",0.029,endometrium,"carcinoma, endometrioid_carcinoma",,
157,97,Q,L,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292788-91292788","hg19,15:g.91292788A>T",0.042,,,,
158,98,E,D,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
159,98,E,K,,,,,,,,,,s,"TRAF2 binding site, 95-98, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
160,99,T,,P,,,,,,,,,s,,,,,,,,,,,,
161,100,Q,H,,,,,,,,,,s,,,"cBioPortal,COSMIC","gbm_tcga_pan_can_atlas_2018, msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,15:91292798-91292798, hg38,15:90749568-90749568","hg19,15:g.91292798G>T, hg38,15:g.90749568G>T",0.039,endometrium,"carcinoma, endometrioid_carcinoma",,
162,101,R,T,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_nmibc_2017, brca_mskcc_2019, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91292800-91292800, hg38,15:90749570-90749570","hg19,15:g.91292800G>C, hg38,15:g.90749570G>C",0.050,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000039801311851,
163,102,G,D,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","bcc_unige_2016, stad_oncosg_2018, stad_pfizer_uhongkong","Basal Cell Carcinoma, Stomach Adenocarcinoma","hg19,15:91292803-91292803, hg38,15:90749573-90749573","hg19,15:g.91292803G>A, hg38,15:g.90749573G>A",0.036,"skin, face, stomach","carcinoma, basal_cell_carcinoma, carcinoma, diffuse_adenocarcinoma",0.0000039805431053,
164,102,G,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
165,102,G,V,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292803-91292803","hg19,15:g.91292803G>T",0.035,,,,
166,103,G,V,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292806-91292806","hg19,15:g.91292806G>T",0.029,,,,
167,104,S,L,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91292809-91292809, hg38,15:90749579-90749579","hg19,15:g.91292809C>T, hg38,15:g.90749579C>T",0.218,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
168,105,K,,,,Ubq,,,,Sumo,,,s,"PCSK cleavage site, 105-109, ELM",,,,,,,,,,,
169,106,S,,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,,,,,,,,,,
170,107,L,S,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91292818-91292818, hg38,15:90749588-90749588","hg19,15:g.91292818T>C, hg38,15:g.90749588T>C",0.088,"large_intestine, caecum","carcinoma, adenocarcinoma",,
171,108,L,F,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
172,109,P,L,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,COSMIC,,,"hg38,15:90749594-90749594","hg38,15:g.90749594C>T",0.032,lung,"carcinoma, adenocarcinoma",,
173,109,P,R,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
174,109,P,S,,,,,,,,,,s,"PCSK cleavage site, 105-109, ELM",,COSMIC,,,"hg38,15:90749593-90749593","hg38,15:g.90749593C>T",0.020,lung,"carcinoma, adenocarcinoma",,
175,110,D,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
176,110,D,N,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, coadread_dfci_2016","Bladder Urothelial Carcinoma, Colorectal Adenocarcinoma","hg19,15:91292826-91292826, hg38,15:90749596-90749596","hg19,15:g.91292826G>A, hg38,15:g.90749596G>A",0.059,"large_intestine, urinary_tract, bladder","carcinoma, carcinoma, adenocarcinoma",,
177,110,D,Y,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91292826-91292826, hg38,15:90749596-90749596","hg19,15:g.91292826G>T, hg38,15:g.90749596G>T",0.041,lung,"carcinoma, adenocarcinoma",,
178,111,F,L,,,,,,,,,,s,"WW domain ligands, 111-116, ELM",,COSMIC,,,"hg38,15:90749601-90749601","hg38,15:g.90749601C>A",0.068,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
179,111,F,V,,,,,,,,,,s,"WW domain ligands, 111-116, ELM",,COSMIC,,,"hg38,15:90749599-90749599","hg38,15:g.90749599T>G",0.020,ovary,"carcinoma, mucinous_carcinoma",,
180,112,L,S,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
181,113,Q,R,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
182,114,T,,P,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,,,,,,,,,,
183,115,P,A,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292841-91292841","hg19,15:g.91292841C>G",0.072,,,,
184,115,P,L,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021, pan_origimed_2020, tmb_mskcc_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91292842-91292842, hg38,15:90749612-90749612","hg19,15:g.91292842C>T, hg38,15:g.90749612C>T",0.075,"large_intestine, caecum, large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000079600722775,
185,115,P,Q,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,COSMIC,,,"hg38,15:90749612-90749612","hg38,15:g.90749612C>A",0.052,"placenta, skin, mucosal, oral_cavity","choriocarcinoma, malignant_melanoma",,
186,115,P,S,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
187,115,P,T,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
188,116,K,N,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|WW domain ligands, 111-116, ELM|FHA phosphopeptide ligands, 112-118, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
189,117,E,K,,,,,,,,,,s,"Cks1 ligand, 112-117, ELM|FHA phosphopeptide ligands, 112-118, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, cscc_ucsf_2021","Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma","hg19,15:91292847-91292847, hg38,15:90749617-90749617","hg19,15:g.91292847G>A, hg38,15:g.90749617G>A",0.034,skin,"carcinoma, basal_cell_carcinoma",,
190,118,V,A,,,,,,,,,,s,"FHA phosphopeptide ligands, 112-118, ELM",,"cBioPortal,Manual annotations from clinvar.csv",lihc_tcga,Hepatocellular Carcinoma,"hg19,15:91292851-91292851","hg19,15:g.91292851T>C",0.019,,,0.0000198987551339,0.0000318471337580
191,118,V,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 112-118, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91292850-91292850, hg38,15:90749620-90749620","hg19,15:g.91292850G>A, hg38,15:g.90749620G>A",0.117,lung,"carcinoma, adenocarcinoma",,
192,119,V,,,,,,,,,,,s,,,,,,,,,,,,
193,120,C,,,,,,,,,,,s,,,,,,,,,,,,
194,121,T,P,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
195,121,T,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
196,122,T,,P,,,,,,,,,s,"WW domain ligands, 122-127, ELM",,,,,,,,,,,
197,123,Q,E,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,cBioPortal,breast_ink4_msk_2021,Breast,"hg19,15:91292865-91292865","hg19,15:g.91292865C>G",0.135,,,,
198,123,Q,R,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
199,124,N,H,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
200,124,N,S,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,"cBioPortal,Manual annotations from clinvar.csv",luad_oncosg_2020,Lung Adenocarcinoma,"hg19,15:91292869-91292869","hg19,15:g.91292869A>G",0.038,,,0.0000477581527147,
201,125,T,A,P,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
202,125,T,P,P,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,15:91292871-91292871, hg38,15:90749641-90749641","hg19,15:g.91292871A>C, hg38,15:g.90749641A>C",0.188,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
203,126,P,A,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
204,126,P,L,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
205,126,P,Q,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,COSMIC,,,,,,prostate,carcinoma,,
206,126,P,R,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
207,126,P,S,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,15:91292874-91292874, hg38,15:90749644-90749644","hg19,15:g.91292874C>T, hg38,15:g.90749644C>T",0.025,skin,"carcinoma, Merkel_cell_carcinoma",,
208,127,T,A,P,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,"cBioPortal,Manual annotations from clinvar.csv",coad_cptac_2019,Colon Adenocarcinoma,"hg19,15:91292877-91292877","hg19,15:g.91292877A>G",0.012,,,0.0000397990941726,
209,127,T,I,P,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
210,127,T,N,P,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|WW domain ligands, 122-127, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
211,128,V,I,,,,,,,,,,s,"Cks1 ligand, 123-128, ELM|FHA phosphopeptide ligands, 123-129, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
212,129,K,N,,,Ubq,,,,Sumo,,,s,"FHA phosphopeptide ligands, 123-129, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91292885-91292885","hg19,15:g.91292885G>T",0.036,,,,
213,130,K,,,,,,,,,,,s,,,,,,,,,,,,
214,131,S,F,P,,,,,,,,,s,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91292890-91292891, hg38,15:90749660-90749661","hg19,15:g.91292890_91292891delinsTT, hg38,15:g.90749660_90749661delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,
215,131,S,P,P,,,,,,,,,s,,,"cBioPortal,COSMIC",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292889-91292889, hg38,15:90749659-90749659","hg19,15:g.91292889T>C, hg38,15:g.90749659T>C",0.030,lung,"carcinoma, large_cell_carcinoma",,
216,132,R,L,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,15:91292893-91292893","hg19,15:g.91292893G>T",0.009,,,,
217,132,R,M,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91292892-91292893","hg19,15:g.91292892_91292893delinsAT",,,,,
218,132,R,Q,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","breast_ink4_msk_2021, msk_access_2021","Breast, Mixed Cancer Types","hg19,15:91292893-91292893","hg19,15:g.91292893G>A",0.020,"large_intestine, appendix","carcinoid-endocrine_tumour, goblet_cell",0.0000119402034611,0.0000637186185803
219,132,R,W,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_met_2021, sarcoma_mskcc_2022, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015","Cutaneous Melanoma, Mixed Cancer Types, Soft Tissue","hg19,15:91292892-91292892, hg38,15:90749662-90749662","hg19,15:g.91292892C>T, hg38,15:g.90749662C>T",0.145,skin,malignant_melanoma,0.0000636851406646,0.0000637064407212
220,133,D,G,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
221,133,D,N,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
222,133,D,V,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292896-91292896","hg19,15:g.91292896A>T",0.018,,,,
223,133,D,Y,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
224,134,T,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM",,,,,,,,,,,
225,135,A,P,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
226,135,A,S,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
227,135,A,T,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292901-91292901","hg19,15:g.91292901G>A",0.163,,,,
228,135,A,V,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91292902-91292902, hg38,15:90749672-90749672","hg19,15:g.91292902C>T, hg38,15:g.90749672C>T",0.064,"large_intestine, caecum","carcinoma, adenocarcinoma",,
229,136,L,V,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91292904-91292904, hg38,15:90749674-90749674","hg19,15:g.91292904C>G, hg38,15:g.90749674C>G",0.009,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
230,137,K,E,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
231,137,K,N,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91292909-91292909","hg19,15:g.91292909G>T",0.149,,,,
232,137,K,R,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749678-90749678","hg38,15:g.90749678A>G",0.106,"skin, head_neck",malignant_melanoma,0.0010227064713045,0.0038853503184713
233,138,K,R,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
234,139,L,S,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
235,140,E,G,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749687-90749687","hg38,15:g.90749687A>G",0.071,prostate,carcinoma,0.0022959325783681,0.0083121019108280
236,140,E,K,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91292916-91292916","hg19,15:g.91292916G>A",0.071,,,,
237,141,F,,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM|WW domain ligands, 141-146, ELM",,,,,,,,,,,
238,142,S,T,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|PP1-docking motif RVXF, 135-142, ELM|PP1-docking motif RVXF, 136-142, ELM|WW domain ligands, 141-146, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292923-91292923","hg19,15:g.91292923G>C",0.117,,,,
239,143,S,Y,P,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|WW domain ligands, 141-146, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91292926-91292926","hg19,15:g.91292926C>A",0.219,,,,
240,144,S,L,P,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|Cyclin N-terminal Domain Docking Motifs, 132-144, ELM|Cyclin N-terminal Domain Docking Motifs, 134-144, ELM|WW domain ligands, 141-146, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91292929-91292929, hg38,15:90749699-90749699","hg19,15:g.91292929C>T, hg38,15:g.90749699C>T",0.211,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
241,145,P,A,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
242,145,P,Q,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
243,145,P,R,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
244,146,D,A,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
245,146,D,H,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
246,146,D,V,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM|WW domain ligands, 141-146, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
247,147,S,F,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91292938-91292938, hg38,15:90749708-90749708","hg19,15:g.91292938C>T, hg38,15:g.90749708C>T",0.196,breast,"carcinoma, ER-positive_carcinoma, carcinoma, lobular_carcinoma",,
248,147,S,Y,,,,,,,,,,s,"Caspase cleavage motif, 143-147, ELM",,cBioPortal,"coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, msk_met_2021, pan_origimed_2020, ucec_cptac_2020","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91292938-91292938","hg19,15:g.91292938C>A",0.165,,,,
249,148,L,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,cBioPortal,"aml_ohsu_2018, mds_mskcc_2020","Acute Myeloid Leukemia, Myelodysplastic Syndromes","hg19,15:91292940-91292940","hg19,15:g.91292940T>A",0.025,,,,
250,149,S,,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,,,,,,,,,,
251,150,T,A,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292946-91292946","hg19,15:g.91292946A>G",0.045,,,,
252,150,T,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,"cBioPortal,COSMIC","glioma_msk_2018, kirc_tcga, kirc_tcga_pub","Diffuse Glioma, Renal Clear Cell Carcinoma","hg19,15:91292947-91292947, hg38,15:90749717-90749717","hg19,15:g.91292947C>T, hg38,15:g.90749717C>T",0.048,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
253,150,T,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292947-91292947","hg19,15:g.91292947C>A",0.068,,,,
254,151,I,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91292951-91292951, hg38,15:90749721-90749721","hg19,15:g.91292951C>G, hg38,15:g.90749721C>G",0.046,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
255,151,I,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
256,151,I,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
257,152,N,D,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
258,152,N,S,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
259,153,D,E,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,cBioPortal,ucs_jhu_2014,Uterine Carcinosarcoma/Uterine Malignant Mixed Mullerian Tumor,"hg19,15:91292957-91292957","hg19,15:g.91292957T>G",0.038,,,,
260,153,D,H,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749725-90749725","hg38,15:g.90749725G>C",0.103,oesophagus,"carcinoma, carcinoma, squamous_cell_carcinoma",0.0000079584251868,
261,153,D,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292955-91292955","hg19,15:g.91292955G>A",0.078,,,,
262,153,D,Y,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,15:91292955-91292955, hg38,15:90749725-90749725","hg19,15:g.91292955G>T, hg38,15:g.90749725G>T",0.140,stomach,"carcinoma, adenocarcinoma",,
263,154,W,C,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
264,154,W,F,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91292959-91292960","hg19,15:g.91292959_91292960delinsTT",,,,,
265,154,W,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 148-154, ELM|Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
266,155,D,Y,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
267,156,D,G,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91292965-91292965","hg19,15:g.91292965A>G",0.556,,,0.0000198970130604,
268,157,M,R,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
269,157,M,T,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
270,157,M,V,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91292967-91292967, hg38,15:90749737-90749737","hg19,15:g.91292967A>G, hg38,15:g.90749737A>G",0.020,"liver, skin","carcinoma, carcinoma, hepatocellular_carcinoma, malignant_melanoma",,
271,158,D,G,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292971-91292971","hg19,15:g.91292971A>G",0.460,,,,
272,158,D,N,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
273,159,D,E,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91292975-91292975, hg38,15:90749745-90749745","hg19,15:g.91292975C>A, hg38,15:g.90749745C>A",0.382,endometrium,"carcinoma, endometrioid_carcinoma",,
274,159,D,N,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292973-91292973","hg19,15:g.91292973G>A",0.316,,,,
275,160,F,,,,,,,,,,,s,"Atg8 protein family ligands, 153-160, ELM|Di-Tryptophan targeting motif to the Delta-COP MHD domain, 153-160, ELM",,,,,,,,,,,
276,161,D,Y,,,,,,,,,,s,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91292979-91292979","hg19,15:g.91292979G>T",0.272,,,,
277,162,T,I,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91292983-91292983","hg19,15:g.91292983C>T",0.100,,,,
278,163,S,F,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
279,163,S,Y,,,,,,,,,,s,,,"cBioPortal,COSMIC","brca_mapk_hp_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91292986-91292986, hg38,15:90749756-90749756","hg19,15:g.91292986C>A, hg38,15:g.90749756C>A",0.181,breast,"carcinoma, ductal_carcinoma",,
280,164,E,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
281,164,E,D,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292990-91292990","hg19,15:g.91292990G>T",0.018,,,,
282,164,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91292988-91292988, hg38,15:90749758-90749758","hg19,15:g.91292988G>A, hg38,15:g.90749758G>A",0.036,breast,"carcinoma, ER-positive_carcinoma, carcinoma, ductal_carcinoma",,
283,164,E,Q,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
284,165,T,S,,,,,,,,,,s,"BRCT phosphopeptide ligands, 165-169, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
285,166,S,L,,,,,,,,,,s,"BRCT phosphopeptide ligands, 165-169, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91292995-91292995","hg19,15:g.91292995C>T",0.112,,,,
286,167,K,E,,,Ubq,,,,,,,s,"BRCT phosphopeptide ligands, 165-169, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
287,167,K,R,,,Ubq,,,,,,,s,"BRCT phosphopeptide ligands, 165-169, ELM|SH3 ligand, 167-173, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91292998-91292998","hg19,15:g.91292998A>G",0.097,,,,
288,168,S,L,P,,,,,,,,,s,"WW domain ligands, 168-173, ELM|BRCT phosphopeptide ligands, 165-169, ELM|SH3 ligand, 167-173, ELM",,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, cscc_dfarber_2015, mel_mskimpact_2020, msk_met_2021","Bladder Urothelial Carcinoma, Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91293001-91293001, hg38,15:90749771-90749771","hg19,15:g.91293001C>T, hg38,15:g.90749771C>T",0.046,"skin, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,
289,169,F,C,,,,,,,,,,s,"Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|BRCT phosphopeptide ligands, 165-169, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
290,169,F,Y,,,,,,,,,,s,"Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|BRCT phosphopeptide ligands, 165-169, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
291,170,V,,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,,,,,,,,,,
292,171,T,A,P,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
293,172,P,A,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
294,172,P,S,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91293012-91293012, hg38,15:90749782-90749782","hg19,15:g.91293012C>T, hg38,15:g.90749782C>T",0.030,skin,"carcinoma, basal_cell_carcinoma",,
295,172,P,T,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|PP4 EVH1-binding docking motifs, 169-172, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,15:91293012-91293012","hg19,15:g.91293012C>A",0.070,,,,
296,173,P,H,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
297,173,P,R,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
298,173,P,T,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM|WW domain ligands, 168-173, ELM|SH3 ligand, 167-173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
299,174,Q,R,,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Cks1 ligand, 169-174, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
300,175,S,I,P,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Atg8 protein family ligands, 175-183, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,15:91293022-91293022, hg38,15:90749792-90749792","hg19,15:g.91293022G>T, hg38,15:g.90749792G>T",0.025,lung,"carcinoma, squamous_cell_carcinoma",,
301,175,S,N,P,,,,,,,,,s,"SCF ubiquitin ligase binding Phosphodegrons, 170-175, ELM|Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
302,176,H,D,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91293024-91293024, hg38,15:90749794-90749794","hg19,15:g.91293024C>G, hg38,15:g.90749794C>G",0.132,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
303,177,F,,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,,,,,,,,,,
304,178,V,I,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
305,179,R,I,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,"cBioPortal,COSMIC","lihc_tcga, lihc_tcga_pan_can_atlas_2018",Hepatocellular Carcinoma,"hg19,15:91293034-91293034, hg38,15:90749804-90749804","hg19,15:g.91293034G>T, hg38,15:g.90749804G>T",0.125,liver,"carcinoma, hepatocellular_carcinoma",,
306,180,V,,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,,,,,,,,,,
307,181,S,I,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
308,181,S,R,,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
309,182,T,A,P,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
310,182,T,I,P,,,,,,,,,s,"Atg8 protein family ligands, 175-183, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
311,183,A,,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|Atg8 protein family ligands, 175-183, ELM",,,,,,,,,,,
312,184,Q,E,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,15:91293048-91293048, hg38,15:90749818-90749818","hg19,15:g.91293048C>G, hg38,15:g.90749818C>G",0.029,breast,carcinoma,,0.0000328536697549
313,184,Q,H,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91293050-91293050, hg38,15:90749820-90749820","hg19,15:g.91293050G>C, hg38,15:g.90749820G>C",0.081,breast,"carcinoma, lobular_carcinoma",,
314,184,Q,L,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91293049-91293049, hg38,15:90749819-90749819","hg19,15:g.91293049A>T, hg38,15:g.90749819A>T",0.075,lung,"carcinoma, squamous_cell_carcinoma",,
315,185,K,I,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,COSMIC,,,"hg38,15:90749822-90749822","hg38,15:g.90749822A>T",0.129,"haematopoietic_and_lymphoid_tissue, breast","lymphoid_neoplasm, breast_implant_associated_anaplastic_large_cell_lymphoma_invasive, ALK_negative",,
316,185,K,N,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
317,186,S,P,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
318,187,K,E,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
319,187,K,N,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
320,187,K,Q,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,COSMIC,,,"hg38,15:90749827-90749827","hg38,15:g.90749827A>C",0.084,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
321,187,K,T,,,,,,,,,,s,"USP7 binding motif, 183-187, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293058-91293058","hg19,15:g.91293058A>C",0.092,,,,
322,188,K,N,,,,,,,,,,s,"NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
323,188,K,R,,,,,,,,,,s,"NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,15:91293061-91293061, hg38,15:90749831-90749831","hg19,15:g.91293061A>G, hg38,15:g.90749831A>G",0.038,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000042758066309,
324,189,G,D,,,,,,,,,,s,"NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
325,189,G,S,,,,,,,,,,s,"NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
326,190,K,E,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91293066-91293066, hg38,15:90749836-90749836","hg19,15:g.91293066A>G, hg38,15:g.90749836A>G",0.120,lung,"carcinoma, adenocarcinoma, carcinoma, non_small_cell_carcinoma",,
327,190,K,N,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
328,191,R,G,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91293069-91293069, hg38,15:90749839-90749839","hg19,15:g.91293069A>G, hg38,15:g.90749839A>G",0.096,lung,"carcinoma, adenocarcinoma",,
329,191,R,I,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM|NLS classical Nuclear Localization Signals, 186-191, ELM|NLS classical Nuclear Localization Signals, 185-191, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_met_2021, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91293070-91293070, hg38,15:90749840-90749840","hg19,15:g.91293070G>T, hg38,15:g.90749840G>T",0.078,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing",0.0000084984150456,
330,192,N,T,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,COSMIC,,,"hg38,15:90749843-90749843","hg38,15:g.90749843A>C",0.023,kidney,"carcinoma, renal_cell_carcinoma_unclassified",,
331,192,N,Y,,,,,,,,,,s,"PCSK cleavage site, 190-192, ELM|PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
332,193,F,L,,,,,,,,,,s,"PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
333,194,F,L,,,,,,,,,,s,"PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
334,194,F,V,,,,,,,,,,s,"PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91293078-91293078","hg19,15:g.91293078T>G",0.029,,,,
335,195,K,,,Me,,,,,Sumo,,,s,"PCSK cleavage site, 191-195, ELM|RIR motif, 191-199, ELM",,,,,,,,,,,
336,196,A,E,,,,,,,,,,s,"RIR motif, 191-199, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
337,196,A,T,,,,,,,,,,s,"RIR motif, 191-199, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91293084-91293084, hg38,15:90749854-90749854","hg19,15:g.91293084G>A, hg38,15:g.90749854G>A",0.049,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
338,197,Q,L,,,,,,,,,,s,"RIR motif, 191-199, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293088-91293088","hg19,15:g.91293088A>T",0.007,,,,
339,198,L,R,,,,,,,,,,s,"RIR motif, 191-199, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91293091-91293091","hg19,15:g.91293091T>G",0.012,,,,
340,198,L,V,,,,,,,,,,s,"RIR motif, 191-199, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
341,199,Y,,P,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|RIR motif, 191-199, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,,,,,,,,,,
342,200,T,A,,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
343,200,T,S,,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
344,201,T,A,P,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293099-91293099","hg19,15:g.91293099A>G",0.064,,,,
345,202,N,D,,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
346,202,N,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
347,202,N,S,,,,,,,,,,s,"FHA phosphopeptide ligands, 199-205, ELM|Phosphotyrosine ligands bound by SH2 domains, 199-202, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018",Breast,"hg19,15:91293103-91293103, hg38,15:90749873-90749873","hg19,15:g.91293103A>G, hg38,15:g.90749873A>G",0.014,breast,"carcinoma, ductal_carcinoma",,
348,203,T,A,,,,,,,,,,d,"FHA phosphopeptide ligands, 199-205, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
349,204,V,I,,,,,,,,,,d,"FHA phosphopeptide ligands, 199-205, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91293108-91293108","hg19,15:g.91293108G>A",0.018,,,,
350,205,K,N,,,,,,,,,,d,"FHA phosphopeptide ligands, 199-205, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
351,205,K,R,,,,,,,,,,d,"FHA phosphopeptide ligands, 199-205, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
352,206,T,A,,,,,,,,,,d,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293114-91293114","hg19,15:g.91293114A>G",0.018,,,,
353,207,D,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
354,208,L,W,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
355,209,P,L,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90749894-90749894","hg38,15:g.90749894C>T",0.044,stomach,"carcinoma, adenocarcinoma",,
356,210,P,L,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,cBioPortal,skcm_mskcc_2014,Cutaneous Melanoma,"hg19,15:91293127-91293127","hg19,15:g.91293127C>T",0.023,,,,
357,210,P,S,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91293126-91293126","hg19,15:g.91293126C>T",0.003,,,,
358,211,P,L,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
359,211,P,S,,,,,,,,,,d,"Calcineurin (PP2B)-docking motif LxvP, 208-211, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91293129-91293129","hg19,15:g.91293129C>T",0.016,,,,
360,212,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91293133-91293133, hg38,15:90749903-90749903, hg38,15:90749903-90749904","hg19,15:g.91293133C>T, hg38,15:g.90749903C>T, hg38,15:g.90749903_90749904delinsTT",0.120,"skin, skin, scalp",malignant_melanoma,0.0000199252404977,0.0000318491623670
361,213,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91293136-91293136, hg38,15:90749906-90749906","hg19,15:g.91293136C>T, hg38,15:g.90749906C>T",0.036,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
362,214,E,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
363,215,S,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
364,216,E,K,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
365,217,Q,H,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
366,217,Q,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
367,218,I,,,,,,,,,,,d,,,,,,,,,,,,
368,219,D,A,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293154-91293154","hg19,15:g.91293154A>C",0.079,,,,
369,219,D,E,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
370,219,D,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
371,219,D,H,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
372,220,L,F,,,,,,,,,,d,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022","Bladder Urothelial Carcinoma, Endometrial Carcinoma, Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91293158-91293158, hg38,15:90749928-90749928","hg19,15:g.91293158G>T, hg38,15:g.90749928G>T",0.064,"urinary_tract, bladder",carcinoma,,
373,221,T,I,,,,,,,,,,d,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad, cellline_nci60",Mixed Cancer Types,"hg19,15:91293160-91293160, hg38,15:90749930-90749930","hg19,15:g.91293160C>T, hg38,15:g.90749930C>T",0.082,"skin, subungual","malignant_melanoma, acral_lentiginous",,
374,221,T,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
375,221,T,S,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
376,222,E,K,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293162-91293162","hg19,15:g.91293162G>A",0.023,,,0.0000756640516108,
377,223,E,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
378,223,E,K,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
379,224,Q,H,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
380,224,Q,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
381,224,Q,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
382,225,K,N,,,Ubq,,,,,,,d,,,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91293173-91293173, hg38,15:90749943-90749943","hg19,15:g.91293173G>T, hg38,15:g.90749943G>T",0.060,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
383,226,D,Y,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
384,227,D,N,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,15:91293177-91293177","hg19,15:g.91293177G>A",0.086,,,,
385,228,S,,,,,,,,,,,s,,,,,,,,,,,,
386,229,E,K,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,15:91293183-91293183, hg38,15:90749953-90749953","hg19,15:g.91293183G>A, hg38,15:g.90749953G>A",0.044,breast,carcinoma,,
387,229,E,Q,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
388,230,W,C,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
389,230,W,R,,,,,,,,,,s,,,cBioPortal,hcc_meric_2021,Hepatocellular Carcinoma,"hg19,15:91293186-91293186","hg19,15:g.91293186T>C",0.028,,,0.0000079625441921,
390,231,L,,,,,,,,,,,s,,,,,,,,,,,,
391,232,S,C,,,,,,,,,,s,,,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,15:91293192-91293192, hg38,15:90749962-90749962","hg19,15:g.91293192A>T, hg38,15:g.90749962A>T",0.055,breast,carcinoma,,
392,232,S,I,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91293193-91293193","hg19,15:g.91293193G>T",0.061,,,,
393,232,S,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
394,233,S,,,,,,,,,,,s,,,,,,,,,,,,
395,234,D,E,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
396,234,D,N,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,15:91293198-91293198","hg19,15:g.91293198G>A",0.097,,,,0.0000318390219052
397,234,D,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
398,235,V,M,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
399,236,I,L,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
400,236,I,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
401,236,I,V,,,,,,,,,,s,,,cBioPortal,egc_msk_tp53_ccr_2022,Esophagogastric Adenocarcinoma,"hg19,15:91293204-91293204","hg19,15:g.91293204A>G",0.038,,,,
402,237,C,,,,,,,,,,,s,,,,,,,,,,,,
403,238,I,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
404,238,I,V,,,,,,,,,,s,,,cBioPortal,"msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,15:91293210-91293210","hg19,15:g.91293210A>G",0.006,,,,
405,239,D,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
406,239,D,H,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91293213-91293213, hg38,15:90749983-90749983","hg19,15:g.91293213G>C, hg38,15:g.90749983G>C",0.136,"stomach, urinary_tract, upper_urinary_tract","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",0.0000199190489849,
407,239,D,N,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv","blca_tcga_pub_2017, cellline_ccle_broad, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91293213-91293213","hg19,15:g.91293213G>A",0.120,,,0.0001075628645186,0.0000636739891754
408,239,D,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
409,240,D,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
410,240,D,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
411,241,G,D,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",difg_glass_2019,Diffuse Glioma,"hg19,15:91293220-91293220, hg38,15:90749990-90749990","hg19,15:g.91293220G>A, hg38,15:g.90749990G>A",0.016,"pancreas, ampulla_of_Vater",carcinoma,0.0000279000063771,0.0000318390219052
412,242,P,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
413,242,P,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
414,243,I,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
415,243,I,V,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91293225-91293225","hg19,15:g.91293225A>G",0.021,,,0.0000119578128363,0.0000636861546300
416,244,A,V,,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91293229-91293229","hg19,15:g.91293229C>T",0.030,,,0.0000039875270155,
417,245,E,K,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91293231-91293231","hg19,15:g.91293231G>A",0.016,,,,
418,246,V,L,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
419,247,H,,,,,,,,,,,s,,,,,,,,,,,,
420,248,I,L,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
421,248,I,V,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,15:91293240-91293240, hg38,15:90750010-90750010","hg19,15:g.91293240A>G, hg38,15:g.90750010A>G",0.027,lung,"carcinoma, undifferentiated_carcinoma",0.0000838557680789,
422,249,N,,,,,,,,,,,s,,,,,,,,,,,,
423,250,E,,,,,,,,,,,d,,,,,,,,,,,,
424,251,D,E,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90750021-90750021","hg38,15:g.90750021T>A",0.071,liver,carcinoma,,
425,251,D,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
426,251,D,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
427,252,A,T,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
428,252,A,V,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91293253-91293253, hg38,15:90750023-90750023","hg19,15:g.91293253C>T, hg38,15:g.90750023C>T",0.131,endometrium,"carcinoma, endometrioid_carcinoma",,
429,253,Q,,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,,,,,,,,,,
430,254,E,Q,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
431,255,S,G,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90750031-90750031","hg38,15:g.90750031A>G",0.015,lung,"carcinoma, non_small_cell_carcinoma",,
432,255,S,N,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91293262-91293262, hg38,15:90750032-90750032","hg19,15:g.91293262G>A, hg38,15:g.90750032G>A",0.074,skin,"carcinoma, squamous_cell_carcinoma",,
433,256,D,,,,,,,,,,,d,"USP7 binding motif, 252-256, ELM",,,,,,,,,,,
434,257,S,C,,,,,,,,,,d,,,cBioPortal,"luad_msk_npjpo_2021, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91293268-91293268","hg19,15:g.91293268C>G",0.070,,,,
435,257,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC","pancan_pcawg_2020, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91293268-91293268, hg38,15:90750038-90750038","hg19,15:g.91293268C>T, hg38,15:g.90750038C>T",0.078,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
436,258,L,M,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
437,259,K,,,,Ubq,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,,,,,,,,,,
438,260,T,N,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
439,261,H,N,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91293279-91293279","hg19,15:g.91293279C>A",0.030,,,,
440,261,H,R,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
441,261,H,Y,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,"cBioPortal,Manual annotations from clinvar.csv","egc_trap_msk_2020, msk_met_2021","Esophagogastric Adenocarcinoma, Mixed Cancer Types","hg19,15:91293279-91293279","hg19,15:g.91293279C>T",0.040,,,,
442,262,L,,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,,,,,,,,,,
443,263,E,,,,,,,,,,,d,"FHA phosphopeptide ligands, 258-264, ELM",,,,,,,,,,,
444,264,D,N,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM|FHA phosphopeptide ligands, 258-264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
445,265,E,G,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91293292-91293292","hg19,15:g.91293292A>G",0.123,,,,
446,265,E,K,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91293291-91293291","hg19,15:g.91293291G>A",0.039,,,,
447,265,E,Q,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015, breast_ink4_msk_2021","Breast, Invasive Breast Carcinoma","hg19,15:91293291-91293291, hg38,15:90750061-90750061","hg19,15:g.91293291G>C, hg38,15:g.90750061G>C",0.038,breast,carcinoma,,
448,266,R,G,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
449,266,R,T,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,cBioPortal,"lung_msk_mind_2020, msk_met_2021","Lung, Mixed Cancer Types","hg19,15:91293295-91293295","hg19,15:g.91293295G>C",0.038,,,,
450,267,D,,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,,,,,,,,,,
451,268,N,S,,,,,,,,,,d,"Caspase cleavage motif, 264-268, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
452,269,S,G,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
453,269,S,N,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
454,269,S,T,P,,,,,,,,,d,,,cBioPortal,"esca_tcga, esca_tcga_pan_can_atlas_2018, stes_tcga_pub","Esophageal Adenocarcinoma, Esophagogastric Adenocarcinoma","hg19,15:91295023-91295023","hg19,15:g.91295023G>C",0.006,,,,
455,270,E,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
456,270,E,K,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
457,271,K,E,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
458,271,K,R,,,,,,,,,,d,,,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91295029-91295029, hg38,15:90751799-90751799","hg19,15:g.91295029A>G, hg38,15:g.90751799A>G",0.037,"large_intestine, caecum","carcinoma, adenocarcinoma",,
459,272,K,N,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90751803-90751803","hg38,15:g.90751803G>T",0.056,liver,"other, neoplasm",,
460,272,K,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
461,273,K,N,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91295036-91295036, hg38,15:90751806-90751806","hg19,15:g.91295036G>T, hg38,15:g.90751806G>T",0.027,endometrium,"carcinoma, endometrioid_carcinoma",,
462,273,K,R,,,,,,,,,,d,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,15:91295035-91295035, hg38,15:90751805-90751805","hg19,15:g.91295035A>G, hg38,15:g.90751805A>G",0.021,lung,"carcinoma, squamous_cell_carcinoma",,
463,274,N,D,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
464,274,N,Y,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
465,275,L,V,,,,,,,,,,d,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91295040-91295040","hg19,15:g.91295040T>G",0.033,,,,
466,276,E,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
467,277,E,,,,,,,,,,,d,,,,,,,,,,,,
468,278,A,T,,,,,,,,,,d,,,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91295049-91295049","hg19,15:g.91295049G>A",0.028,,,,
469,278,A,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
470,279,E,K,,,,,,,,,,d,,,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,15:91295052-91295052, hg38,15:90751822-90751822","hg19,15:g.91295052G>A, hg38,15:g.90751822G>A",0.159,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
471,280,L,,,,,,,,,,,d,,,,,,,,,,,,
472,281,H,P,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",prad_mskcc,Prostate Adenocarcinoma,"hg19,15:91295059-91295059, hg38,15:90751829-90751829","hg19,15:g.91295059A>C, hg38,15:g.90751829A>C",0.025,prostate,"carcinoma, adenocarcinoma",0.0001034842345749,0.0001592559561728
473,281,H,Q,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
474,281,H,R,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
475,282,S,,P,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,,,,,,,,,,
476,283,T,A,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
477,283,T,S,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
478,284,E,K,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,cBioPortal,"brca_mbcproject_2022, brca_mbcproject_wagle_2017",Invasive Breast Carcinoma,"hg19,15:91295067-91295067","hg19,15:g.91295067G>A",0.048,,,,
479,285,K,,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,,,,,,,,,,
480,286,V,D,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,15:91295074-91295074","hg19,15:g.91295074T>A",0.019,,,,
481,286,V,F,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
482,287,P,S,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,"cBioPortal,COSMIC",skcm_yale,Cutaneous Melanoma,"hg19,15:91295076-91295076, hg38,15:90751846-90751846","hg19,15:g.91295076C>T, hg38,15:g.90751846C>T",0.095,skin,malignant_melanoma,,
483,287,P,T,,,,,,,,,,d,"FHA phosphopeptide ligands, 281-287, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
484,288,C,F,,,,,,,,,,d,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91295080-91295080, hg38,15:90751850-90751850","hg19,15:g.91295080G>T, hg38,15:g.90751850G>T",0.063,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
485,288,C,S,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
486,288,C,Y,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90751850-90751850","hg38,15:g.90751850G>A",0.038,prostate,"carcinoma, adenocarcinoma",,
487,289,I,F,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91295082-91295082","hg19,15:g.91295082A>T",0.023,,,,
488,289,I,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
489,290,E,K,,,,,,,,,,d,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91295085-91295085","hg19,15:g.91295085G>A",0.143,,,,
490,291,F,C,,,,,,,,,,d,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91295089-91295089","hg19,15:g.91295089T>G",0.064,,,,
491,291,F,Y,,,,,,,,,,d,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91295089-91295089","hg19,15:g.91295089T>A",0.039,,,,
492,292,D,G,,,,,,,,,,s,,,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,15:91295092-91295092, hg38,15:90751862-90751862","hg19,15:g.91295092A>G, hg38,15:g.90751862A>G",0.038,stomach,"carcinoma, adenocarcinoma",,
493,292,D,H,,,,,,,,,,s,,,cBioPortal,"msk_access_2021, msk_met_2021",Mixed Cancer Types,"hg19,15:91295091-91295091","hg19,15:g.91295091G>C",0.062,,,,
494,293,D,,,,,,,,,,,s,,,,,,,,,,,,
495,294,D,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
496,294,D,N,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",hnsc_broad,Head and Neck Squamous Cell Carcinoma,"hg19,15:91295097-91295097","hg19,15:g.91295097G>A",0.039,,,,
497,295,D,E,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
498,295,D,N,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91295100-91295100, hg38,15:90751870-90751870","hg19,15:g.91295100G>A, hg38,15:g.90751870G>A",0.076,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000039799094173,0.0000318654005481
499,295,D,Y,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,15:91295100-91295100, hg38,15:90751870-90751870","hg19,15:g.91295100G>T, hg38,15:g.90751870G>T",0.221,"large_intestine, colon","carcinoma, adenocarcinoma",0.0000159196376690,0.0000318654005481
500,296,Y,C,P,,,,,,,,,s,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
501,296,Y,D,P,,,,,,,,,s,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
502,296,Y,F,P,,,,,,,,,s,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90751874-90751874","hg38,15:g.90751874A>T",0.016,prostate,carcinoma,0.0000238785061607,
503,296,Y,H,P,,,,,,,,,s,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
504,297,D,N,,,,,,,,,,D,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,15:91295106-91295106, hg38,15:90751876-90751876","hg19,15:g.91295106G>A, hg38,15:g.90751876G>A",0.080,"urinary_tract, bladder","carcinoma, small_cell_carcinoma",,
505,298,T,M,,,,,,,,,,D,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90751880-90751880","hg38,15:g.90751880C>T",0.022,"breast, large_intestine, stomach","adenoma, carcinoma, carcinoma, adenocarcinoma",0.0098186709969115,0.0057987637800293
506,299,D,G,,,,,,,,,,D,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM|SH3 ligand, 299-305, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
507,299,D,N,,,,,,,,,,D,"FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM|SH3 ligand, 299-305, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,15:91295112-91295112, hg38,15:90751882-90751882","hg19,15:g.91295112G>A, hg38,15:g.90751882G>A",0.173,"upper_aerodigestive_tract, head_neck",carcinoma,0.0000039800044576,
508,300,F,C,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 300-303, ELM|FHA phosphopeptide ligands, 296-302, ELM|Phosphotyrosine ligands bound by SH2 domains, 296-300, ELM|SH3 ligand, 299-305, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91295116-91295116, hg38,15:90751886-90751886","hg19,15:g.91295116T>G, hg38,15:g.90751886T>G",0.072,endometrium,"carcinoma, endometrioid_carcinoma",,
509,301,V,,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 300-303, ELM|WW domain ligands, 301-306, ELM|FHA phosphopeptide ligands, 296-302, ELM|SH3 ligand, 299-305, ELM",,,,,,,,,,,
510,302,P,L,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 300-303, ELM|WW domain ligands, 301-306, ELM|FHA phosphopeptide ligands, 296-302, ELM|SH3 ligand, 299-305, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
511,303,P,S,,,,,,,,,,C,"PP4 EVH1-binding docking motifs, 300-303, ELM|WW domain ligands, 301-306, ELM|SH3 ligand, 299-305, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91295124-91295124","hg19,15:g.91295124C>T",0.364,,,,
512,304,S,A,P,,,,,,,,,S,"WW domain ligands, 301-306, ELM|SH3 ligand, 299-305, ELM|TRAF2 binding site, 304-307, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
513,304,S,Y,P,,,,,,,,,S,"WW domain ligands, 301-306, ELM|SH3 ligand, 299-305, ELM|TRAF2 binding site, 304-307, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91295128-91295128","hg19,15:g.91295128C>A",0.401,,,,
514,305,P,R,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|WW domain ligands, 301-306, ELM|SH3 ligand, 299-305, ELM|TRAF2 binding site, 304-307, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
515,305,P,S,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|WW domain ligands, 301-306, ELM|SH3 ligand, 299-305, ELM|TRAF2 binding site, 304-307, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91295130-91295130, hg38,15:90751900-90751900","hg19,15:g.91295130C>T, hg38,15:g.90751900C>T",0.403,skin,"carcinoma, squamous_cell_carcinoma",,
516,306,E,G,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|WW domain ligands, 301-306, ELM|TRAF2 binding site, 304-307, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
517,306,E,K,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|WW domain ligands, 301-306, ELM|TRAF2 binding site, 304-307, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91295133-91295133","hg19,15:g.91295133G>A",0.110,,,,
518,307,E,A,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|TRAF2 binding site, 304-307, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91295137-91295137","hg19,15:g.91295137A>C",0.158,,,,
519,307,E,G,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM|TRAF2 binding site, 304-307, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91295137-91295137","hg19,15:g.91295137A>G",0.107,,,,
520,308,I,S,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM",,cBioPortal,"mixed_cfdna_msk_2020, msk_met_2021, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91295140-91295140","hg19,15:g.91295140T>G",0.019,,,,
521,308,I,V,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
522,309,I,F,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91295142-91295142","hg19,15:g.91295142A>T",0.049,,,,
523,309,I,T,,,,,,,,,,C,"USP7 binding motif, 305-311, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
524,310,S,C,,,,,,,,,,s,"USP7 binding motif, 305-311, ELM",,cBioPortal,"cesc_tcga, cesc_tcga_pan_can_atlas_2018",Cervical Squamous Cell Carcinoma,"hg19,15:91295146-91295146","hg19,15:g.91295146C>G",0.209,,,,
525,311,A,P,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM|USP7 binding motif, 305-311, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91295148-91295148","hg19,15:g.91295148G>C",0.034,,,,
526,311,A,S,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM|USP7 binding motif, 305-311, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
527,312,S,A,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
528,312,S,T,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
529,313,S,,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,,,,,,,,,,
530,314,S,,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,,,,,,,,,,
531,315,S,F,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91295161-91295161","hg19,15:g.91295161C>T",0.189,,,,
532,315,S,Y,,,,,,,,,,s,"SPOP SBC docking motif, 311-315, ELM|USP7 binding motif, 311-315, ELM",,COSMIC,,,"hg38,15:90751931-90751931","hg38,15:g.90751931C>A",0.199,"urinary_tract, bladder",carcinoma,,
533,316,S,,,,,,,,,,,s,,,,,,,,,,,,
534,317,K,,,,,,,,Sumo,,,s,,,,,,,,,,,,
535,318,C,S,,,,,,,,,,s,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91295170-91295170, hg38,15:90751940-90751940","hg19,15:g.91295170G>C, hg38,15:g.90751940G>C",0.059,large_intestine,"carcinoma, adenocarcinoma",,
536,318,C,W,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
537,319,L,F,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
538,320,S,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91295176-91295176","hg19,15:g.91295176G>A",0.087,,,,
539,320,S,T,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
540,321,T,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,cBioPortal,"msk_access_2021, msk_met_2021",Mixed Cancer Types,"hg19,15:91298043-91298043","hg19,15:g.91298043C>T",0.052,,,0.0000119768128902,
541,322,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,,,,,,,,,,
542,323,K,N,,,Ubq,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,cBioPortal,"metastatic_solid_tumors_mich_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91298050-91298050","hg19,15:g.91298050G>C, hg19,15:g.91298050G>T",0.086,,,,
543,323,K,Q,,,Ubq,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
544,323,K,R,,,Ubq,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90754819-90754819","hg38,15:g.90754819A>G",0.113,prostate,carcinoma,0.0003708429699338,0.0005094892370399
545,324,D,,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,,,,,,,,,,
546,325,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 319-325, ELM",,,,,,,,,,,
547,326,D,N,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
548,327,T,N,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
549,327,T,S,P,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91298061-91298061","hg19,15:g.91298061C>G",0.045,,,,
550,328,S,A,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
551,328,S,C,P,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, breast_ink4_msk_2021","Bladder Urothelial Carcinoma, Breast","hg19,15:91298064-91298064, hg38,15:90754834-90754834","hg19,15:g.91298064C>G, hg38,15:g.90754834C>G",0.023,"urinary_tract, bladder",carcinoma,,
552,328,S,F,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
553,329,D,H,,,,,,,,,,s,"NRD cleavage site, 329-331, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91298066-91298066","hg19,15:g.91298066G>C",0.054,,,,
554,329,D,N,,,,,,,,,,s,"NRD cleavage site, 329-331, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
555,330,R,K,,,,,,,,,,s,"NRD cleavage site, 329-331, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91298070-91298070","hg19,15:g.91298070G>A",0.014,,,,
556,331,K,E,,,Ubq,,,,Sumo,,,s,"NRD cleavage site, 329-331, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
557,331,K,T,,,Ubq,,,,Sumo,,,s,"NRD cleavage site, 329-331, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
558,332,E,Q,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
559,332,E,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
560,333,D,E,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91298080-91298080","hg19,15:g.91298080T>A",0.019,,,,
561,333,D,Y,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
562,334,V,D,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
563,334,V,I,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91298081-91298081, hg38,15:90754851-90754851","hg19,15:g.91298081G>A, hg38,15:g.90754851G>A",0.049,endometrium,"carcinoma, endometrioid_carcinoma",,
564,335,L,F,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,"cBioPortal,COSMIC","msk_met_2021, skcm_tcga, skcm_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91298083-91298084, hg19,15:91298084-91298084, hg38,15:90754854-90754854","hg19,15:g.91298083_91298084delinsAT, hg19,15:g.91298084C>T, hg38,15:g.90754854C>T",0.086,skin,malignant_melanoma,,
565,335,L,V,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
566,336,S,G,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
567,336,S,N,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
568,337,T,I,,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
569,338,S,A,P,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
570,338,S,L,P,,,,,,,,,s,"SPOP SBC docking motif, 334-338, ELM|FHA phosphopeptide ligands, 335-341, ELM",,cBioPortal,hcc_meric_2021,Hepatocellular Carcinoma,"hg19,15:91298094-91298094","hg19,15:g.91298094C>T",0.130,,,,
571,339,K,E,,,Ubq,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
572,339,K,N,,,Ubq,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,cBioPortal,"msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91298098-91298098","hg19,15:g.91298098A>C",0.031,,,,
573,340,D,E,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
574,340,D,H,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
575,340,D,N,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90754869-90754869","hg38,15:g.90754869G>A",0.109,breast,"carcinoma, ductal_carcinoma",,
576,340,D,Y,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91298099-91298099, hg38,15:90754869-90754869","hg19,15:g.91298099G>T, hg38,15:g.90754869G>T",0.029,"endometrium, thyroid","carcinoma, carcinoma, endometrioid_carcinoma",,
577,341,L,F,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91298102-91298102, hg38,15:90754872-90754872","hg19,15:g.91298102C>T, hg38,15:g.90754872C>T",0.172,skin,"carcinoma, basal_cell_carcinoma",,
578,341,L,I,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM|FHA phosphopeptide ligands, 335-341, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91298102-91298102, hg38,15:90754872-90754872","hg19,15:g.91298102C>A, hg38,15:g.90754872C>A",0.162,"large_intestine, caecum","carcinoma, adenocarcinoma",,
579,342,L,S,,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
580,343,S,A,P,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
581,343,S,L,P,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91298109-91298109, hg38,15:90754879-90754879","hg19,15:g.91298109C>T, hg38,15:g.90754879C>T",0.107,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000119520007649,
582,343,S,T,P,,,,,,,,,s,"PCSK cleavage site, 339-343, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
583,344,K,N,,,Ubq,,,,Sumo,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
584,345,P,H,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91298115-91298115","hg19,15:g.91298115C>A",0.051,,,,
585,346,E,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
586,346,E,K,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90754887-90754887","hg38,15:g.90754887G>A",0.025,oesophagus,"carcinoma, squamous_cell_carcinoma",,
587,347,K,E,,,,,,,Sumo,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
588,347,K,N,,,,,,,Sumo,,,s,,,"cBioPortal,COSMIC","ccle_broad_2019, cellline_nci60",Mixed Cancer Types,"hg19,15:91298122-91298122, hg38,15:90754892-90754892","hg19,15:g.91298122A>C, hg38,15:g.90754892A>C",0.022,large_intestine,"carcinoma, adenocarcinoma",,
589,348,M,I,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91298125-91298125, hg38,15:90754895-90754895","hg19,15:g.91298125G>A, hg19,15:g.91298125G>T, hg38,15:g.90754895G>A",0.022,"cervix, haematopoietic_and_lymphoid_tissue, stomach","adenoma, carcinoma, squamous_cell_carcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0002431460709987,0.0001592356687898
590,348,M,V,,,,,,,,,,s,,,"cBioPortal,COSMIC","kirp_tcga, kirp_tcga_pan_can_atlas_2018",Papillary Renal Cell Carcinoma,"hg19,15:91298123-91298123, hg38,15:90754893-90754893","hg19,15:g.91298123A>G, hg38,15:g.90754893A>G",0.093,kidney,"carcinoma, papillary_renal_cell_carcinoma",0.0000039848257834,
591,349,S,G,P,,,,,,,,,s,"TRAF2 binding site, 349-352, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
592,349,S,N,P,,,,,,,,,s,"TRAF2 binding site, 349-352, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
593,350,M,I,,,,,,,,,,s,"TRAF2 binding site, 349-352, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91298131-91298131, hg38,15:90754901-90754901","hg19,15:g.91298131G>A, hg38,15:g.90754901G>A",0.016,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039855563438,
594,351,Q,,,,,,,,,,,s,"TRAF2 binding site, 349-352, ELM",,,,,,,,,,,
595,352,E,K,,,,,,,,,,s,"TRAF2 binding site, 349-352, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
596,353,L,V,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",odg_msk_2017,Oligodendroglioma,"hg19,15:91298138-91298138","hg19,15:g.91298138C>G",0.010,,,,
597,354,N,K,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91298143-91298143","hg19,15:g.91298143T>G",0.023,,,,
598,355,P,A,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
599,355,P,L,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91298144-91298145, hg38,15:90754914-90754915","hg19,15:g.91298144_91298145delinsTT, hg38,15:g.90754914_90754915delinsTT",,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
600,355,P,R,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
601,355,P,S,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM",,cBioPortal,skcm_dfci_2015,Cutaneous Melanoma,"hg19,15:91298144-91298144","hg19,15:g.91298144C>T",0.055,,,,
602,356,E,K,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM",,COSMIC,,,"hg38,15:90754917-90754917","hg38,15:g.90754917G>A",0.109,lung,"carcinoma, small_cell_carcinoma",,
603,357,T,I,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
604,358,S,I,P,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
605,358,S,R,P,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
606,359,T,K,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91298157-91298157","hg19,15:g.91298157C>A",0.034,,,,
607,359,T,P,,,,,,,,,,s,"SPOP SBC docking motif, 355-359, ELM|USP7 binding motif, 355-359, ELM|FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
608,360,D,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91298159-91298159","hg19,15:g.91298159G>A",0.041,,,,
609,361,C,Y,,,,,,,,,,s,"FHA phosphopeptide ligands, 355-361, ELM|FHA phosphopeptide ligands, 357-363, ELM",,"cBioPortal,COSMIC",uccc_nih_2017,Uterine Clear Cell Carcinoma,"hg19,15:91298163-91298163, hg38,15:90754933-90754933","hg19,15:g.91298163G>A, hg38,15:g.90754933G>A",0.039,endometrium,"carcinoma, clear_cell_carcinoma",,
610,362,D,,,,,,,,,,,C,"FHA phosphopeptide ligands, 357-363, ELM",,,,,,,,,,,
611,363,A,S,,,,,,,,,,C,"FHA phosphopeptide ligands, 357-363, ELM",,COSMIC,,,"hg38,15:90754938-90754938","hg38,15:g.90754938G>T",0.076,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
612,363,A,T,,,,,,,,,,C,"FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
613,363,A,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 357-363, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
614,364,R,K,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
615,365,Q,L,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,COSMIC,,,"hg38,15:90760153-90760153","hg38,15:g.90760153A>T",0.034,liver,"other, neoplasm",,
616,366,I,L,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
617,366,I,T,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760156-90760156","hg38,15:g.90760156T>C",0.005,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0001910143658721,0.0001278200293986
618,367,S,N,P,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
619,368,L,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,,,,,,,,,,
620,369,Q,H,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303396-91303396","hg19,15:g.91303396G>C",0.125,,,,
621,369,Q,K,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 364-369, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
622,370,Q,P,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
623,371,Q,,,,,,,,,,,S,,,,,,,,,,,,
624,372,L,F,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
625,372,L,I,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
626,373,I,N,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
627,373,I,V,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
628,374,H,D,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760179-90760179","hg38,15:g.90760179C>G",0.033,oesophagus,"carcinoma, squamous_cell_carcinoma",,
629,374,H,R,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
630,374,H,Y,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,COSMIC,,,"hg38,15:90760179-90760179","hg38,15:g.90760179C>T",0.039,thyroid,"carcinoma, papillary_carcinoma",,
631,375,V,L,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
632,376,M,L,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
633,376,M,T,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
634,377,E,D,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91303420-91303420","hg19,15:g.91303420G>T",0.034,,,,
635,377,E,Q,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91303418-91303418, hg38,15:90760188-90760188","hg19,15:g.91303418G>C, hg38,15:g.90760188G>C",0.203,"urinary_tract, bladder",carcinoma,,
636,378,H,N,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303421-91303421","hg19,15:g.91303421C>A",0.106,,,,
637,378,H,Y,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 372-378, ELM|Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
638,379,I,M,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 372-381, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303426-91303426","hg19,15:g.91303426C>G",0.275,,,,
639,379,I,S,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
640,379,I,V,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 372-381, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
641,380,C,S,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 372-381, ELM",,COSMIC,,,"hg38,15:90760198-90760198","hg38,15:g.90760198G>C",0.795,thyroid,carcinoma,,
642,381,K,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 372-381, ELM",,,,,,,,,,,
643,382,L,,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 382-390, ELM",,,,,,,,,,,
644,383,I,T,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,"cBioPortal,Manual annotations from clinvar.csv",acc_2019,Adrenocortical Carcinoma,"hg19,15:91303437-91303437","hg19,15:g.91303437T>C",0.169,,,0.0000079539940981,0.0000318430773150
645,383,I,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
646,384,D,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
647,384,D,Y,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,"cBioPortal,COSMIC","msk_impact_2017, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91303439-91303439, hg38,15:90760209-90760209","hg19,15:g.91303439G>T, hg38,15:g.90760209G>T",0.750,"urinary_tract, urethra","carcinoma, squamous_cell_carcinoma",,
648,385,T,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
649,385,T,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
650,386,I,M,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91303447-91303447","hg19,15:g.91303447T>G",0.307,,,,
651,386,I,S,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
652,386,I,T,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303446-91303446","hg19,15:g.91303446T>C",0.338,,,,
653,386,I,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
654,387,P,,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,,,,,,,,,,
655,388,D,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,COSMIC,,,"hg38,15:90760221-90760221","hg38,15:g.90760221G>C",0.067,oesophagus,"carcinoma, squamous_cell_carcinoma",,
656,388,D,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303452-91303452","hg19,15:g.91303452A>T",0.043,,,,
657,389,D,G,,,,,,,,,,C,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
658,389,D,H,,,,,,,,,,C,"FHA phosphopeptide ligands, 383-389, ELM|Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
659,390,K,T,,,Ubq,,,,,,,S,"Binding motif for UBA3 adenylation domain, 382-390, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
660,391,L,,,,,,,,,,,S,,,,,,,,,,,,
661,392,K,,,,,,,,Sumo,,,S,,,,,,,,,,,,
662,393,L,F,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
663,393,L,I,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
664,394,L,V,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303469-91303469","hg19,15:g.91303469T>G",0.435,,,,
665,395,D,,,,,,,,,,,S,,,,,,,,,,,,
666,396,C,R,,,,,,,,,,S,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91303475-91303475, hg38,15:90760245-90760245","hg19,15:g.91303475T>C, hg38,15:g.90760245T>C",0.757,liver,carcinoma,,
667,396,C,Y,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90760246-90760246","hg38,15:g.90760246G>A",0.701,thyroid,carcinoma,,
668,397,G,E,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
669,397,G,W,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90760248-90760248","hg38,15:g.90760248G>T",0.620,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,
670,398,N,,,,,,,,,,,S,,,,,,,,,,,,
671,399,E,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
672,399,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","coadread_dfci_2016, pan_origimed_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91303484-91303484, hg38,15:90760254-90760254","hg19,15:g.91303484G>A, hg38,15:g.90760254G>A",0.051,large_intestine,"carcinoma, adenocarcinoma",0.0001352232774941,
673,399,E,Q,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
674,400,L,,,,,,,,,,,S,,,,,,,,,,,,
675,401,L,F,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
676,402,Q,E,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303493-91303493","hg19,15:g.91303493C>G",0.163,,,,
677,403,Q,H,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91303498-91303498, hg38,15:90760268-90760268","hg19,15:g.91303498G>C, hg38,15:g.90760268G>C",0.055,lung,"carcinoma, non_small_cell_carcinoma",,
678,403,Q,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
679,404,R,L,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760270-90760270","hg38,15:g.90760270G>T",0.470,lung,"carcinoma, non_small_cell_carcinoma",,
680,404,R,Q,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_met_2021, pancan_pcawg_2020, ucec_ccr_cfdna_msk_2022, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91303500-91303500, hg38,15:90760270-90760270","hg19,15:g.91303500G>A, hg38,15:g.90760270G>A",0.294,"skin, extremity","malignant_melanoma, superficial_spreading",0.0000278458453999,
681,404,R,W,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
682,405,N,S,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91303503-91303503","hg19,15:g.91303503A>G",0.094,,,,
683,406,I,T,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
684,406,I,V,,,,,,,,,,S,"Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
685,407,R,I,,,,,,,,,,S,"NRD cleavage site, 407-409, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
686,407,R,K,,,,,,,,,,S,"NRD cleavage site, 407-409, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
687,407,R,S,,,,,,,,,,S,"NRD cleavage site, 407-409, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
688,407,R,T,,,,,,,,,,S,"NRD cleavage site, 407-409, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
689,408,R,K,,,,,,,,,,S,"NRD cleavage site, 407-409, ELM|PCSK cleavage site, 408-412, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|di Arginine retention/retrieving signal, 406-408, ELM",,"cBioPortal,Manual annotations from clinvar.csv",luad_oncosg_2020,Lung Adenocarcinoma,"hg19,15:91303826-91303826","hg19,15:g.91303826G>A",0.196,,,0.0000040198096218,
690,409,K,,,,Ubq,,,,Sumo,,,S,"NRD cleavage site, 407-409, ELM|PCSK cleavage site, 408-412, ELM|PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM",,,,,,,,,,,
691,410,L,F,,,,,,,,,,S,"PCSK cleavage site, 408-412, ELM|PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
692,410,L,V,,,,,,,,,,S,"PCSK cleavage site, 408-412, ELM|PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
693,411,L,V,,,,,,,,,,S,"PCSK cleavage site, 408-412, ELM|PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
694,412,T,M,P,,,,,,,,,S,"PCSK cleavage site, 408-412, ELM|PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","difg_glass_2019, msk_met_2021","Diffuse Glioma, Mixed Cancer Types","hg19,15:91303838-91303838, hg38,15:90760608-90760608","hg19,15:g.91303838C>T, hg38,15:g.90760608C>T",0.055,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",0.0000200211423263,
695,413,E,K,,,,,,,,,,C,"PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,"cBioPortal,Manual annotations from clinvar.csv",sclc_cancercell_gardner_2017,Small Cell Lung Cancer,"hg19,15:91303840-91303840","hg19,15:g.91303840G>A",0.052,,,0.0000040016326661,0.0000636942675159
696,413,E,Q,,,,,,,,,,C,"PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
697,413,E,V,,,,,,,,,,C,"PCSK cleavage site, 409-413, ELM|APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
698,414,V,,,,,,,,,,,C,"APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,,,,,,,,,,
699,415,D,H,,,,,,,,,,s,"APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91303846-91303846","hg19,15:g.91303846G>C",0.044,,,,
700,415,D,Y,,,,,,,,,,s,"APCC-binding Destruction motifs, 407-415, ELM|Cyclin N-terminal Domain Docking Motifs, 404-415, ELM|Cyclin N-terminal Domain Docking Motifs, 405-415, ELM|MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, pan_origimed_2020, ucec_cptac_2020","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91303846-91303846, hg38,15:90760616-90760616","hg19,15:g.91303846G>T, hg38,15:g.90760616G>T",0.116,endometrium,"carcinoma, endometrioid_carcinoma",,
701,416,F,,,,,,,,,,,s,"MAPK docking motifs, 407-416, ELM|MAPK docking motifs, 408-416, ELM|14-3-3 binding phosphopeptide motif, 408-416, ELM|FHA phosphopeptide ligands, 410-416, ELM",,,,,,,,,,,
702,417,N,S,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021, pan_origimed_2020","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91303853-91303853, hg38,15:90760623-90760623","hg19,15:g.91303853A>G, hg38,15:g.90760623A>G",0.038,"urinary_tract, bladder","carcinoma, small_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,
703,418,K,,,,Ubq,,,,Sumo,,,s,,,,,,,,,,,,
704,419,S,,P,,,,,,,,,s,,,,,,,,,,,,
705,420,D,G,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91303862-91303862","hg19,15:g.91303862A>G",0.006,,,0.0000039912193175,
706,420,D,H,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91303861-91303861","hg19,15:g.91303861G>C",0.099,,,,
707,421,A,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
708,421,A,T,,,,,,,,,,s,,,"Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv",,,,,,,,,
709,422,S,,P,,,,,,,,,s,,,,,,,,,,,,
710,423,L,,,,,,,,,,,s,,,,,,,,,,,,
711,424,L,I,,,,,,,,,,s,,,cBioPortal,ucec_ccr_msk_2022,Endometrial Carcinoma,"hg19,15:91303873-91303873","hg19,15:g.91303873C>A",0.025,,,,
712,425,G,D,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
713,426,S,L,P,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91303880-91303880, hg38,15:90760650-90760650","hg19,15:g.91303880C>T, hg38,15:g.90760650C>T",0.027,"skin, scrotum","carcinoma, squamous_cell_carcinoma",0.0000079714303935,
714,427,L,,,,,,,,,,,s,,,,,,,,,,,,
715,428,W,,,,,,,,,,,s,,,,,,,,,,,,
716,429,R,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91303889-91303889, hg38,15:90760659-90760659","hg19,15:g.91303889G>A, hg38,15:g.90760659G>A",0.037,lung,"carcinoma, adenocarcinoma",0.0000000000000000,
717,429,R,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
718,430,Y,H,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
719,431,R,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,15:91303895-91303895, hg38,15:90760665-90760665","hg19,15:g.91303895G>A, hg38,15:g.90760665G>A",0.024,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
720,432,P,,,,,,,,,,,s,,,,,,,,,,,,
721,433,D,H,,,,,,,,,,s,"Caspase cleavage motif, 433-437, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,15:91303900-91303900, hg38,15:90760670-90760670","hg19,15:g.91303900G>C, hg38,15:g.90760670G>C",0.048,cervix,"carcinoma, squamous_cell_carcinoma",,
722,434,S,,P,,,,,,,,,s,"Caspase cleavage motif, 433-437, ELM",,,,,,,,,,,
723,435,L,F,,,,,,,,,,s,"Caspase cleavage motif, 433-437, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
724,436,D,E,,,,,,,,,,s,"Caspase cleavage motif, 433-437, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
725,437,G,V,,,,,,,,,,s,"Caspase cleavage motif, 433-437, ELM",,"cBioPortal,COSMIC","msk_ch_2020, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91303913-91303913, hg38,15:90760683-90760683","hg19,15:g.91303913G>T, hg38,15:g.90760683G>T",0.021,endometrium,"carcinoma, endometrioid_carcinoma",,
726,438,P,H,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91303916-91303916","hg19,15:g.91303916C>A",0.060,,,,
727,438,P,S,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,"cBioPortal,COSMIC","luad_broad, mel_mskimpact_2020, msk_met_2021, nsclc_tcga_broad_2016, pancan_pcawg_2020","Cutaneous Melanoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91303915-91303915, hg38,15:90760685-90760685","hg19,15:g.91303915C>T, hg38,15:g.90760685C>T",0.023,lung,"carcinoma, adenocarcinoma",0.0000039800678204,
728,439,M,I,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91303920-91303920","hg19,15:g.91303920G>A",0.091,,,,
729,439,M,L,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91303918-91303918","hg19,15:g.91303918A>T",0.021,,,,
730,439,M,V,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
731,440,E,G,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
732,440,E,K,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303921-91303921","hg19,15:g.91303921G>A",0.010,,,0.0000039801311851,
733,441,G,V,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
734,442,D,,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,,,,,,,,,,
735,443,S,,P,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,,,,,,,,,,
736,444,C,F,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
737,444,C,G,,,,,,,,,,s,"USP7 binding motif, 438-444, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
738,445,P,L,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","breast_msk_2018, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91303937-91303937, hg38,15:90760707-90760707","hg19,15:g.91303937C>T, hg38,15:g.90760707C>T",0.071,breast,"carcinoma, ductal_carcinoma",,
739,446,T,I,,,,,,,,,,s,,,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91303940-91303940, hg38,15:90760710-90760710","hg19,15:g.91303940C>T, hg38,15:g.90760710C>T",0.023,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
740,446,T,K,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
741,446,T,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
742,447,G,R,,,,,,,,,,s,,,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,15:91303942-91303942","hg19,15:g.91303942G>A",0.103,,,,
743,447,G,W,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303942-91303942","hg19,15:g.91303942G>T",0.101,,,,
744,448,N,,,,,,,,,,,s,,,,,,,,,,,,
745,449,S,C,P,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760719-90760719","hg38,15:g.90760719C>G",0.134,oesophagus,"carcinoma, squamous_cell_carcinoma",,
746,449,S,T,P,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
747,449,S,Y,P,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91303949-91303949","hg19,15:g.91303949C>A",0.054,,,,
748,450,M,I,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,COSMIC,,,"hg38,15:90760723-90760723","hg38,15:g.90760723G>A",0.057,lung,carcinoma,,
749,450,M,K,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
750,450,M,T,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
751,450,M,V,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
752,451,K,,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM",,,,,,,,,,,
753,452,E,G,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,15:91303958-91303958, hg38,15:90760728-90760728","hg19,15:g.91303958A>G, hg38,15:g.90760728A>G",0.045,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, squamous_cell_carcinoma",,
754,453,L,,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,,,,,,,,,,
755,454,N,D,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303963-91303963","hg19,15:g.91303963A>G",0.019,,,,
756,454,N,I,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91303964-91303964","hg19,15:g.91303964A>T",0.022,,,,
757,454,N,S,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
758,454,N,Y,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303963-91303963","hg19,15:g.91303963A>T",0.012,,,,
759,455,F,,,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,,,,,,,,,,
760,456,S,L,P,,,,,,,,,s,"PP1-docking motif RVXF, 449-456, ELM|Atg8 protein family ligands, 452-463, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, mel_dfci_2019","Basal Cell Carcinoma, Melanoma","hg19,15:91303970-91303970, hg38,15:90760740-90760740","hg19,15:g.91303970C>T, hg38,15:g.90760740C>T",0.036,skin,"carcinoma, basal_cell_carcinoma",,
761,457,H,R,,,,,,,,,,s,"Atg8 protein family ligands, 452-463, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91303973-91303973","hg19,15:g.91303973A>G",0.022,,,,
762,457,H,Y,,,,,,,,,,s,"Atg8 protein family ligands, 452-463, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
763,458,L,,,,,,,,,,,s,"Atg8 protein family ligands, 452-463, ELM",,,,,,,,,,,
764,459,P,H,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|Atg8 protein family ligands, 452-463, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
765,459,P,L,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|Atg8 protein family ligands, 452-463, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91303979-91303979, hg38,15:90760749-90760749","hg19,15:g.91303979C>T, hg38,15:g.90760749C>T",0.042,skin,"carcinoma, basal_cell_carcinoma",0.0000039841589839,
766,459,P,S,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|Atg8 protein family ligands, 452-463, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021, pog570_bcgsc_2020","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91303978-91303978","hg19,15:g.91303978C>T",0.028,,,,
767,460,S,,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|Atg8 protein family ligands, 452-463, ELM",,,,,,,,,,,
768,461,N,,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|WW domain ligands, 461-466, ELM|Atg8 protein family ligands, 452-463, ELM",,,,,,,,,,,
769,462,S,Y,P,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|WW domain ligands, 461-466, ELM|Atg8 protein family ligands, 452-463, ELM",,"cBioPortal,COSMIC","msk_met_2021, pan_origimed_2020, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91303988-91303988, hg38,15:90760758-90760758","hg19,15:g.91303988C>A, hg38,15:g.90760758C>A",0.114,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
770,463,V,G,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|WW domain ligands, 461-466, ELM|Atg8 protein family ligands, 452-463, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
771,463,V,I,,,,,,,,,,s,"USP7 binding motif, 459-463, ELM|WW domain ligands, 461-466, ELM|Atg8 protein family ligands, 452-463, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
772,464,S,F,P,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91303994-91303994","hg19,15:g.91303994C>T",0.047,,,,
773,465,P,H,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
774,465,P,L,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91303997-91303997, hg38,15:90760767-90760767","hg19,15:g.91303997C>T, hg38,15:g.90760767C>T",0.027,skin,"carcinoma, basal_cell_carcinoma",0.0000039871136487,
775,465,P,S,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91303996-91303996","hg19,15:g.91303996C>T",0.020,,,,
776,466,G,E,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
777,466,G,L,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91303999-91304000","hg19,15:g.91303999_91304000delinsTT",,,,,
778,466,G,R,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
779,466,G,V,,,,,,,,,,s,"WW domain ligands, 461-466, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91304000-91304000","hg19,15:g.91304000G>T",0.026,,,,
780,467,D,G,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90760773-90760773","hg38,15:g.90760773A>G",0.109,large_intestine,"carcinoma, adenocarcinoma",,
781,467,D,N,,,,,,,,,,s,,,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,15:91304002-91304002","hg19,15:g.91304002G>A",0.064,,,,
782,468,C,W,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
783,469,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,,,,,,,,,,
784,470,L,,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,,,,,,,,,,
785,471,T,A,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
786,471,T,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
787,472,T,N,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
788,473,T,A,P,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
789,473,T,I,P,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
790,474,L,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91304022-91304023","hg19,15:g.91304022_91304023delinsAA",,,,,
791,475,G,,,,,,,,,,,s,"FHA phosphopeptide ligands, 469-475, ELM",,,,,,,,,,,
792,476,K,R,,,Ubq,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
793,477,T,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
794,478,G,A,,,,,,,,,,s,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760806-90760806","hg38,15:g.90760806G>C",0.049,lung,"carcinoma, non_small_cell_carcinoma",0.0000119786301239,
795,478,G,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
796,479,F,C,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
797,479,F,L,,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, lung_msk_2017, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018, ucec_tcga_pan_can_atlas_2018","Endometrial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91304040-91304040, hg38,15:90760810-90760810","hg19,15:g.91304040C>A, hg19,15:g.91304040C>G, hg38,15:g.90760810C>A, hg38,15:g.90760810C>G",0.025,lung,"carcinoma, adenocarcinoma",,
798,479,F,Y,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
799,480,S,F,P,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91304042-91304042, hg38,15:90760812-90760812","hg19,15:g.91304042C>T, hg38,15:g.90760812C>T",0.048,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
800,480,S,P,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
801,481,A,T,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 481-488, ELM",,"cBioPortal,COSMIC",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91304044-91304044, hg38,15:90760814-90760814","hg19,15:g.91304044G>A, hg38,15:g.90760814G>A",0.080,large_intestine,"carcinoma, adenocarcinoma",,
802,481,A,V,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 481-488, ELM",,cBioPortal,"crc_dd_2022, msk_met_2021, rectal_msk_2022","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91304045-91304045","hg19,15:g.91304045C>T",0.026,,,,
803,482,T,,,,,,,,,,,s,"NRD cleavage site, 482-484, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM",,,,,,,,,,,
804,483,R,,,,,,,,,,,s,"NRD cleavage site, 482-484, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM",,,,,,,,,,,
805,484,K,N,,,Ubq,,,,Sumo,,,s,"NRD cleavage site, 482-484, ELM|PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91304055-91304055, hg38,15:90760825-90760825","hg19,15:g.91304055G>T, hg38,15:g.90760825G>T",0.012,endometrium,"carcinoma, endometrioid_carcinoma",,
806,485,N,K,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
807,486,L,V,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,COSMIC,,,"hg38,15:90760829-90760829","hg38,15:g.90760829C>G",0.067,"biliary_tract, bile_duct",carcinoma,,
808,487,F,C,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91304063-91304063","hg19,15:g.91304063T>G",0.068,,,,
809,487,F,L,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
810,487,F,S,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
811,488,E,K,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_nmibc_2017, luad_msk_npjpo_2021, luad_mskcc_2020, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91304065-91304065, hg38,15:90760835-90760835","hg19,15:g.91304065G>A, hg38,15:g.90760835G>A",0.088,"lung, urinary_tract, bladder","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,
812,488,E,Q,,,,,,,,,,s,"PCSK cleavage site, 484-488, ELM|Cyclin N-terminal Domain Docking Motifs, 481-488, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,"cBioPortal,COSMIC","cesc_tcga, cesc_tcga_pan_can_atlas_2018, msk_met_2021","Cervical Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91304065-91304065, hg38,15:90760835-90760835","hg19,15:g.91304065G>C, hg38,15:g.90760835G>C",0.107,cervix,"carcinoma, squamous_cell_carcinoma",,
813,489,R,,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,,,,,,,,,,
814,490,P,R,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
815,490,P,S,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM|PP4 EVH1-binding docking motifs, 487-490, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91304071-91304071, hg38,15:90760841-90760841","hg19,15:g.91304071C>T, hg38,15:g.90760841C>T",0.036,skin,malignant_melanoma,,
816,491,L,,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,,,,,,,,,,
817,492,F,L,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91304079-91304079","hg19,15:g.91304079C>G",0.023,,,,
818,493,N,S,,,,,,,,,,s,"PCSK cleavage site, 489-493, ELM|Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,15:91304081-91304081, hg38,15:90760851-90760851","hg19,15:g.91304081A>G, hg38,15:g.90760851A>G",0.041,stomach,"carcinoma, adenocarcinoma",,
819,494,T,A,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
820,494,T,I,,,,,,,,,,s,"Cyclin N-terminal Domain Docking Motifs, 483-494, ELM|Cyclin N-terminal Domain Docking Motifs, 484-494, ELM|Cyclin N-terminal Domain Docking Motifs, 486-494, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
821,495,H,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
822,496,L,,,,,,,,,,,s,,,,,,,,,,,,
823,497,Q,P,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
824,497,Q,R,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv","acc_2019, cll_broad_2015","Adrenocortical Carcinoma, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","hg19,15:91304093-91304093","hg19,15:g.91304093A>G",0.020,,,0.0000359525426437,
825,498,K,,,,,,,,Sumo,,,s,,,,,,,,,,,,
826,499,S,F,P,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91304099-91304099","hg19,15:g.91304099C>T",0.127,,,0.0000159776313162,
827,499,S,T,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
828,500,F,,,,,,,,,,,s,,,,,,,,,,,,
829,501,V,E,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
830,501,V,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
831,502,S,T,P,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
832,503,S,N,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
833,504,N,,,,,,,,,,,s,,,,,,,,,,,,
834,505,W,C,,,,,,,,,,s,"WW domain ligands, 505-510, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
835,506,A,,,,,,,,,,,s,"WW domain ligands, 505-510, ELM|FHA phosphopeptide ligands, 506-512, ELM",,,,,,,,,,,
836,507,E,K,,,,,,,,,,s,"WW domain ligands, 505-510, ELM|FHA phosphopeptide ligands, 506-512, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90760892-90760892","hg38,15:g.90760892G>A",0.064,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",0.0000159732926547,
837,508,T,,P,,,,,,,,,s,"WW domain ligands, 505-510, ELM|FHA phosphopeptide ligands, 506-512, ELM",,,,,,,,,,,
838,509,P,L,,,,,,,,,,s,"WW domain ligands, 505-510, ELM|FHA phosphopeptide ligands, 506-512, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
839,510,R,K,,,,,,,,,,s,"WW domain ligands, 505-510, ELM|FHA phosphopeptide ligands, 506-512, ELM",,COSMIC,,,"hg38,15:90760902-90760902","hg38,15:g.90760902G>A",0.019,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000000000000000,
840,511,L,I,,,,,,,,,,s,"FHA phosphopeptide ligands, 506-512, ELM",,"cBioPortal,COSMIC",hnsc_tcga_pan_can_atlas_2018,Head and Neck Squamous Cell Carcinoma,"hg19,15:91304134-91304134, hg38,15:90760904-90760904","hg19,15:g.91304134C>A, hg38,15:g.90760904C>A",0.055,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000000000000000,
841,511,L,Q,,,,,,,,,,s,"FHA phosphopeptide ligands, 506-512, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
842,511,L,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 506-512, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
843,512,G,E,,,,,,,,,,s,"FHA phosphopeptide ligands, 506-512, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91304138-91304138, hg38,15:90760908-90760908","hg19,15:g.91304138G>A, hg38,15:g.90760908G>A",0.037,lung,"carcinoma, small_cell_carcinoma",0.0000041481039017,
844,512,G,R,,,,,,,,,,s,"FHA phosphopeptide ligands, 506-512, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,15:91304137-91304137, hg38,15:90760907-90760907","hg19,15:g.91304137G>A, hg38,15:g.90760907G>A",0.047,breast,"carcinoma, basal_(triple-negative)_carcinoma",0.0000000000000000,
845,513,K,R,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91304141-91304141","hg19,15:g.91304141A>G",0.037,,,,
846,514,K,I,,,Ubq,,,,Sumo,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
847,514,K,R,,,Ubq,,,,Sumo,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
848,515,N,I,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90760917-90760917","hg38,15:g.90760917A>T",0.052,"skin, mucosal, nasopharynx",malignant_melanoma,,
849,515,N,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
850,516,E,,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM",,,,,,,,,,,
851,517,S,T,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
852,518,S,F,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
853,518,S,P,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
854,519,Y,C,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM|Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,15:91304159-91304159, hg38,15:90760929-90760929","hg19,15:g.91304159A>G, hg38,15:g.90760929A>G",0.095,liver,"carcinoma, hepatocellular_carcinoma",,
855,519,Y,D,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM|Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
856,520,F,S,,,,,,,,,,s,"BRCT phosphopeptide ligands, 516-520, ELM|MLH1 C-terminal Domain Ligand, 516-520, ELM|Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
857,521,P,K,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91304164-91304165","hg19,15:g.91304164_91304165delinsAA",,,,,
858,521,P,Q,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,COSMIC,,,"hg38,15:90760935-90760935","hg38,15:g.90760935C>A",0.048,placenta,choriocarcinoma,,
859,521,P,S,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
860,522,G,R,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 519-522, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
861,523,N,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
862,524,V,,,,,,,,,,,s,"SPOP SBC docking motif, 524-528, ELM",,,,,,,,,,,
863,525,L,V,,,,,,,,,,s,"SPOP SBC docking motif, 524-528, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
864,526,T,P,,,,,,,,,,s,"SPOP SBC docking motif, 524-528, ELM",,"cBioPortal,COSMIC",blca_bgi,Bladder Urothelial Carcinoma,"hg19,15:91304179-91304179, hg38,15:90760949-90760949","hg19,15:g.91304179A>C, hg38,15:g.90760949A>C",0.158,"urinary_tract, bladder","carcinoma, carcinoma, transitional_cell_carcinoma",,
865,527,S,,,,,,,,,,,s,"SPOP SBC docking motif, 524-528, ELM",,,,,,,,,,,
866,528,T,I,,,,,,,,,,s,"SPOP SBC docking motif, 524-528, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
867,529,A,,,,,,,,,,,s,,,,,,,,,,,,
868,530,V,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
869,530,V,L,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90760961-90760961","hg38,15:g.90760961G>T",0.026,lung,"carcinoma, large_cell_neuroendocrine_carcinoma, mixed",,
870,531,K,N,,,Ubq,,,,,,,s,"USP7 binding motif, 531-535, ELM",,"cBioPortal,Manual annotations from clinvar.csv",glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91304196-91304196","hg19,15:g.91304196A>T",0.042,,,,
871,531,K,T,,,Ubq,,,,,,,s,"USP7 binding motif, 531-535, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
872,532,D,G,,,,,,,,,,s,"USP7 binding motif, 531-535, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
873,532,D,H,,,,,,,,,,s,"USP7 binding motif, 531-535, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
874,533,Q,H,,,,,,,,,,s,"USP7 binding motif, 531-535, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91304202-91304202, hg38,15:90760972-90760972","hg19,15:g.91304202G>C, hg38,15:g.90760972G>C",0.041,cervix,"carcinoma, mixed_adenosquamous_carcinoma",,
875,534,N,S,,,,,,,,,,s,"USP7 binding motif, 531-535, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
876,535,K,Q,,,Ubq,,,,,,,s,"USP7 binding motif, 531-535, ELM|FHA phosphopeptide ligands, 535-541, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pan_can_atlas_2018, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,15:91304206-91304206, hg38,15:90760976-90760976","hg19,15:g.91304206A>C, hg38,15:g.90760976A>C",0.079,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
877,536,H,,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,,,,,,,,,,
878,537,T,N,P,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
879,537,T,S,P,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,COSMIC,,,"hg38,15:90760983-90760983","hg38,15:g.90760983C>G",0.033,prostate,carcinoma,,
880,538,A,P,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
881,538,A,T,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
882,538,A,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
883,539,S,,P,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,,,,,,,,,,
884,540,I,K,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
885,540,I,M,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
886,540,I,V,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
887,541,N,S,,,,,,,,,,s,"FHA phosphopeptide ligands, 535-541, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
888,542,D,E,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
889,542,D,Y,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv",hcc_meric_2021,Hepatocellular Carcinoma,"hg19,15:91304227-91304227","hg19,15:g.91304227G>T",0.077,,,,
890,543,L,,,,,,,,,,,s,,,,,,,,,,,,
891,544,E,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
892,544,E,K,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
893,545,R,G,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
894,545,R,S,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91304238-91304238","hg19,15:g.91304238A>T",0.030,,,,
895,546,E,D,,,,,,,,,,s,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91304241-91304241","hg19,15:g.91304241A>T",0.013,,,,
896,546,E,K,,,,,,,,,,s,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91304239-91304239","hg19,15:g.91304239G>A",0.034,,,,
897,546,E,Q,,,,,,,,,,s,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,15:91304239-91304239, hg38,15:90761009-90761009","hg19,15:g.91304239G>C, hg38,15:g.90761009G>C",0.032,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
898,547,T,I,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
899,548,Q,K,,,,,,,,,,s,,,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91304245-91304245, hg38,15:90761015-90761015","hg19,15:g.91304245C>A, hg38,15:g.90761015C>A",0.098,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000040842665882,
900,549,P,,,,,,,,,,,s,,,,,,,,,,,,
901,550,S,F,P,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91304252-91304252","hg19,15:g.91304252C>T",0.028,,,,
902,551,Y,C,P,,,,,,,,,s,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91304255-91304255, hg38,15:90761025-90761025","hg19,15:g.91304255A>G, hg38,15:g.90761025A>G",0.030,large_intestine,"carcinoma, adenocarcinoma",0.0000125541922633,
903,552,D,H,,,,,,,,,,s,,,cBioPortal,blca_msk_tcga_2020,Bladder Urothelial Carcinoma,"hg19,15:91304257-91304257","hg19,15:g.91304257G>C",0.195,,,,
904,553,I,T,,,,,,,,,,s,,,cBioPortal,prad_msk_stopsack_2021,Prostate Adenocarcinoma,"hg19,15:91304261-91304261","hg19,15:g.91304261T>C",0.022,,,,
905,553,I,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
906,554,D,N,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
907,554,D,V,,,,,,,,,,s,,,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91304264-91304264","hg19,15:g.91304264A>T",0.355,,,,
908,555,N,,,,,,,,,,,s,,,,,,,,,,,,
909,556,F,,,,,,,,,,,s,,,,,,,,,,,,
910,557,D,,,,,,,,,,,s,,,,,,,,,,,,
911,558,I,T,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
912,559,D,E,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
913,559,D,F,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
914,559,D,G,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
915,559,D,N,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91304278-91304278","hg19,15:g.91304278G>A",0.199,,,,
916,559,D,V,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
917,560,D,H,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
918,560,D,N,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91304281-91304281","hg19,15:g.91304281G>A",0.120,,,,
919,561,F,D,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
920,562,D,E,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
921,562,D,V,,,,,,,,,,s,"Apple-PAN domain ligand motif, 558-562, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
922,563,D,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
923,564,D,E,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91304295-91304295","hg19,15:g.91304295T>G",0.101,,,,
924,564,D,G,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
925,564,D,V,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
926,565,D,G,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91304297-91304297","hg19,15:g.91304297A>G",0.118,,,,
927,565,D,N,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,15:91304296-91304296, hg38,15:90761066-90761066","hg19,15:g.91304296G>A, hg38,15:g.90761066G>A",0.095,breast,carcinoma,,
928,566,D,,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,,,,,,,,,,
929,567,W,F,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91304303-91304304","hg19,15:g.91304303_91304304delinsTT",,,,,
930,568,E,K,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91304305-91304305","hg19,15:g.91304305G>A",0.223,,,,
931,568,E,Q,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
932,569,D,G,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
933,569,D,N,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91304308-91304308, hg38,15:90761078-90761078","hg19,15:g.91304308G>A, hg38,15:g.90761078G>A",0.008,skin,malignant_melanoma,,
934,570,I,L,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
935,570,I,T,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
936,570,I,V,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
937,571,M,T,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
938,572,H,P,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
939,572,H,R,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
940,573,N,K,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
941,574,L,,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,,,,,,,,,,
942,575,A,V,,,,,,,,,,s,"Atg8 protein family ligands, 564-575, ELM|Atg8 protein family ligands, 565-575, ELM|Atg8 protein family ligands, 566-575, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
943,576,A,,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,,,,,,,,,,
944,577,S,N,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
945,577,S,R,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
946,578,K,N,,,Ubq,,,,,,,s,"USP7 binding motif, 576-580, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
947,578,K,T,,,Ubq,,,,,,,s,"USP7 binding motif, 576-580, ELM|Binding motif for UBA3 adenylation domain, 570-578, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
948,579,S,F,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91304339-91304339, hg38,15:90761109-90761109","hg19,15:g.91304339C>T, hg38,15:g.90761109C>T",0.084,skin,"carcinoma, basal_cell_carcinoma",,
949,579,S,Y,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018",Bladder Urothelial Carcinoma,"hg19,15:91304339-91304339, hg38,15:90761109-90761109","hg19,15:g.91304339C>A, hg38,15:g.90761109C>A",0.086,"urinary_tract, bladder",carcinoma,,
950,580,S,C,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
951,580,S,F,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM",,"cBioPortal,COSMIC",brca_igr_2015,Invasive Breast Carcinoma,"hg19,15:91304342-91304342, hg38,15:90761112-90761112","hg19,15:g.91304342C>T, hg38,15:g.90761112C>T",0.084,"breast, liver","carcinoma, carcinoma, HER-positive_carcinoma, carcinoma, hepatocellular_carcinoma",,
952,580,S,P,,,,,,,,,,s,"USP7 binding motif, 576-580, ELM",,COSMIC,,,"hg38,15:90761111-90761111","hg38,15:g.90761111T>C",0.033,"large_intestine, colon, right","carcinoma, adenocarcinoma",,
953,581,T,A,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
954,582,A,,,,,,,,,,,s,,,,,,,,,,,,
955,583,A,S,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
956,583,A,V,,,,,,,,,,s,,,cBioPortal,"difg_glass_2019, lgg_ucsf_2014, msk_met_2021, tmb_mskcc_2018","Diffuse Glioma, Mixed Cancer Types","hg19,15:91304351-91304351","hg19,15:g.91304351C>T",0.059,,,,
957,584,Y,C,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-587, ELM|Y-based sorting signal, 584-587, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
958,585,Q,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-587, ELM|Y-based sorting signal, 584-587, ELM",,,,,,,,,,,
959,586,P,S,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-587, ELM|Y-based sorting signal, 584-587, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
960,587,I,M,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-587, ELM|Y-based sorting signal, 584-587, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
961,587,I,T,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-587, ELM|Y-based sorting signal, 584-587, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91304363-91304363","hg19,15:g.91304363T>C",0.052,,,,
962,588,K,,,,Ubq,,,,Sumo,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM|Phosphotyrosine ligands bound by SH2 domains, 584-588, ELM",,,,,,,,,,,
963,589,E,,,,,,,,,,,s,"PP2A holoenzyme B56-docking site, 584-589, ELM",,,,,,,,,,,
964,590,G,A,,,,,,,,,,s,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90761142-90761142","hg38,15:g.90761142G>C",0.181,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",0.0000054393350957,
965,591,R,L,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91304375-91304375","hg19,15:g.91304375G>T",0.015,,,,
966,591,R,Q,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
967,591,R,W,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91304374-91304374","hg19,15:g.91304374C>T",0.076,,,0.0000054493537067,
968,592,P,L,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
969,592,P,S,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
970,593,I,,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,,,,,,,,,,
971,594,K,I,,,Ubq,,,,Sumo,,,s,"PCSK cleavage site, 591-595, ELM|USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
972,595,S,L,,,,,,,,,,s,"PCSK cleavage site, 591-595, ELM|USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
973,596,V,I,,,,,,,,,,s,"USP7 binding motif, 592-596, ELM|14-3-3 binding phosphopeptide motif, 591-597, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
974,597,S,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 591-597, ELM",,,,,,,,,,,
975,598,E,D,,,,,,,,,,s,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91304397-91304397","hg19,15:g.91304397A>C",0.024,,,,
976,599,R,K,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,"cBioPortal,COSMIC","brca_igr_2015, msk_impact_2017","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91304399-91304399, hg38,15:90761169-90761169","hg19,15:g.91304399G>A, hg38,15:g.90761169G>A",0.019,"breast, central_nervous_system, brain","carcinoma, ER-PR-positive_carcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
977,600,L,F,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91304401-91304401, hg38,15:90761171-90761171","hg19,15:g.91304401C>T, hg38,15:g.90761171C>T",0.022,endometrium,"carcinoma, endometrioid_carcinoma",,
978,601,S,C,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pptc_2019,Mixed Cancer Types,"hg19,15:91304405-91304405","hg19,15:g.91304405C>G",0.046,,,,
979,601,S,F,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
980,601,S,Y,P,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91304405-91304405, hg38,15:90761175-90761175","hg19,15:g.91304405C>A, hg38,15:g.90761175C>A",0.036,haematopoietic_and_lymphoid_tissue,lymphoid_neoplasm,,
981,602,S,A,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
982,602,S,L,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
983,603,A,D,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
984,603,A,G,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
985,603,A,V,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91304411-91304411","hg19,15:g.91304411C>T",0.039,,,,
986,604,K,N,,,Ubq,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, lung_msk_pdx, msk_met_2021","Lung, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91304415-91304415","hg19,15:g.91304415G>T",0.019,,,,
987,605,T,,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,,,,,,,,,,
988,606,D,N,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91304419-91304419, hg38,15:90761189-90761189","hg19,15:g.91304419G>A, hg38,15:g.90761189G>A",0.031,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
989,607,C,W,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
990,608,L,F,,,,,,,,,,s,"14-3-3 binding phosphopeptide motif, 599-608, ELM|FHA phosphopeptide ligands, 603-609, ELM",,cBioPortal,glioma_msk_2018,Diffuse Glioma,"hg19,15:91304425-91304425","hg19,15:g.91304425C>T",0.131,,,,
991,609,P,L,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM|FHA phosphopeptide ligands, 603-609, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91304429-91304429","hg19,15:g.91304429C>T",0.047,,,,
992,609,P,T,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM|FHA phosphopeptide ligands, 603-609, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
993,610,V,,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM",,,,,,,,,,,
994,611,S,L,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
995,612,S,,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM",,,,,,,,,,,
996,613,T,I,,,,,,,,,,s,"SPOP SBC docking motif, 609-613, ELM|USP7 binding motif, 609-613, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
997,614,A,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
998,614,A,V,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
999,615,Q,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1000,616,N,Y,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1001,617,I,L,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1002,617,I,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1003,618,N,S,,,,,,,,,,s,,,cBioPortal,prad_su2c_2019,Prostate Adenocarcinoma,"hg19,15:91304456-91304456","hg19,15:g.91304456A>G",0.032,,,,
1004,619,F,C,,,,,,,,,,s,,,"cBioPortal,COSMIC","crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91304459-91304459, hg38,15:90761229-90761229","hg19,15:g.91304459T>G, hg38,15:g.90761229T>G",0.081,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000000000000000,
1005,619,F,L,,,,,,,,,,s,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91304460-91304460, hg38,15:90761230-90761230","hg19,15:g.91304460C>A, hg38,15:g.90761230C>A",0.050,"large_intestine, colon, urinary_tract, upper_urinary_tract","carcinoma, adenocarcinoma, carcinoma, transitional_cell_carcinoma",,
1006,619,F,S,,,,,,,,,,s,,,cBioPortal,coad_cptac_2019,Colon Adenocarcinoma,"hg19,15:91304459-91304459","hg19,15:g.91304459T>C",0.030,,,,
1007,620,S,,,,,,,,,,,s,,,,,,,,,,,,
1008,621,E,D,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1009,621,E,Q,,,,,,,,,,s,,,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91304464-91304464, hg38,15:90761234-90761234","hg19,15:g.91304464G>C, hg38,15:g.90761234G>C",0.034,breast,"carcinoma, lobular_carcinoma",,
1010,622,S,P,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1011,623,I,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1012,624,Q,R,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1013,625,N,,,,,,,,,,,s,,,,,,,,,,,,
1014,626,Y,F,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 626-629, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1015,627,T,A,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 626-629, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1016,628,D,,,,,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 626-629, ELM",,,,,,,,,,,
1017,629,K,,,,Ubq,,,,,,,s,"Phosphotyrosine ligands bound by SH2 domains, 626-629, ELM",,,,,,,,,,,
1018,630,S,P,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1019,630,S,T,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1020,631,A,,,,,,,,,,,s,,,,,,,,,,,,
1021,632,Q,E,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91306207-91306207","hg19,15:g.91306207C>G",0.077,,,,
1022,632,Q,K,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1023,632,Q,L,,,,,,,,,,s,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91306208-91306208","hg19,15:g.91306208A>T",0.107,,,,
1024,632,Q,P,,,,,,,,,,s,,,Manual annotations from clinvar.csv,,,,,,,,,
1025,633,N,H,,,,,,,,,,s,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91306210-91306210, hg38,15:90762980-90762980","hg19,15:g.91306210A>C, hg38,15:g.90762980A>C",0.064,pancreas,"carcinoma, medullary_carcinoma",,
1026,634,L,F,,,,,,,,,,s,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91306215-91306215","hg19,15:g.91306215A>T",0.113,,,,
1027,635,A,S,,,,,,,,,,s,,,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020",Bladder Urothelial Carcinoma,"hg19,15:91306216-91306216, hg38,15:90762986-90762986","hg19,15:g.91306216G>T, hg38,15:g.90762986G>T",0.102,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
1028,635,A,T,,,,,,,,,,s,,,COSMIC,,,"hg38,15:90762986-90762986","hg38,15:g.90762986G>A",0.142,large_intestine,"carcinoma, adenocarcinoma",,
1029,636,S,C,,,,,,,,,,D,,,Manual annotations from clinvar.csv,,,,,,,,,
1030,637,R,I,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, gbm_tcga_pan_can_atlas_2018","Glioblastoma Multiforme, Invasive Breast Carcinoma","hg19,15:91306223-91306223, hg38,15:90762993-90762993","hg19,15:g.91306223G>T, hg38,15:g.90762993G>T",0.228,breast,carcinoma,,
1031,638,N,H,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM",,COSMIC,,,"hg38,15:90762995-90762995","hg38,15:g.90762995A>C",0.271,prostate,carcinoma,,
1032,638,N,S,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1033,638,N,T,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1034,639,L,,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM",,,,,,,,,,,
1035,640,K,,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM|MAPK docking motifs, 640-649, ELM",,,,,,,,,,,
1036,641,H,L,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM|MAPK docking motifs, 640-649, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1037,641,H,R,,,,,,,,,,C,"PCSK cleavage site, 637-641, ELM|MAPK docking motifs, 640-649, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91306235-91306235","hg19,15:g.91306235A>G",0.270,,,,
1038,642,E,K,,,,,,,,,,C,"MAPK docking motifs, 640-649, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91306237-91306237","hg19,15:g.91306237G>A",0.223,,,0.0000239725753738,0.0001273966494681
1039,643,R,C,,,,,,,,,,C,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","coadread_dfci_2016, msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Colorectal Adenocarcinoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91306240-91306240, hg38,15:90763010-90763010","hg19,15:g.91306240C>T, hg38,15:g.90763010C>T",0.215,"endometrium, large_intestine, large_intestine, colon, sigmoid, large_intestine, colon, transverse","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0000479581804666,0.0001275022312890
1040,643,R,H,,,,,,,,,,C,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv","cll_iuopa_2015, msk_met_2021, tmb_mskcc_2018","Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mixed Cancer Types","hg19,15:91306241-91306241, hg38,15:90763011-90763011","hg19,15:g.91306241G>A, hg38,15:g.90763011G>A",0.145,"endometrium, haematopoietic_and_lymphoid_tissue, prostate","carcinoma, lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma, other, adenosarcoma",0.0033296825409515,0.0023571383066828
1041,643,R,L,,,,,,,,,,C,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|Atg8 protein family ligands, 642-650, ELM",,COSMIC,,,"hg38,15:90763011-90763011","hg38,15:g.90763011G>T",0.215,"liver, lung","carcinoma, non_small_cell_carcinoma, other, neoplasm",,
1042,643,R,S,,,,,,,,,,C,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|Atg8 protein family ligands, 642-650, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1043,644,F,Y,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|Atg8 protein family ligands, 642-650, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1044,645,Q,K,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,COSMIC,,,"hg38,15:90763016-90763016","hg38,15:g.90763016C>A",0.089,oesophagus,"carcinoma, adenocarcinoma",,
1045,645,Q,L,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1046,645,Q,R,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, rectal_msk_2022","Bowel, Mixed Cancer Types","hg19,15:91306247-91306247","hg19,15:g.91306247A>G",0.166,,,0.0000439346252776,0.0000636861546300
1047,646,S,G,P,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90763019-90763019","hg38,15:g.90763019A>G",0.121,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000239712345186,0.0000318532203606
1048,647,L,F,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91306252-91306252, hg38,15:90763022-90763022","hg19,15:g.91306252C>T, hg38,15:g.90763022C>T",0.103,skin,"carcinoma, basal_cell_carcinoma",,
1049,647,L,I,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,15:91306252-91306252, hg38,15:90763022-90763022","hg19,15:g.91306252C>A, hg38,15:g.90763022C>A",0.106,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",,
1050,647,L,P,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1051,647,L,V,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1052,648,S,G,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91306255-91306255","hg19,15:g.91306255A>G",0.112,,,,
1053,648,S,N,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|14-3-3 binding phosphopeptide motif, 643-648, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,COSMIC,,,"hg38,15:90763026-90763026","hg38,15:g.90763026G>A",0.197,"skin, face",malignant_melanoma,,
1054,649,F,Y,,,,,,,,,,S,"MAPK docking motifs, 640-649, ELM|BRCT phosphopeptide ligands, 645-649, ELM|Atg8 protein family ligands, 642-650, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91306259-91306259","hg19,15:g.91306259T>A",0.329,,,,
1055,650,P,L,,,,,,,,,,S,"Atg8 protein family ligands, 642-650, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91306262-91306262","hg19,15:g.91306262C>T",0.622,,,,
1056,651,H,,,,,,,,,,,S,,,,,,,,,,,,
1057,652,T,A,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1058,652,T,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1059,653,K,M,,,Ubq,,,,,,,S,"USP7 binding motif, 653-657, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91306271-91306271, hg38,15:90763041-90763041","hg19,15:g.91306271A>T, hg38,15:g.90763041A>T",0.396,"urinary_tract, bladder",carcinoma,,
1060,653,K,N,,,Ubq,,,,,,,S,"USP7 binding motif, 653-657, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91306272-91306272, hg38,15:90763042-90763042","hg19,15:g.91306272G>T, hg38,15:g.90763042G>T",0.256,endometrium,"carcinoma, endometrioid_carcinoma",,
1061,653,K,T,,,Ubq,,,,,,,S,"USP7 binding motif, 653-657, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1062,654,E,,,,,,,,,,,S,"USP7 binding motif, 653-657, ELM",,,,,,,,,,,
1063,655,M,I,,,,,,,,,,S,"USP7 binding motif, 653-657, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91306278-91306278","hg19,15:g.91306278G>T",0.521,,,,
1064,655,M,T,,,,,,,,,,S,"USP7 binding motif, 653-657, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91306277-91306277","hg19,15:g.91306277T>C",0.816,,,0.0000199057264794,
1065,656,M,V,,,,,,,,,,S,"USP7 binding motif, 653-657, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1066,657,K,E,,,,,,Ac,,,,S,"USP7 binding motif, 653-657, ELM|USP7 binding motif, 657-661, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1067,657,K,M,,,,,,Ac,,,,S,"USP7 binding motif, 653-657, ELM|USP7 binding motif, 657-661, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1068,658,I,M,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021, rectal_msk_2022","Bowel, Breast, Mixed Cancer Types","hg19,15:91306287-91306287, hg38,15:90763057-90763057","hg19,15:g.91306287T>G, hg38,15:g.90763057T>G",0.475,breast,"carcinoma, ductal_carcinoma",,
1069,658,I,T,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1070,658,I,V,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1071,659,F,,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,,,,,,,,,,
1072,660,H,L,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91306292-91306292","hg19,15:g.91306292A>T",0.522,,,,
1073,660,H,Q,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,"cBioPortal,COSMIC","kirc_tcga, kirc_tcga_pub",Renal Clear Cell Carcinoma,"hg19,15:91306293-91306293, hg38,15:90763063-90763063","hg19,15:g.91306293T>A, hg38,15:g.90763063T>A",0.310,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
1074,660,H,R,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1075,660,H,Y,,,,,,,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,15:91306291-91306291, hg38,15:90763061-90763061","hg19,15:g.91306291C>T, hg38,15:g.90763061C>T",0.436,"skin, skin, abdomen","carcinoma, Merkel_cell_carcinoma, malignant_melanoma",,
1076,661,K,,,,,,,Ac,,,,S,"USP7 binding motif, 657-661, ELM|Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,,,,,,,,,,
1077,662,K,,,,Ubq,,,Ac,Sumo,,,S,"Pex14 ligand motif, 659-663, ELM|Binding motif for UBA3 adenylation domain, 655-662, ELM",,,,,,,,,,,
1078,663,F,C,,,,,,,,,,S,"Pex14 ligand motif, 659-663, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,15:91306301-91306301","hg19,15:g.91306301T>G",0.886,,,,
1079,663,F,I,,,,,,,,,,S,"Pex14 ligand motif, 659-663, ELM",,COSMIC,,,"hg38,15:90763070-90763070","hg38,15:g.90763070T>A",0.886,stomach,"carcinoma, intestinal_adenocarcinoma",,
1080,664,G,,,,,,,,,,,S,,,,,,,,,,,,
1081,665,L,,,,,,,,,,,S,,,,,,,,,,,,
1082,666,H,,,,,,,,,,,S,,,,,,,,,,,,
1083,667,N,,,,,,,,,,,S,,,,,,,,,,,,
1084,668,F,,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,,,,,,,,,,
1085,669,R,,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,,,,,,,,,,
1086,670,T,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,"cBioPortal,COSMIC",hcc_inserm_fr_2015,Hepatocellular Carcinoma,"hg19,15:91306322-91306322, hg38,15:90763092-90763092","hg19,15:g.91306322C>A, hg38,15:g.90763092C>A",0.286,liver,"carcinoma, hepatocellular_carcinoma",,
1087,671,N,,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,,,,,,,,,,
1088,672,Q,R,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,15:91306328-91306328, hg38,15:90763098-90763098","hg19,15:g.91306328A>G, hg38,15:g.90763098A>G",0.961,"haematopoietic_and_lymphoid_tissue, thyroid","carcinoma, papillary_carcinoma, lymphoid_neoplasm, acute_lymphoblastic_T_cell_leukaemia",0.0000238720458343,
1089,673,L,,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,,,,,,,,,,
1090,674,E,Q,,,,,,,,,,S,"FHA phosphopeptide ligands, 668-674, ELM",,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018",Head and Neck Squamous Cell Carcinoma,"hg19,15:91306333-91306333, hg38,15:90763103-90763103","hg19,15:g.91306333G>C, hg38,15:g.90763103G>C",0.227,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
1091,675,A,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","crc_dd_2022, crc_msk_2017, msk_impact_2017, msk_met_2021, rectal_msk_2022","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91306337-91306337, hg38,15:90763107-90763107","hg19,15:g.91306337C>T, hg38,15:g.90763107C>T",0.708,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
1092,676,I,,,,,,,,,,,S,,,,,,,,,,,,
1093,677,N,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_plasmacytoid_mskcc_2016, msk_impact_2017","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91306343-91306343, hg38,15:90763113-90763113","hg19,15:g.91306343A>G, hg38,15:g.90763113A>G",0.347,"urinary_tract, bladder",carcinoma,0.0000039784210443,
1094,678,A,,,,,,,,,,,S,,,,,,,,,,,,
1095,679,A,S,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90763118-90763118","hg38,15:g.90763118G>T",0.029,liver,"carcinoma, hepatocellular_carcinoma",,
1096,679,A,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1097,680,L,,,,,,,,,,,S,,,,,,,,,,,,
1098,681,L,F,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1099,682,G,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1100,683,E,K,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM",,cBioPortal,brca_smc_2018,Invasive Breast Carcinoma,"hg19,15:91306360-91306360","hg19,15:g.91306360G>A",0.246,,,,
1101,684,D,A,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1102,684,D,N,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1103,684,D,Y,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM",,"cBioPortal,COSMIC","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,15:91306363-91306363, hg38,15:90763133-90763133","hg19,15:g.91306363G>T, hg38,15:g.90763133G>T",0.681,stomach,"carcinoma, adenocarcinoma",,
1104,685,C,Y,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1105,686,F,L,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM|TRFH domain docking motifs, 686-690, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1106,687,I,M,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM|TRFH domain docking motifs, 686-690, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91306374-91306374","hg19,15:g.91306374C>G",0.272,,,,
1107,688,L,,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM|TRFH domain docking motifs, 686-690, ELM",,,,,,,,,,,
1108,689,M,,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM|TRFH domain docking motifs, 686-690, ELM",,,,,,,,,,,
1109,690,P,L,,,,,,,,,,S,"Atg8 protein family ligands, 683-690, ELM|Atg8 protein family ligands, 684-690, ELM|TRFH domain docking motifs, 686-690, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1110,691,T,I,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1111,691,T,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1112,692,G,E,,,,,,,,,,S,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91308526-91308526","hg19,15:g.91308526G>A",0.927,,,,
1113,692,G,V,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91308526-91308526, hg38,15:90765296-90765296","hg19,15:g.91308526G>T, hg38,15:g.90765296G>T",0.945,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000079549432017,
1114,693,G,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1115,693,G,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1116,694,G,N,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90765301-90765302","hg38,15:g.90765301_90765302delinsAA",,"skin, upper_extremity","carcinoma, Merkel_cell_carcinoma",,
1117,695,K,N,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91308536-91308536","hg19,15:g.91308536G>C",0.870,,,,
1118,695,K,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1119,696,S,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1120,696,S,N,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1121,697,L,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1122,698,C,,,,,,,,,,,S,,,,,,,,,,,,
1123,699,Y,,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 699-703, ELM",,,,,,,,,,,
1124,700,Q,H,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 699-703, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91308551-91308551","hg19,15:g.91308551G>T",0.864,,,,
1125,701,L,R,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 699-703, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1126,702,P,S,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 699-703, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91308555-91308555, hg38,15:90765325-90765325","hg19,15:g.91308555C>T, hg38,15:g.90765325C>T",0.911,skin,"carcinoma, basal_cell_carcinoma",,
1127,703,A,V,,,,,,,,,,S,"WW domain ligands, 703-708, ELM|Phosphotyrosine ligands bound by SH2 domains, 699-703, ELM",,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,15:91308559-91308559, hg38,15:90765329-90765329","hg19,15:g.91308559C>T, hg38,15:g.90765329C>T",0.328,large_intestine,"carcinoma, adenocarcinoma",,
1128,704,C,F,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,COSMIC,,,"hg38,15:90765332-90765332","hg38,15:g.90765332G>T",0.441,prostate,carcinoma,,
1129,704,C,R,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,cBioPortal,esca_tcga_pan_can_atlas_2018,Esophageal Adenocarcinoma,"hg19,15:91308561-91308561","hg19,15:g.91308561T>C",0.603,,,,
1130,705,V,D,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1131,705,V,F,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,COSMIC,,,"hg38,15:90765334-90765334","hg38,15:g.90765334G>T",0.182,liver,"other, neoplasm",,
1132,705,V,L,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1133,706,S,F,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91308568-91308568, hg38,15:90765338-90765338","hg19,15:g.91308568C>T, hg38,15:g.90765338C>T",0.486,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
1134,707,P,S,,,,,,,,,,S,"WW domain ligands, 703-708, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","skcm_tcga, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,15:91308570-91308570, hg38,15:90765340-90765340","hg19,15:g.91308570C>T, hg38,15:g.90765340C>T",0.284,"lung, prostate, skin, skin, head_neck","carcinoma, carcinoma, bronchioloalveolar_adenocarcinoma, malignant_melanoma, malignant_melanoma, nodular",0.0016425128458026,0.0017843487127199
1135,708,G,E,,,,,,,,,,S,"WW domain ligands, 703-708, ELM|FHA phosphopeptide ligands, 708-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1136,708,G,L,,,,,,,,,,S,"WW domain ligands, 703-708, ELM|FHA phosphopeptide ligands, 708-714, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91308573-91308574","hg19,15:g.91308573_91308574delinsTT",,,,,
1137,708,G,R,,,,,,,,,,S,"WW domain ligands, 703-708, ELM|FHA phosphopeptide ligands, 708-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1138,709,V,D,,,,,,,,,,S,"FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1139,710,T,,,,,,,,,,,S,"FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,,,,,,,,,,
1140,711,V,I,,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1141,712,V,,,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,,,,,,,,,,
1142,713,I,M,,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1143,713,I,T,,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91308589-91308589","hg19,15:g.91308589T>C",0.907,,,,
1144,713,I,V,,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1145,714,S,F,P,,,,,,,,,S,"WW domain ligands, 711-716, ELM|FHA phosphopeptide ligands, 708-714, ELM|SH3 ligand, 709-715, ELM|SUMO interaction site, 709-714, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91308592-91308592","hg19,15:g.91308592C>T",0.890,,,,
1146,715,P,F,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM|WW domain ligands, 711-716, ELM|SH3 ligand, 709-715, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91308594-91308595, hg38,15:90765364-90765365","hg19,15:g.91308594_91308595delinsTT, hg38,15:g.90765364_90765365delinsTT",,skin,"carcinoma, basal_cell_carcinoma",,
1147,715,P,L,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM|WW domain ligands, 711-716, ELM|SH3 ligand, 709-715, ELM",,"cBioPortal,COSMIC","cscc_hgsc_bcm_2014, hnsc_tcga, hnsc_tcga_pan_can_atlas_2018","Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","hg19,15:91308595-91308595, hg38,15:90765365-90765365","hg19,15:g.91308595C>T, hg38,15:g.90765365C>T",0.701,"skin, head_neck, upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
1148,715,P,Q,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM|WW domain ligands, 711-716, ELM|SH3 ligand, 709-715, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91308595-91308596","hg19,15:g.91308595_91308596delinsAA",,,,,
1149,715,P,S,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM|WW domain ligands, 711-716, ELM|SH3 ligand, 709-715, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91308594-91308594","hg19,15:g.91308594C>T",0.690,,,,
1150,716,L,F,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM|WW domain ligands, 711-716, ELM",,cBioPortal,"msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91308599-91308599","hg19,15:g.91308599G>C",0.804,,,,
1151,717,R,T,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1152,718,S,,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM",,,,,,,,,,,
1153,719,L,F,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1154,719,L,P,,,,,,,,,,S,"USP7 binding motif, 715-719, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91308607-91308607, hg38,15:90765377-90765377","hg19,15:g.91308607T>C, hg38,15:g.90765377T>C",0.940,skin,"carcinoma, basal_cell_carcinoma",,
1155,720,I,F,,,,,,,,,,S,,,"cBioPortal,COSMIC",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91308609-91308609, hg38,15:90765379-90765379","hg19,15:g.91308609A>T, hg38,15:g.90765379A>T",0.862,lung,"carcinoma, non_small_cell_carcinoma",,
1156,721,V,A,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91308613-91308613","hg19,15:g.91308613T>C",0.176,,,0.0000039781678150,
1157,721,V,I,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cscc_hgsc_bcm_2014","Cutaneous Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91308612-91308612, hg38,15:90765382-90765382","hg19,15:g.91308612G>A, hg38,15:g.90765382G>A",0.026,"skin, head_neck","carcinoma, squamous_cell_carcinoma",0.0000437657656224,0.0000637145587767
1158,721,V,T,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91308612-91308613","hg19,15:g.91308612_91308613delinsAC",,,,,
1159,722,D,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1160,722,D,H,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91308615-91308615","hg19,15:g.91308615G>C",0.859,,,,
1161,723,Q,E,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1162,724,V,A,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1163,724,V,I,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv",mel_dfci_2019,Melanoma,"hg19,15:91308621-91308621","hg19,15:g.91308621G>A",0.115,,,,
1164,725,Q,,,,,,,,,,,S,,,,,,,,,,,,
1165,726,K,R,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91308628-91308628","hg19,15:g.91308628A>G",0.142,,,,
1166,727,L,,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,,,,,,,,,,
1167,728,T,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1168,728,T,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1169,728,T,S,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1170,729,S,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1171,729,S,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 726-732, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Basal Cell Carcinoma, Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91308637-91308637, hg19,15:91308637-91308638, hg38,15:90765407-90765407, hg38,15:90765407-90765408","hg19,15:g.91308637C>T, hg19,15:g.91308637_91308638delinsTT, hg38,15:g.90765407C>T, hg38,15:g.90765407_90765408delinsTT",0.256,", skin","carcinoma, basal_cell_carcinoma, malignant_melanoma",,
1172,730,L,F,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM|FHA phosphopeptide ligands, 726-732, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91308641-91308641","hg19,15:g.91308641G>T",0.077,,,,
1173,731,D,E,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM|FHA phosphopeptide ligands, 726-732, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90765414-90765414","hg38,15:g.90765414T>G",0.614,ovary,"carcinoma, clear_cell_carcinoma",0.0000119504772224,
1174,731,D,G,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM|FHA phosphopeptide ligands, 726-732, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91308643-91308643","hg19,15:g.91308643A>G",0.556,,,,
1175,731,D,N,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM|FHA phosphopeptide ligands, 726-732, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1176,732,I,F,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM|FHA phosphopeptide ligands, 726-732, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91310140-91310140","hg19,15:g.91310140A>T",0.552,,,,
1177,733,P,S,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91310143-91310143, hg38,15:90766913-90766913","hg19,15:g.91310143C>T, hg38,15:g.90766913C>T",0.159,skin,malignant_melanoma,0.0000040136141793,
1178,733,P,T,,,,,,,,,,S,"Calcineurin (PP2B)-docking motif LxvP, 730-733, ELM",,COSMIC,,,"hg38,15:90766913-90766913","hg38,15:g.90766913C>A",0.233,lung,"carcinoma, non_small_cell_carcinoma",,
1179,734,A,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1180,734,A,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1181,735,T,I,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1182,736,Y,C,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","luad_mskcc_2020, msk_met_2021, summit_2018","Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91310153-91310153, hg38,15:90766923-90766923","hg19,15:g.91310153A>G, hg38,15:g.90766923A>G",0.437,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000040058966799,
1183,736,Y,H,P,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1184,737,L,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,,,,,,,,,,
1185,738,T,A,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1186,738,T,R,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1187,739,G,S,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1188,739,G,V,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 736-739, ELM",,cBioPortal,"chol_tcga, chol_tcga_pan_can_atlas_2018",Cholangiocarcinoma,"hg19,15:91310162-91310162","hg19,15:g.91310162G>T",0.955,,,,
1189,740,D,,,,,,,,,,,C,"Caspase cleavage motif, 740-744, ELM|FHA phosphopeptide ligands, 740-746, ELM",,,,,,,,,,,
1190,741,K,N,,,Ubq,,,,,,,C,"Caspase cleavage motif, 740-744, ELM|FHA phosphopeptide ligands, 740-746, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91310169-91310169","hg19,15:g.91310169G>T",0.067,,,,
1191,742,T,S,,,,,,,,,,C,"Caspase cleavage motif, 740-744, ELM|FHA phosphopeptide ligands, 740-746, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1192,743,D,N,,,,,,,,,,C,"Caspase cleavage motif, 740-744, ELM|FHA phosphopeptide ligands, 740-746, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016, pan_origimed_2020","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91310173-91310173, hg38,15:90766943-90766943","hg19,15:g.91310173G>A, hg38,15:g.90766943G>A",0.369,"central_nervous_system, brain, lung","carcinoma, adenocarcinoma, glioma, oligodendroglioma_Grade_III, anaplastic",,
1193,744,S,,,,,,,,,,,C,"Caspase cleavage motif, 740-744, ELM|FHA phosphopeptide ligands, 740-746, ELM",,,,,,,,,,,
1194,745,E,K,,,,,,,,,,C,"FHA phosphopeptide ligands, 740-746, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1195,746,A,T,,,,,,,,,,C,"FHA phosphopeptide ligands, 740-746, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1196,746,A,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 740-746, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91310183-91310183","hg19,15:g.91310183C>T",0.331,,,0.0000399456738835,0.0000956327701626
1197,747,T,A,,,,,,,,,,C,"Atg8 protein family ligands, 747-758, ELM",,"cBioPortal,COSMIC","lgg_tcga_pan_can_atlas_2018, lgggbm_tcga_pub, pan_origimed_2020","Diffuse Glioma, Mixed Cancer Types","hg19,15:91310185-91310185, hg38,15:90766955-90766955","hg19,15:g.91310185A>G, hg38,15:g.90766955A>G",0.026,"central_nervous_system, brain",glioma,,
1198,748,N,,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM",,,,,,,,,,,
1199,749,I,N,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,15:91310192-91310192, hg38,15:90766962-90766962","hg19,15:g.91310192T>A, hg38,15:g.90766962T>A",0.370,skin,malignant_melanoma,,
1200,750,Y,S,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91310195-91310195, hg38,15:90766965-90766965","hg19,15:g.91310195A>C, hg38,15:g.90766965A>C",0.311,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
1201,751,L,F,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1202,752,Q,H,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,15:91310202-91310202","hg19,15:g.91310202G>T",0.339,,,,
1203,752,Q,K,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1204,752,Q,L,,,,,,,,,,S,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91310201-91310201","hg19,15:g.91310201A>T",0.345,,,,
1205,753,L,,,,,,,,,,,C,"Atg8 protein family ligands, 747-758, ELM|Phosphotyrosine ligands bound by SH2 domains, 750-753, ELM|Y-based sorting signal, 750-753, ELM",,,,,,,,,,,
1206,754,S,P,,,,,,,,,,C,"Atg8 protein family ligands, 747-758, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1207,755,K,E,,,Ubq,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1208,756,K,,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,,,,,,,,,,
1209,757,D,E,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1210,757,D,G,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,COSMIC,,,"hg38,15:90766986-90766986","hg38,15:g.90766986A>G",0.246,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
1211,757,D,H,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1212,757,D,N,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91310215-91310215","hg19,15:g.91310215G>A",0.207,,,,
1213,758,P,K,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91310218-91310219","hg19,15:g.91310218_91310219delinsAA",,,,,
1214,758,P,L,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM|Atg8 protein family ligands, 747-758, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1215,759,I,N,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1216,759,I,T,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1217,759,I,V,,,,,,,,,,C,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91310221-91310221","hg19,15:g.91310221A>G",0.243,,,,
1218,760,I,V,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1219,761,K,E,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1220,761,K,N,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1221,761,K,T,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91310228-91310228","hg19,15:g.91310228A>C",0.837,,,,
1222,762,L,F,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,15:91310230-91310230","hg19,15:g.91310230C>T",0.804,,,,
1223,762,L,R,,,,,,,,,,S,"MAPK docking motifs, 755-762, ELM|MAPK docking motifs, 755-762, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91310231-91310231","hg19,15:g.91310231T>G",0.908,,,,
1224,763,L,I,,,,,,,,,,S,"WW domain ligands, 763-768, ELM",,"cBioPortal,COSMIC","crc_msk_2017, gbm_tcga_pan_can_atlas_2018, msk_impact_2017, msk_met_2021, rectal_msk_2019","Colorectal Adenocarcinoma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,15:91310233-91310233, hg38,15:90767003-90767003","hg19,15:g.91310233C>A, hg38,15:g.90767003C>A",0.208,"central_nervous_system, brain, large_intestine, rectum","carcinoma, adenocarcinoma, glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,0.0000318654005481
1225,764,Y,C,,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM",,cBioPortal,"coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,15:91310237-91310237","hg19,15:g.91310237A>G",0.849,,,,
1226,765,V,I,,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1227,766,T,,P,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM",,,,,,,,,,,
1228,767,P,,,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM|Phosphotyrosine ligands bound by SH2 domains, 764-767, ELM",,,,,,,,,,,
1229,768,E,G,,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM",,cBioPortal,acc_2019,Adrenocortical Carcinoma,"hg19,15:91310249-91310249","hg19,15:g.91310249A>G",0.838,,,,
1230,768,E,K,,,,,,,,,,S,"Cks1 ligand, 764-769, ELM|WW domain ligands, 763-768, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1231,769,K,,,,Ubq,,,,,,,S,"Cks1 ligand, 764-769, ELM",,,,,,,,,,,
1232,770,I,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",stad_utokyo,Stomach Adenocarcinoma,"hg19,15:91312365-91312365, hg38,15:90769135-90769135","hg19,15:g.91312365C>G, hg38,15:g.90769135C>G",0.420,stomach,"carcinoma, carcinoma, diffuse_adenocarcinoma",,
1233,771,C,Y,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1234,772,A,E,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312370-91312370","hg19,15:g.91312370C>A",0.684,,,,
1235,772,A,V,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1236,773,S,N,P,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1237,774,N,S,,,,,,,,,,C,"Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1238,775,R,G,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1239,775,R,T,,,,,,,,,,C,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91312379-91312379, hg38,15:90769149-90769149","hg19,15:g.91312379G>C, hg38,15:g.90769149G>C",0.200,,"carcinoma, of_unknown_primary",,
1240,776,L,F,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1241,776,L,V,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1242,777,I,T,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1243,777,I,V,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 772-777, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1244,778,S,C,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1245,778,S,F,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,15:91312388-91312388, hg38,15:90769158-90769158","hg19,15:g.91312388C>T, hg38,15:g.90769158C>T",0.677,breast,carcinoma,,
1246,779,T,,,,,,,,,,,S,"14-3-3 binding phosphopeptide motif, 775-781, ELM",,,,,,,,,,,
1247,780,L,M,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM|14-3-3 binding phosphopeptide motif, 775-781, ELM",,cBioPortal,ucec_cptac_2020,Endometrial Carcinoma,"hg19,15:91312393-91312393","hg19,15:g.91312393C>A",0.525,,,,
1248,781,E,D,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM|14-3-3 binding phosphopeptide motif, 775-781, ELM",,cBioPortal,"msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91312398-91312398","hg19,15:g.91312398G>T",0.105,,,,
1249,781,E,K,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM|14-3-3 binding phosphopeptide motif, 775-781, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1250,782,N,S,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1251,782,N,T,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312400-91312400","hg19,15:g.91312400A>C",0.261,,,,
1252,783,L,F,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1253,783,L,I,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM",,COSMIC,,,"hg38,15:90769172-90769172","hg38,15:g.90769172C>A",0.211,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
1254,784,Y,C,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,"cBioPortal,Manual annotations from clinvar.csv","coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,15:91312406-91312406","hg19,15:g.91312406A>G",0.358,,,0.0000159062169449,0.0000318471337580
1255,784,Y,N,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1256,785,E,A,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,15:91312409-91312409","hg19,15:g.91312409A>C",0.206,,,,
1257,785,E,K,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91312408-91312408","hg19,15:g.91312408G>A",0.152,,,,
1258,786,R,K,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PCSK cleavage site, 786-790, ELM|PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1259,786,R,S,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PCSK cleavage site, 786-790, ELM|PP2A holoenzyme B56-docking site, 780-786, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91312413-91312413, hg38,15:90769183-90769183","hg19,15:g.91312413G>T, hg38,15:g.90769183G>T",0.618,"autonomic_ganglia, adrenal_gland",neuroblastoma,,
1260,787,K,E,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1261,787,K,R,,,,,,,,,,S,"NRD cleavage site, 785-787, ELM|PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1262,788,L,F,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1263,788,L,H,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91312418-91312418, hg38,15:90769188-90769188","hg19,15:g.91312418T>A, hg38,15:g.90769188T>A",0.669,lung,"carcinoma, non_small_cell_carcinoma",,
1264,788,L,I,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,"cBioPortal,Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv",acc_2019,Adrenocortical Carcinoma,"hg19,15:91312417-91312417","hg19,15:g.91312417C>A",0.503,,,0.0009106019516307,0.0008598726114650
1265,788,L,V,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM|Phosphotyrosine ligands bound by SH2 domains, 784-788, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1266,789,L,F,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1267,789,L,M,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM",,COSMIC,,,"hg38,15:90769190-90769190","hg38,15:g.90769190T>A",0.386,lung,"carcinoma, mixed_small_cell_carcinoma-adenocarcinoma",,
1268,790,A,S,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90769193-90769193","hg38,15:g.90769193G>T",0.060,liver,"other, neoplasm",,
1269,790,A,V,,,,,,,,,,S,"PCSK cleavage site, 786-790, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1270,791,R,C,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv","cellline_ccle_broad, msk_met_2021",Mixed Cancer Types,"hg19,15:91312426-91312426, hg38,15:90769196-90769196","hg19,15:g.91312426C>T, hg38,15:g.90769196C>T",0.411,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0001312294208408,0.0000318410494810
1271,791,R,H,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91312427-91312427, hg38,15:90769197-90769197","hg19,15:g.91312427G>A, hg38,15:g.90769197G>A",0.490,"large_intestine, large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000039765858624,
1272,792,F,V,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1273,793,V,I,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1274,794,I,T,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1275,795,D,G,,,,,,,,,,S,"SPAK-OSR1 docking motif, 791-795, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1276,796,E,K,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312441-91312441","hg19,15:g.91312441G>A",0.964,,,,
1277,797,A,T,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from mutations_icope_sentieon.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91312444-91312444, hg38,15:90769214-90769214","hg19,15:g.91312444G>A, hg38,15:g.90769214G>A",0.893,oesophagus,"carcinoma, adenocarcinoma",,
1278,797,A,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1279,798,H,D,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1280,798,H,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1281,798,H,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1282,799,C,,,,,,,,,,,C,,,,,,,,,,,,
1283,800,V,,,,,,,,,,,C,,,,,,,,,,,,
1284,801,S,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1285,802,Q,,,,,,,,,,,C,,,,,,,,,,,,
1286,803,W,C,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,COSMIC,,,"hg38,15:90769440-90769440","hg38,15:g.90769440G>T",0.853,stomach,"carcinoma, adenocarcinoma",,
1287,803,W,R,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90769438-90769438","hg38,15:g.90769438T>C",0.861,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",0.0000079549432017,
1288,804,G,R,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91312671-91312671","hg19,15:g.91312671G>A",0.865,,,,
1289,804,G,V,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,15:91312672-91312672, hg38,15:90769442-90769442","hg19,15:g.91312672G>T, hg38,15:g.90769442G>T",0.897,cervix,"carcinoma, squamous_cell_carcinoma",,
1290,805,H,Q,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1291,805,H,R,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91312675-91312675","hg19,15:g.91312675A>G",0.900,,,,
1292,805,H,Y,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,"cBioPortal,COSMIC","cll_broad_2015, cll_iuopa_2015, cllsll_icgc_2011",Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,"hg19,15:91312674-91312674, hg38,15:90769444-90769444","hg19,15:g.91312674C>T, hg38,15:g.90769444C>T",0.898,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma",,
1293,806,D,,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,,,,,,,,,,
1294,807,F,L,,,,,,,,,,C,"Pex14 ligand motif, 803-807, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91312682-91312682","hg19,15:g.91312682T>A",0.817,,,,
1295,808,R,C,,,,,,,,,,C,"PCSK cleavage site, 808-814, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, lusc_tcga_pan_can_atlas_2018, mel_mskimpact_2020, msk_impact_2017, msk_met_2021, nsclc_tcga_broad_2016, pan_origimed_2020, skcm_broad, skcm_tcga_pan_can_atlas_2018","Cutaneous Melanoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91312683-91312683, hg38,15:90769453-90769453","hg19,15:g.91312683C>T, hg38,15:g.90769453C>T",0.660,"lung, skin, small_intestine, duodenum","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",0.0000397718685619,0.0000318654005481
1296,808,R,H,,,,,,,,,,C,"PCSK cleavage site, 808-814, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","pan_origimed_2020, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub","Mixed Cancer Types, Stomach Adenocarcinoma","hg19,15:91312684-91312684, hg38,15:90769454-90769454","hg19,15:g.91312684G>A, hg38,15:g.90769454G>A",0.603,stomach,"carcinoma, adenocarcinoma",,0.0000318755578223
1297,809,Q,,,,,,,,,,,C,"PCSK cleavage site, 808-814, ELM",,,,,,,,,,,
1298,810,D,H,,,,,,,,,,C,"PCSK cleavage site, 808-814, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","gct_msk_2016, msk_impact_2017, msk_met_2021","Mixed Cancer Types, Testis","hg19,15:91312689-91312689, hg38,15:90769459-90769459","hg19,15:g.91312689G>C, hg38,15:g.90769459G>C",0.678,testis,"germ_cell_tumour, mixed",0.0000079539940981,
1299,811,Y,C,,,,,,,,,,C,"PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90769463-90769463","hg38,15:g.90769463A>G",0.445,liver,"other, neoplasm",0.0000039769337841,0.0000318532203606
1300,812,K,E,,,,,,,,,,C,"PCSK cleavage site, 812-814, ELM|PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_msk_tcga_2020, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91312695-91312695, hg38,15:90769465-90769465","hg19,15:g.91312695A>G, hg38,15:g.90769465A>G",0.491,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",,
1301,812,K,Q,,,,,,,,,,C,"PCSK cleavage site, 812-814, ELM|PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1302,813,R,T,,,,,,,,,,C,"PCSK cleavage site, 812-814, ELM|PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91312699-91312699","hg19,15:g.91312699G>C",0.240,,,0.0000039767756303,
1303,814,M,I,,,,,,,,,,C,"PCSK cleavage site, 812-814, ELM|PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1304,814,M,T,,,,,,,,,,C,"PCSK cleavage site, 812-814, ELM|PCSK cleavage site, 808-814, ELM|Y-based sorting signal, 811-814, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1305,815,N,K,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1306,816,M,I,,,,,,,,,,C,,,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,15:91312709-91312709, hg38,15:90769479-90769479","hg19,15:g.91312709G>A, hg38,15:g.90769479G>A",0.058,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000079532982328,
1307,816,M,K,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1308,816,M,L,,,,,,,,,,C,,,COSMIC,,,"hg38,15:90769477-90769477","hg38,15:g.90769477A>C",0.104,lung,"carcinoma, adenocarcinoma",,
1309,816,M,T,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312708-91312708","hg19,15:g.91312708T>C",0.095,,,,
1310,816,M,V,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1311,817,L,,,,,,,,,,,S,,,,,,,,,,,,
1312,818,R,C,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, pan_origimed_2020, pancan_pcawg_2020, skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015, tmb_mskcc_2018, ucec_cptac_2020","Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91312713-91312713, hg38,15:90769483-90769483","hg19,15:g.91312713C>T, hg38,15:g.90769483C>T",0.433,"skin, skin, lower_leg",malignant_melanoma,0.0000079534247447,
1313,818,R,G,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1314,818,R,H,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, gbm_tcga_pan_can_atlas_2018, msk_met_2021, pan_origimed_2020","Glioblastoma Multiforme, Mixed Cancer Types","hg19,15:91312714-91312714","hg19,15:g.91312714G>A",0.466,,,0.0000079535512606,
1315,818,R,L,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1316,819,Q,R,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91312717-91312717","hg19,15:g.91312717A>G",0.050,,,0.0000079534880022,
1317,820,K,N,,,Ubq,,,,Sumo,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1318,820,K,R,,,Ubq,,,,Sumo,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1319,821,F,S,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,15:91312723-91312723, hg38,15:90769493-90769493","hg19,15:g.91312723T>C, hg38,15:g.90769493T>C",0.631,lung,"carcinoma, squamous_cell_carcinoma",,
1320,822,P,L,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91312726-91312726","hg19,15:g.91312726C>T",0.242,,,,
1321,822,P,R,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1322,822,P,S,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, luad_mskcc_2020, mel_dfci_2019, mel_mskimpact_2020, msk_impact_2017, msk_met_2021, skcm_broad, tmb_mskcc_2018","Basal Cell Carcinoma, Cutaneous Melanoma, Lung Adenocarcinoma, Melanoma, Mixed Cancer Types","hg19,15:91312725-91312725, hg38,15:90769495-90769495","hg19,15:g.91312725C>T, hg38,15:g.90769495C>T",0.202,skin,"carcinoma, basal_cell_carcinoma, malignant_melanoma",,
1323,822,P,T,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91312725-91312725","hg19,15:g.91312725C>A",0.242,,,,
1324,823,S,C,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91312729-91312729, hg38,15:90769499-90769499","hg19,15:g.91312729C>G, hg38,15:g.90769499C>G",0.064,"urinary_tract, bladder",carcinoma,,
1325,823,S,F,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,COSMIC","lusc_tcga, lusc_tcga_pan_can_atlas_2018, lusc_tcga_pub, mel_mskimpact_2020, msk_met_2021, nsclc_tcga_broad_2016, pancan_pcawg_2020","Cutaneous Melanoma, Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91312729-91312729, hg38,15:90769499-90769499","hg19,15:g.91312729C>T, hg38,15:g.90769499C>T",0.068,lung,"carcinoma, squamous_cell_carcinoma",,
1326,824,V,,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,,,,,,,,,,
1327,825,P,H,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91312735-91312736","hg19,15:g.91312735_91312736delinsAT",,,,,
1328,825,P,L,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,Manual annotations from clinvar.csv","acc_2019, mixed_allen_2018, skcm_mskcc_2014, ucec_ccr_msk_2022","Adrenocortical Carcinoma, Cutaneous Melanoma, Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91312735-91312735","hg19,15:g.91312735C>T",0.329,,,0.0000238635007756,
1329,825,P,Q,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM|SH3 ligand, 819-825, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91312735-91312735, hg38,15:90769505-90769505","hg19,15:g.91312735C>A, hg38,15:g.90769505C>A",0.220,endometrium,"carcinoma, endometrioid_carcinoma",,
1330,826,V,L,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91312737-91312737","hg19,15:g.91312737G>T",0.051,,,,
1331,826,V,M,,,,,,,,,,S,"MAPK docking motifs, 818-826, ELM|MAPK docking motifs, 818-826, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91312737-91312737","hg19,15:g.91312737G>A",0.065,,,,
1332,827,M,I,,,,,,,,,,S,,,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, pan_origimed_2020","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91312742-91312742, hg38,15:90769512-90769512","hg19,15:g.91312742G>A, hg19,15:g.91312742G>T, hg38,15:g.90769512G>A",0.302,lung,"carcinoma, adenocarcinoma",,
1333,827,M,K,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1334,827,M,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1335,827,M,V,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312740-91312740","hg19,15:g.91312740A>G",0.435,,,,
1336,828,A,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1337,829,L,,,,,,,,,,,S,,,,,,,,,,,,
1338,830,T,A,P,,,,,,,,,S,,,cBioPortal,"dlbc_broad_2012, dlbcl_dfci_2018","Diffuse Large B-Cell Lymphoma, NOS","hg19,15:91312749-91312749","hg19,15:g.91312749A>G",0.596,,,,
1339,830,T,K,P,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1340,830,T,M,P,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","lung_msk_2017, msk_impact_2017, msk_met_2021, ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub, skcm_broad_brafresist_2012","Cutaneous Melanoma, High-Grade Serous Ovarian Cancer, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91312750-91312750, hg38,15:90769520-90769520","hg19,15:g.91312750C>T, hg38,15:g.90769520C>T",0.644,", lung, ovary","carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, malignant_melanoma",0.0000079551963342,
1341,830,T,R,P,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1342,831,A,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1343,832,T,,P,,,,,,,,,S,,,,,,,,,,,,
1344,833,A,T,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv","crc_dd_2022, msk_met_2021, rectal_msk_2022","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91312758-91312758","hg19,15:g.91312758G>A",0.574,,,0.0000079557659414,
1345,834,N,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1346,834,N,Y,,,,,,,,,,S,,,"cBioPortal,COSMIC","gbm_tcga, gbm_tcga_pan_can_atlas_2018, lgggbm_tcga_pub","Diffuse Glioma, Glioblastoma Multiforme","hg19,15:91312761-91312761, hg38,15:90769531-90769531","hg19,15:g.91312761A>T, hg38,15:g.90769531A>T",0.380,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1347,835,P,H,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91312765-91312765","hg19,15:g.91312765C>A",0.201,,,,
1348,835,P,L,,,,,,,,,,S,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91312765-91312765, hg38,15:90769535-90769535","hg19,15:g.91312765C>T, hg38,15:g.90769535C>T",0.156,skin,"carcinoma, basal_cell_carcinoma",,0.0000318654005481
1349,835,P,S,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91312764-91312764","hg19,15:g.91312764C>T",0.107,,,,
1350,836,R,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1351,836,R,K,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91312768-91312768","hg19,15:g.91312768G>A",0.295,,,,
1352,836,R,M,,,,,,,,,,S,,,"cBioPortal,COSMIC","hnsc_tcga_pan_can_atlas_2018, lung_msk_2017, msk_impact_2017, msk_met_2021","Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91312768-91312768, hg38,15:90769538-90769538","hg19,15:g.91312768G>T, hg38,15:g.90769538G>T",0.520,"lung, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,
1353,837,V,I,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91312770-91312770","hg19,15:g.91312770G>A",0.296,,,,
1354,837,V,L,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90769540-90769540","hg38,15:g.90769540G>T",0.462,liver,"other, neoplasm",,
1355,838,Q,K,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1356,838,Q,P,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91312774-91312774","hg19,15:g.91312774A>C",0.634,,,,
1357,839,K,E,,,Ubq,,,,Sumo,,,S,"PCSK cleavage site, 839-843, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",cellline_ccle_broad,Mixed Cancer Types,"hg19,15:91312776-91312776, hg38,15:90769546-90769546","hg19,15:g.91312776A>G, hg38,15:g.90769546A>G",0.157,stomach,"carcinoma, adenocarcinoma",0.0001511812026067,0.0001274534794800
1358,839,K,R,,,Ubq,,,,Sumo,,,S,"PCSK cleavage site, 839-843, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1359,840,D,A,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1360,840,D,H,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1361,840,D,N,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1362,841,I,,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM|Binding motif for UBA3 adenylation domain, 841-846, ELM",,,,,,,,,,,
1363,842,L,M,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM|Binding motif for UBA3 adenylation domain, 841-846, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1364,843,T,I,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM|Binding motif for UBA3 adenylation domain, 841-846, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1365,843,T,N,,,,,,,,,,S,"PCSK cleavage site, 839-843, ELM|Binding motif for UBA3 adenylation domain, 841-846, ELM",,COSMIC,,,"hg38,15:90769559-90769559","hg38,15:g.90769559C>A",0.078,prostate,"carcinoma, adenocarcinoma",,
1366,844,Q,H,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 841-846, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1367,845,L,P,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 841-846, ELM",,COSMIC,,,"hg38,15:90769565-90769565","hg38,15:g.90769565T>C",0.794,breast,"carcinoma, carcinoma, ductal_carcinoma",,
1368,846,K,E,,,,,,,,,,C,"Binding motif for UBA3 adenylation domain, 841-846, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1369,846,K,T,,,,,,,,,,C,"Binding motif for UBA3 adenylation domain, 841-846, ELM",,"Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv",,,,,,,,,
1370,847,I,F,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1371,847,I,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1372,847,I,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1373,848,L,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1374,848,L,V,,,,,,,,,,C,,,"cBioPortal,COSMIC",gbm_tcga_pan_can_atlas_2018,Glioblastoma Multiforme,"hg19,15:91312803-91312803, hg38,15:90769573-90769573","hg19,15:g.91312803C>G, hg38,15:g.90769573C>G",0.048,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1375,849,R,K,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1376,849,R,T,,,,,,,,,,C,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub",Head and Neck Squamous Cell Carcinoma,"hg19,15:91312807-91312807, hg38,15:90769577-90769577","hg19,15:g.91312807G>C, hg38,15:g.90769577G>C",0.042,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",,
1377,850,P,L,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1378,851,Q,E,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",mixed_impact_subset_2022,Mixed Cancer Types,"hg19,15:91312812-91312812, hg38,15:90769582-90769582","hg19,15:g.91312812C>G, hg38,15:g.90769582C>G",0.173,urinary_tract,"carcinoma, transitional_cell_carcinoma",0.0000119540010041,
1379,851,Q,H,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1380,851,Q,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1381,852,V,L,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1382,853,F,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,,,,,,,,,,
1383,854,S,G,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1384,854,S,N,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1385,855,M,I,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021, pan_origimed_2020","Breast, Mixed Cancer Types","hg19,15:91326061-91326061, hg38,15:90782831-90782831","hg19,15:g.91326061G>A, hg38,15:g.90782831G>A",0.278,breast,"carcinoma, lobular_carcinoma",,
1386,855,M,V,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1387,856,S,T,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,COSMIC,,,"hg38,15:90782833-90782833","hg38,15:g.90782833G>C",0.355,"skin, mucosal, anorectal",malignant_melanoma,,
1388,857,F,C,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91326066-91326066","hg19,15:g.91326066T>G",0.906,,,,
1389,857,F,S,,,,,,,,,,S,"BRCT phosphopeptide ligands, 853-857, ELM|Pex14 ligand motif, 853-857, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1390,858,N,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1391,859,R,,,,,,,,,,,S,,,,,,,,,,,,
1392,860,H,,,,,,,,,,,S,,,,,,,,,,,,
1393,861,N,,,,,,,,,,,S,,,,,,,,,,,,
1394,862,L,V,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 862-867, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_met_2021, sclc_ucologne_2015","Mixed Cancer Types, Small Cell Lung Cancer","hg19,15:91326080-91326080, hg38,15:90782850-90782850","hg19,15:g.91326080C>G, hg38,15:g.90782850C>G",0.453,lung,"carcinoma, small_cell_carcinoma",,
1395,863,K,,,,Ubq,,,Ac,,,,S,"Immunoreceptor tyrosine-based motif, 862-867, ELM",,,,,,,,,,,
1396,864,Y,,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,,,,,,,,,,
1397,865,Y,C,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 865-871, ELM|Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91326090-91326090","hg19,15:g.91326090A>G",0.087,,,0.0000198978048742,
1398,865,Y,S,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 865-871, ELM|Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1399,866,V,I,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 865-871, ELM|Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1400,866,V,L,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 865-871, ELM|Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,COSMIC,,,"hg38,15:90782862-90782862","hg38,15:g.90782862G>T",0.448,liver,"other, neoplasm",0.0000039794342836,
1401,867,L,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 865-871, ELM|Immunoreceptor tyrosine-based motif, 862-867, ELM|Y-based sorting signal, 864-867, ELM",,,,,,,,,,,
1402,868,P,A,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,COSMIC,,,"hg38,15:90782868-90782868","hg38,15:g.90782868C>G",0.204,"large_intestine, colon","carcinoma, adenocarcinoma",,
1403,868,P,L,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",msk_impact_2017,Mixed Cancer Types,"hg19,15:91326099-91326099, hg38,15:90782869-90782869","hg19,15:g.91326099C>T, hg38,15:g.90782869C>T",0.184,"haematopoietic_and_lymphoid_tissue, ovary, prostate, soft_tissue, blood_vessel, central_nervous_system","carcinoma, carcinoma, adenocarcinoma, carcinoma, serous_carcinoma, haemangioblastoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0556126186381298,0.0686474755856258
1404,868,P,Q,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1405,868,P,R,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|Phosphotyrosine ligands bound by SH2 domains, 865-868, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1406,869,K,Q,,,,,,,,,,S,"MAPK docking motifs, 869-876, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1407,870,K,Q,,,,,,,,,,S,"MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1408,870,K,R,,,,,,,,,,S,"MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,"cBioPortal,COSMIC","lung_msk_mind_2020, msk_impact_2017, tmb_mskcc_2018","Lung, Mixed Cancer Types","hg19,15:91326105-91326105, hg38,15:90782875-90782875","hg19,15:g.91326105A>G, hg38,15:g.90782875A>G",0.136,lung,"carcinoma, undifferentiated_carcinoma",,
1409,871,P,,,,,,,,,,,S,"MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 865-871, ELM|SH3 ligand, 868-873, ELM|SH3 ligand, 865-871, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,,,,,,,,,,
1410,872,K,,,,,,,,,,,S,"MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,,,,,,,,,,
1411,873,K,E,,,Ubq,,,,Sumo,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1412,873,K,N,,,Ubq,,,,Sumo,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM|USP7 binding motif, 869-873, ELM|SH3 ligand, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM|NLS classical Nuclear Localization Signals, 868-873, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90782885-90782885","hg38,15:g.90782885G>C",0.034,"upper_aerodigestive_tract, head_neck",carcinoma,0.0000477528313450,0.0000636699350567
1413,874,V,M,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1414,875,A,E,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1415,875,A,T,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,COSMIC,,,"hg38,15:90782889-90782889","hg38,15:g.90782889G>A",0.134,liver,"carcinoma, hepatocellular_carcinoma",,
1416,876,F,L,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|MAPK docking motifs, 869-876, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91326122-91326122","hg19,15:g.91326122T>C",0.043,,,,
1417,877,D,G,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ihch_msk_2021,Intrahepatic Cholangiocarcinoma,"hg19,15:91326126-91326126","hg19,15:g.91326126A>G",0.420,,,0.0000039799727770,
1418,877,D,H,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,15:91326125-91326125","hg19,15:g.91326125G>C",0.424,,,,
1419,877,D,N,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,cBioPortal,"msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91326125-91326125","hg19,15:g.91326125G>A",0.200,,,,
1420,877,D,Y,,,,,,,,,,S,"PCSK cleavage site, 873-877, ELM|PP1-docking motif RVXF, 870-877, ELM|PP1-docking motif RVXF, 871-877, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91326125-91326125","hg19,15:g.91326125G>T",0.464,,,,
1421,878,C,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1422,878,C,Y,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90782899-90782899","hg38,15:g.90782899G>A",0.562,"central_nervous_system, cerebellum","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1423,879,L,V,,,,,,,,,,S,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90782901-90782901","hg38,15:g.90782901C>G",0.021,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,
1424,880,E,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1425,880,E,Q,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, lihc_tcga","Hepatocellular Carcinoma, Mixed Cancer Types","hg19,15:91326134-91326134","hg19,15:g.91326134G>C",0.051,,,0.0000517565372488,0.0001591748376417
1426,881,W,C,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1427,881,W,L,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90782908-90782908","hg38,15:g.90782908G>T",0.319,large_intestine,"carcinoma, adenocarcinoma",,
1428,882,I,M,,,,,,,,,,S,"NRD cleavage site, 882-884, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91326142-91326142","hg19,15:g.91326142C>G",0.338,,,,
1429,883,R,G,,,,,,,,,,S,"NRD cleavage site, 882-884, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1430,884,K,,,,,,,,,,,C,"NRD cleavage site, 882-884, ELM",,,,,,,,,,,
1431,885,H,N,,,,,,,,,,S,,,"cBioPortal,COSMIC",ov_tcga_pan_can_atlas_2018,High-Grade Serous Ovarian Cancer,"hg19,15:91326149-91326149, hg38,15:90782919-90782919","hg19,15:g.91326149C>A, hg38,15:g.90782919C>A",0.028,ovary,"carcinoma, serous_carcinoma",,
1432,885,H,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1433,886,H,N,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91326152-91326152, hg38,15:90782922-90782922","hg19,15:g.91326152C>A, hg38,15:g.90782922C>A",0.218,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",0.0000238984792601,
1434,886,H,P,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1435,887,P,S,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91326155-91326155","hg19,15:g.91326155C>T",0.337,,,,
1436,888,Y,H,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1437,889,D,N,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91328153-91328153","hg19,15:g.91328153G>A",0.355,,,,
1438,889,D,Y,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91328153-91328153, hg38,15:90784923-90784923","hg19,15:g.91328153G>T, hg38,15:g.90784923G>T",0.808,lung,"carcinoma, adenocarcinoma",,
1439,890,S,,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,,,,,,,,,,
1440,891,G,E,,,,,,,,,,S,"USP7 binding motif, 887-891, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91328160-91328160","hg19,15:g.91328160G>A",0.866,,,,
1441,892,I,T,,,,,,,,,,S,,,"cBioPortal,COSMIC","msk_met_2021, nbl_broad_2013","Mixed Cancer Types, Neuroblastoma","hg19,15:91328163-91328163, hg38,15:90784933-90784933","hg19,15:g.91328163T>C, hg38,15:g.90784933T>C",0.856,autonomic_ganglia,neuroblastoma,,
1442,892,I,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1443,893,I,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91328167-91328167, hg38,15:90784937-90784937","hg19,15:g.91328167T>G, hg38,15:g.90784937T>G",0.659,endometrium,"carcinoma, endometrioid_carcinoma",,
1444,894,Y,H,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91328168-91328168","hg19,15:g.91328168T>C",0.898,,,,
1445,895,C,G,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1446,896,L,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1447,896,L,P,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,cBioPortal,luad_mskcc_2020,Lung Adenocarcinoma,"hg19,15:91328175-91328175","hg19,15:g.91328175T>C",0.903,,,,
1448,896,L,V,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1449,897,S,C,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1450,897,S,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, skcm_broad","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91328178-91328178, hg19,15:91328178-91328179, hg38,15:90784948-90784948","hg19,15:g.91328178C>T, hg19,15:g.91328178_91328179delinsTT, hg38,15:g.90784948C>T",0.896,skin,malignant_melanoma,,
1451,897,S,P,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 894-897, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1452,898,R,W,,,,,,,,,,S,"NRD cleavage site, 898-900, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Lung Adenocarcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91328180-91328180, hg38,15:90784950-90784950","hg19,15:g.91328180A>T, hg38,15:g.90784950A>T",0.808,lung,"carcinoma, adenocarcinoma",,
1453,899,R,G,,,,,,,,,,S,"NRD cleavage site, 898-900, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1454,899,R,L,,,,,,,,,,S,"NRD cleavage site, 898-900, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,15:91328184-91328185",,,,,,
1455,899,R,Q,,,,,,,,,,S,"NRD cleavage site, 898-900, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1456,900,E,Q,,,,,,,,,,S,"NRD cleavage site, 898-900, ELM",,cBioPortal,breast_ink4_msk_2021,Breast,"hg19,15:91328186-91328186","hg19,15:g.91328186G>C",0.426,,,,
1457,901,C,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1458,901,C,Y,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90784960-90784960","hg38,15:g.90784960G>A",0.875,lung,"carcinoma, adenocarcinoma",0.0000039770603161,
1459,902,D,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,"cBioPortal,COSMIC","cesc_tcga_pan_can_atlas_2018, msk_met_2021","Cervical Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91328192-91328192, hg38,15:90784962-90784962","hg19,15:g.91328192G>C, hg38,15:g.90784962G>C",0.894,cervix,"carcinoma, squamous_cell_carcinoma",,
1460,903,T,N,P,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1461,904,M,K,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91328199-91328199, hg38,15:90784969-90784969","hg19,15:g.91328199T>A, hg38,15:g.90784969T>A",0.703,lung,"carcinoma, adenocarcinoma",,
1462,905,A,T,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1463,906,D,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91328204-91328204, hg38,15:90784974-90784974","hg19,15:g.91328204G>A, hg38,15:g.90784974G>A",0.245,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, plasma_cell_myeloma",,
1464,906,D,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1465,907,T,A,P,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1466,907,T,M,P,,,,,,,,,S,"FHA phosphopeptide ligands, 901-907, ELM",,"cBioPortal,COSMIC,Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv","msk_met_2021, ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91328208-91328208, hg38,15:90784978-90784978","hg19,15:g.91328208C>T, hg38,15:g.90784978C>T",0.280,"biliary_tract, gallbladder, endometrium","carcinoma, adenocarcinoma, carcinoma, endometrioid_carcinoma",0.0001033978111479,0.0001274128814423
1467,908,L,,,,,,,,,,,S,,,,,,,,,,,,
1468,909,Q,E,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1469,909,Q,P,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1470,909,Q,R,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91328214-91328214, hg38,15:90784984-90784984","hg19,15:g.91328214A>G, hg38,15:g.90784984A>G",0.170,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, non_small_cell_carcinoma, lymphoid_neoplasm",0.0000119295678315,
1471,910,R,K,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1472,910,R,T,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91328217-91328217, hg38,15:90784987-90784987","hg19,15:g.91328217G>C, hg38,15:g.90784987G>C",0.181,"urinary_tract, bladder",carcinoma,,
1473,911,D,G,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1474,911,D,N,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,15:91328219-91328219","hg19,15:g.91328219G>A",0.230,,,,
1475,911,D,V,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1476,912,G,E,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1477,913,L,F,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,cBioPortal,glioma_msk_2018,Diffuse Glioma,"hg19,15:91328225-91328225","hg19,15:g.91328225C>T",0.310,,,,
1478,913,L,I,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91328225-91328225","hg19,15:g.91328225C>A",0.187,,,,
1479,913,L,R,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91328226-91328226, hg38,15:90784996-90784996","hg19,15:g.91328226T>G, hg38,15:g.90784996T>G",0.723,endometrium,"carcinoma, endometrioid_carcinoma",,
1480,914,A,T,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,Manual annotations from clinvar.csv","paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,15:91328228-91328228","hg19,15:g.91328228G>A",0.110,,,0.0000198838781516,
1481,914,A,V,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91328229-91328229","hg19,15:g.91328229C>T",0.196,,,,
1482,915,A,T,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,Manual annotations from clinvar.csv",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,15:91328231-91328231","hg19,15:g.91328231G>A",0.765,,,,
1483,915,A,V,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90785002-90785002","hg38,15:g.90785002C>T",0.592,lung,"carcinoma, adenocarcinoma",0.0000278378722321,0.0000318390219052
1484,916,L,F,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,15:91328234-91328234, hg38,15:90785004-90785004","hg19,15:g.91328234C>T, hg38,15:g.90785004C>T",0.583,skin,malignant_melanoma,,
1485,916,L,V,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1486,917,A,,,,,,,,,,,S,"APCC-binding Destruction motifs, 909-917, ELM",,,,,,,,,,,
1487,918,Y,,,,,,,,,,,S,,,,,,,,,,,,
1488,919,H,N,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1489,919,H,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1490,920,A,S,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90785016-90785016","hg38,15:g.90785016G>T",0.663,liver,"other, neoplasm",,
1491,920,A,T,,,,,,,,,,S,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91328246-91328246","hg19,15:g.91328246G>A",0.825,,,,
1492,921,G,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91328250-91328250, hg38,15:90785020-90785020","hg19,15:g.91328250G>T, hg38,15:g.90785020G>T",0.819,"liver, urinary_tract, bladder","carcinoma, other, neoplasm",,
1493,922,L,,,,,,,,,,,S,,,,,,,,,,,,
1494,923,S,I,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91328256-91328256","hg19,15:g.91328256G>T",0.655,,,,
1495,923,S,N,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1496,923,S,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1497,924,D,N,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91328258-91328258, hg38,15:90785028-90785028","hg19,15:g.91328258G>A, hg38,15:g.90785028G>A",0.399,"urinary_tract, bladder",carcinoma,,
1498,925,S,A,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1499,925,S,P,,,,,,,,,,S,,,"cBioPortal,COSMIC","acc_2019, msk_impact_2017, msk_met_2021","Adrenocortical Carcinoma, Mixed Cancer Types","hg19,15:91328261-91328261, hg38,15:90785031-90785031","hg19,15:g.91328261T>C, hg38,15:g.90785031T>C",0.279,"salivary_gland, mouth_roof","carcinoma, adenoid_cystic_carcinoma",,
1500,925,S,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1501,926,A,S,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1502,926,A,V,,,,,,,,,,S,,,cBioPortal,metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,15:91328265-91328265","hg19,15:g.91328265C>T",0.166,,,,
1503,927,R,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1504,928,D,E,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1505,928,D,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1506,929,E,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1507,930,V,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1508,931,Q,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1509,932,Q,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1510,933,K,,,,,,,,,,,S,,,,,,,,,,,,
1511,934,W,C,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1512,935,I,V,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91328291-91328291, hg38,15:90785061-90785061","hg19,15:g.91328291A>G, hg38,15:g.90785061A>G",0.154,endometrium,"carcinoma, endometrioid_carcinoma",0.0000079546900853,
1513,936,N,D,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91328294-91328294, hg38,15:90785064-90785064","hg19,15:g.91328294A>G, hg38,15:g.90785064A>G",0.550,skin,"carcinoma, basal_cell_carcinoma",0.0000039775032417,
1514,937,Q,,,,,,,,,,,S,,,,,,,,,,,,
1515,938,D,,,,,,,,,,,S,,,,,,,,,,,,
1516,939,G,,,,,,,,,,,S,,,,,,,,,,,,
1517,940,C,R,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90785076-90785076","hg38,15:g.90785076T>C",0.849,thyroid,carcinoma,,
1518,941,Q,R,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1519,942,V,A,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91333880-91333880, hg38,15:90790650-90790650","hg19,15:g.91333880T>C, hg38,15:g.90790650T>C",0.868,,"carcinoma, of_unknown_primary",,
1520,943,I,M,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1521,943,I,V,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1522,944,C,,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,,,,,,,,,,
1523,945,A,T,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1524,946,T,I,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1525,946,T,K,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1526,947,I,T,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1527,947,I,V,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90790664-90790664","hg38,15:g.90790664A>G",0.113,gastrointestinal_tract_(site_indeterminate),carcinoma,0.0002067972670946,0.0001592458118351
1528,948,A,E,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1529,949,F,I,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,cBioPortal,dlbcl_dfci_2018,"Diffuse Large B-Cell Lymphoma, NOS","hg19,15:91333900-91333900","hg19,15:g.91333900T>A",0.899,,,,
1530,950,G,E,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,"cBioPortal,COSMIC","bcc_unige_2016, cesc_tcga_pan_can_atlas_2018, msk_met_2021","Basal Cell Carcinoma, Cervical Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91333904-91333904, hg38,15:90790674-90790674","hg19,15:g.91333904G>A, hg38,15:g.90790674G>A",0.929,skin,"carcinoma, basal_cell_carcinoma",,
1531,951,M,I,,,,,,,,,,C,"NES Nuclear Export Signal, 941-957, ELM",,"cBioPortal,Manual annotations from clinvar.csv","mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91333908-91333908","hg19,15:g.91333908G>A",0.852,,,,
1532,952,G,V,,,,,,,,,,C,"NES Nuclear Export Signal, 941-957, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91333910-91333910","hg19,15:g.91333910G>T",0.942,,,0.0000039769970491,
1533,953,I,T,,,,,,,,,,C,"NES Nuclear Export Signal, 941-957, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91333913-91333913","hg19,15:g.91333913T>C",0.898,,,,
1534,954,D,,,,,,,,,,,C,"NES Nuclear Export Signal, 941-957, ELM",,,,,,,,,,,
1535,955,K,,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,,,,,,,,,,
1536,956,P,L,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, crc_msk_2017, lymphoma_cellline_msk_2020, msk_met_2021","Colorectal Adenocarcinoma, Lymphoid, Mixed Cancer Types","hg19,15:91333922-91333922, hg38,15:90790692-90790692","hg19,15:g.91333922C>T, hg38,15:g.90790692C>T",0.850,"haematopoietic_and_lymphoid_tissue, large_intestine, rectum","carcinoma, adenocarcinoma, lymphoid_neoplasm, Burkitt_lymphoma",0.0000079544369850,
1537,957,D,,,,,,,,,,,S,"NES Nuclear Export Signal, 941-957, ELM",,,,,,,,,,,
1538,958,V,E,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1539,958,V,M,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_met_2021, rectal_msk_2022","Bowel, Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91333927-91333927, hg38,15:90790697-90790697","hg19,15:g.91333927G>A, hg38,15:g.90790697G>A",0.878,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",0.0000159083678015,0.0000318390219052
1540,959,R,Q,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1541,960,F,,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,,,,,,,,,,
1542,961,V,A,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1543,961,V,L,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1544,962,I,F,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1545,963,H,Q,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91333944-91333944, hg38,15:90790714-90790714","hg19,15:g.91333944T>A, hg38,15:g.90790714T>A",0.687,liver,carcinoma,,
1546,963,H,Y,,,,,,,,,,S,"SPAK-OSR1 docking motif, 959-963, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91333942-91333942, hg38,15:90790712-90790712","hg19,15:g.91333942C>T, hg38,15:g.90790712C>T",0.877,"upper_aerodigestive_tract, pharynx, oropharynx","carcinoma, squamous_cell_carcinoma",,
1547,964,A,T,,,,,,,,,,S,,,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pub",Colorectal Adenocarcinoma,"hg19,15:91333945-91333945, hg38,15:90790715-90790715","hg19,15:g.91333945G>A, hg38,15:g.90790715G>A",0.402,"large_intestine, caecum","carcinoma, adenocarcinoma",,
1548,965,S,C,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1549,965,S,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1550,966,L,V,,,,,,,,,,S,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91333951-91333951, hg38,15:90790721-90790721","hg19,15:g.91333951C>G, hg38,15:g.90790721C>G",0.576,lung,"carcinoma, adenocarcinoma",,
1551,967,P,H,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1552,967,P,N,,,,,,,,,,S,,,cBioPortal,skcm_tcga_pub_2015,Cutaneous Melanoma,"hg19,15:91333954-91333955","hg19,15:g.91333954_91333955delinsAA",,,,,
1553,967,P,S,,,,,,,,,,S,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91333954-91333954","hg19,15:g.91333954C>T",0.908,,,,
1554,968,K,,,,,,,,,,,S,,,,,,,,,,,,
1555,969,S,,,,,,,,,,,S,,,,,,,,,,,,
1556,970,V,,,,,,,,,,,S,,,,,,,,,,,,
1557,971,E,K,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1558,972,G,V,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91333970-91333970","hg19,15:g.91333970G>T",0.814,,,0.0000079542471703,
1559,973,Y,N,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1560,974,Y,S,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 974-977, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1561,975,Q,E,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 974-977, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1562,976,E,G,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 974-977, ELM",,COSMIC,,,"hg38,15:90790752-90790752","hg38,15:g.90790752A>G",0.858,"skin, mucosal, female_genital_tract_(site_indeterminate)",malignant_melanoma,,
1563,977,S,A,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 974-977, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1564,977,S,P,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 974-977, ELM",,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91333984-91333984, hg38,15:90790754-90790754","hg19,15:g.91333984T>C, hg38,15:g.90790754T>C",0.830,lung,"carcinoma, adenocarcinoma",,
1565,978,G,,,,,,,,,,,S,,,,,,,,,,,,
1566,979,R,K,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91333991-91333991","hg19,15:g.91333991G>A",0.946,,,,
1567,979,R,T,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91333991-91333991, hg38,15:90790761-90790761","hg19,15:g.91333991G>C, hg38,15:g.90790761G>C",0.973,"urinary_tract, bladder",carcinoma,,
1568,980,A,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1569,981,G,,,,,,,,,,,S,,,,,,,,,,,,
1570,982,R,K,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1571,983,D,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1572,983,D,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1573,984,G,E,,,,,,,,,,S,,,"cBioPortal,COSMIC",msk_met_2021,Mixed Cancer Types,"hg19,15:91334006-91334006, hg38,15:90790776-90790776","hg19,15:g.91334006G>A, hg38,15:g.90790776G>A",0.941,lung,carcinoma,,
1574,984,G,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1575,984,G,V,,,,,,,,,,S,,,"cBioPortal,COSMIC",luad_tcga_pan_can_atlas_2018,Lung Adenocarcinoma,"hg19,15:91334006-91334006, hg38,15:90790776-90790776","hg19,15:g.91334006G>T, hg38,15:g.90790776G>T",0.953,"lung, right_upper_lobe","carcinoma, adenocarcinoma",,
1576,985,E,,,,,,,,,,,S,,,,,,,,,,,,
1577,986,I,T,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1578,986,I,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1579,987,S,C,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1580,987,S,F,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1581,988,H,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1582,989,C,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1583,990,L,M,,,,,,,,,,S,,,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,15:91334023-91334023, hg38,15:90790793-90790793","hg19,15:g.91334023C>A, hg38,15:g.90790793C>A",0.186,oesophagus,"carcinoma, adenocarcinoma",,
1584,990,L,V,,,,,,,,,,S,,,cBioPortal,"ccle_broad_2019, utuc_msk_2019, utuc_pdx_msk_2019","Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,15:91334023-91334023","hg19,15:g.91334023C>G",0.020,,,,
1585,991,L,,,,,,,,,,,S,,,,,,,,,,,,
1586,992,F,L,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1587,992,F,S,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1588,992,F,V,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91334029-91334029","hg19,15:g.91334029T>G",0.734,,,,
1589,993,Y,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91334033-91334033","hg19,15:g.91334033A>T",0.641,,,,
1590,994,T,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1591,994,T,I,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM",,COSMIC,,,"hg38,15:90790806-90790806","hg38,15:g.90790806C>T",0.433,lung,"carcinoma, non_small_cell_carcinoma",,
1592,995,Y,C,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM|Y-based sorting signal, 995-998, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90790809-90790809","hg38,15:g.90790809A>G",0.843,pancreas,"carcinoma, ductal_carcinoma",0.0000039783577339,
1593,995,Y,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM|Y-based sorting signal, 995-998, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017","Breast, Mixed Cancer Types","hg19,15:91334039-91334039, hg38,15:90790809-90790809","hg19,15:g.91334039A>T, hg38,15:g.90790809A>T",0.478,breast,"carcinoma, ductal_carcinoma",0.0000039783577339,
1594,995,Y,H,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM|Y-based sorting signal, 995-998, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1595,995,Y,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM|Y-based sorting signal, 995-998, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1596,996,H,R,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Phosphotyrosine ligands bound by SH2 domains, 993-996, ELM|Y-based sorting signal, 995-998, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1597,997,D,N,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Y-based sorting signal, 995-998, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91334044-91334044","hg19,15:g.91334044G>A",0.854,,,,
1598,998,V,,,,,,,,,,,S,"FHA phosphopeptide ligands, 992-998, ELM|Atg8 protein family ligands, 994-1001, ELM|Y-based sorting signal, 995-998, ELM",,,,,,,,,,,
1599,999,T,I,,,,,,,,,,S,"Atg8 protein family ligands, 994-1001, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91334051-91334051, hg38,15:90790821-90790821","hg19,15:g.91334051C>T, hg38,15:g.90790821C>T",0.189,pancreas,carcinoid-endocrine_tumour,,
1600,999,T,S,,,,,,,,,,S,"Atg8 protein family ligands, 994-1001, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1601,1000,R,S,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|Atg8 protein family ligands, 994-1001, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1602,1000,R,T,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|Atg8 protein family ligands, 994-1001, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91334054-91334054","hg19,15:g.91334054G>C",0.660,,,,
1603,1001,L,,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|Atg8 protein family ligands, 994-1001, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,,,,,,,,,,
1604,1002,K,R,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1605,1002,K,T,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1606,1003,R,G,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,15:91334062-91334062","hg19,15:g.91334062A>G",0.687,,,,
1607,1003,R,K,,,,,,,,,,S,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91334063-91334063, hg38,15:90790833-90790833","hg19,15:g.91334063G>A, hg38,15:g.90790833G>A",0.253,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
1608,1004,L,F,,,,,,,,,,C,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1609,1004,L,H,,,,,,,,,,C,"PCSK cleavage site, 1000-1004, ELM|PCSK cleavage site, 1002-1004, ELM|Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1610,1005,I,K,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1611,1005,I,L,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91334068-91334068, hg38,15:90790838-90790838","hg19,15:g.91334068A>T, hg38,15:g.90790838A>T",0.339,skin,malignant_melanoma,,
1612,1005,I,M,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91334070-91334070","hg19,15:g.91334070A>G",0.515,,,,
1613,1005,I,T,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","hnc_mskcc_2016, msk_impact_2017, msk_met_2021","Head and Neck, Mixed Cancer Types","hg19,15:91334069-91334069, hg38,15:90790839-90790839","hg19,15:g.91334069T>C, hg38,15:g.90790839T>C",0.852,"upper_aerodigestive_tract, pharynx, hypopharynx","carcinoma, squamous_cell_carcinoma",0.0000119428653323,
1614,1005,I,V,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM|Adaptin binding Endosome-Lysosome-Basolateral sorting signals, 1000-1005, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1615,1006,M,I,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Squamous Cell Carcinoma, Non-Small Cell Lung Cancer","hg19,15:91334073-91334073, hg38,15:90790843-90790843","hg19,15:g.91334073G>A, hg38,15:g.90790843G>A",0.090,lung,"carcinoma, squamous_cell_carcinoma",,
1616,1006,M,K,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1617,1006,M,T,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1618,1007,M,I,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1619,1008,E,V,,,,,,,,,,C,"Clathrin box, 1004-1008, ELM|Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1620,1009,K,E,,,,,,,,,,C,"Binding motif for UBA3 adenylation domain, 1004-1009, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91337402-91337402","hg19,15:g.91337402A>G",0.345,,,,
1621,1010,D,V,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1622,1011,G,E,,,,,,,,,,C,,,cBioPortal,"mixed_allen_2018, skcm_dfci_2015","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91337409-91337409","hg19,15:g.91337409G>A",0.539,,,,
1623,1011,G,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1624,1012,N,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1625,1013,H,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1626,1014,H,D,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1627,1014,H,N,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91337417-91337417","hg19,15:g.91337417C>A",0.281,,,,
1628,1014,H,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1629,1015,T,A,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1630,1015,T,I,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","cellline_ccle_broad, es_dfarber_broad_2014","Ewing Sarcoma, Mixed Cancer Types","hg19,15:91337421-91337421, hg38,15:90794191-90794191","hg19,15:g.91337421C>T, hg38,15:g.90794191C>T",0.431,"bone, haematopoietic_and_lymphoid_tissue, pleura","Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma, mesothelioma, biphasic",0.0001205468002861,0.0002234708210956
1631,1015,T,R,,,,,,,,,,C,,,COSMIC,,,"hg38,15:90794191-90794191","hg38,15:g.90794191C>G",0.406,oesophagus,"carcinoma, squamous_cell_carcinoma",0.0000040182266762,
1632,1016,R,G,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1633,1016,R,I,,,,,,,,,,C,,,"cBioPortal,COSMIC","lusc_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016, pancan_pcawg_2020","Lung Squamous Cell Carcinoma, Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91337424-91337424, hg38,15:90794194-90794194","hg19,15:g.91337424G>T, hg38,15:g.90794194G>T",0.221,lung,"carcinoma, squamous_cell_carcinoma",,
1634,1016,R,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1635,1017,E,G,,,,,,,,,,C,"Atg8 protein family ligands, 1017-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1636,1017,E,K,,,,,,,,,,C,"Atg8 protein family ligands, 1017-1027, ELM",,cBioPortal,ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91337426-91337426","hg19,15:g.91337426G>A",0.103,,,,
1637,1018,T,A,,,,,,,,,,C,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1638,1019,H,P,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1639,1020,F,,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,,,,,,,,,,
1640,1021,N,D,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1641,1021,N,I,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1642,1021,N,S,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91337439-91337439","hg19,15:g.91337439A>G",0.326,,,0.0000241680160476,
1643,1022,N,T,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1644,1023,L,V,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91337444-91337444","hg19,15:g.91337444T>G",0.710,,,,
1645,1023,L,W,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM",,COSMIC,,,"hg38,15:90794215-90794215","hg38,15:g.90794215T>G",0.906,pancreas,"carcinoma, medullary_carcinoma",,
1646,1024,Y,C,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,"Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv",,,,,,,,,
1647,1025,S,G,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91337450-91337450","hg19,15:g.91337450A>G",0.658,,,,
1648,1026,M,I,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91337455-91337455","hg19,15:g.91337455G>T",0.714,,,,
1649,1026,M,L,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91337453-91337453, hg38,15:90794223-90794223","hg19,15:g.91337453A>C, hg38,15:g.90794223A>C",0.569,,"carcinoma, of_unknown_primary",,
1650,1026,M,T,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91337454-91337454","hg19,15:g.91337454T>C",0.892,,,,
1651,1026,M,V,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1652,1027,V,A,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1653,1027,V,I,,,,,,,,,,S,"Atg8 protein family ligands, 1017-1027, ELM|Atg8 protein family ligands, 1018-1027, ELM|Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM|Y-based sorting signal, 1024-1027, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1654,1028,H,R,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1655,1028,H,Y,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1024-1028, ELM",,"cBioPortal,COSMIC",coadread_tcga_pan_can_atlas_2018,Colorectal Adenocarcinoma,"hg19,15:91337459-91337459, hg38,15:90794229-90794229","hg19,15:g.91337459C>T, hg38,15:g.90794229C>T",0.439,"large_intestine, caecum","carcinoma, adenocarcinoma",,
1656,1029,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,,,,,,,,,,
1657,1030,C,F,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,"cBioPortal,COSMIC","luad_tcga_pan_can_atlas_2018, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91337466-91337466, hg38,15:90794236-90794236","hg19,15:g.91337466G>T, hg38,15:g.90794236G>T",0.857,lung,"carcinoma, adenocarcinoma",,
1658,1030,C,G,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1659,1031,E,G,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1660,1031,E,K,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1661,1031,E,Q,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91337468-91337468","hg19,15:g.91337468G>C",0.697,,,,
1662,1032,N,Y,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1030-1035, ELM|Phosphotyrosine ligands bound by SH2 domains, 1029-1032, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1663,1033,I,T,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1664,1033,I,V,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,"cBioPortal,COSMIC","lung_msk_2017, msk_impact_2017, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91337474-91337474, hg38,15:90794244-90794244","hg19,15:g.91337474A>G, hg38,15:g.90794244A>G",0.234,lung,"carcinoma, adenocarcinoma",,
1665,1034,T,K,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1666,1034,T,M,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91337478-91337478, hg38,15:90794248-90794248","hg19,15:g.91337478C>T, hg38,15:g.90794248C>T",0.190,large_intestine,"carcinoma, adenocarcinoma",0.0000040159674867,
1667,1035,E,G,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91337481-91337481","hg19,15:g.91337481A>G",0.645,,,,
1668,1035,E,K,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91337480-91337480","hg19,15:g.91337480G>A",0.645,,,,
1669,1035,E,Q,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1030-1035, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91337480-91337480","hg19,15:g.91337480G>C",0.484,,,0.0000080305804504,
1670,1036,C,F,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1671,1037,R,G,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1672,1037,R,K,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1673,1037,R,S,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,cBioPortal,"egc_mskcc_2020, msk_met_2021","Esophagus/Stomach, Mixed Cancer Types","hg19,15:91337488-91337488","hg19,15:g.91337488G>T",0.748,,,,
1674,1038,R,I,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,"cBioPortal,COSMIC",mbl_sickkids_2016,Medulloblastoma,"hg19,15:91337490-91337490, hg38,15:90794260-90794260","hg19,15:g.91337490G>T, hg38,15:g.90794260G>T",0.880,liver,"other, neoplasm",,
1675,1038,R,S,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1676,1038,R,T,,,,,,,,,,S,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1677,1039,I,K,,,,,,,,,,C,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1678,1039,I,M,,,,,,,,,,C,"NRD cleavage site, 1037-1039, ELM|di Arginine retention/retrieving signal, 1037-1039, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1679,1040,Q,,,,,,,,,,,S,,,,,,,,,,,,
1680,1041,L,F,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1681,1042,L,,,,,,,,,,,S,,,,,,,,,,,,
1682,1043,A,D,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1683,1043,A,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1684,1044,Y,C,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_apc_impact_2020, crc_msk_2017, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91337508-91337508, hg38,15:90794278-90794278","hg19,15:g.91337508A>G, hg38,15:g.90794278A>G",0.890,"haematopoietic_and_lymphoid_tissue, large_intestine, colon, transverse","carcinoma, adenocarcinoma, lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000120092230833,
1685,1045,F,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,,,,,,,,,,
1686,1046,G,R,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1687,1046,G,S,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1688,1046,G,V,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1689,1047,E,K,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1044-1047, ELM",,COSMIC,,,"hg38,15:90794286-90794286","hg38,15:g.90794286G>A",0.889,"upper_aerodigestive_tract, head_neck","carcinoma, squamous_cell_carcinoma",0.0000040046453887,
1690,1048,N,H,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91337519-91337519","hg19,15:g.91337519A>C",0.121,,,,
1691,1049,G,E,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1692,1049,G,R,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91337522-91337522, hg38,15:90794292-90794292","hg19,15:g.91337522G>A, hg38,15:g.90794292G>A",0.222,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
1693,1049,G,V,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,cBioPortal,pog570_bcgsc_2020,Mixed Cancer Types,"hg19,15:91337523-91337523","hg19,15:g.91337523G>T",0.146,,,,
1694,1050,F,L,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1695,1051,N,K,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1696,1052,P,T,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1697,1053,D,,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,,,,,,,,,,
1698,1054,F,C,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91337538-91337538","hg19,15:g.91337538T>G",0.649,,,,
1699,1054,F,V,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1700,1054,F,Y,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM|Pex14 ligand motif, 1050-1054, ELM",,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_impact_2017, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91337538-91337538, hg38,15:90794308-90794308","hg19,15:g.91337538T>A, hg38,15:g.90794308T>A",0.364,skin,malignant_melanoma,,
1701,1055,C,R,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1702,1055,C,S,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,,,,"large_intestine, appendix","carcinoid-endocrine_tumour, goblet_cell",,
1703,1055,C,Y,,,,,,,,,,C,"PTB ligand, 1048-1055, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1704,1056,K,R,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91337544-91337544, hg38,15:90794314-90794314","hg19,15:g.91337544A>G, hg38,15:g.90794314A>G",0.181,"skin, trunk",malignant_melanoma,0.0000040167740484,
1705,1057,K,I,,,Ubq,,,,,,,C,,,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91337547-91337547, hg38,15:90794317-90794317","hg19,15:g.91337547A>T, hg38,15:g.90794317A>T",0.488,penis,"carcinoma, squamous_cell_carcinoma",,
1706,1058,H,D,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1707,1058,H,R,,,,,,,,,,C,,,"cBioPortal,COSMIC",cesc_tcga_pan_can_atlas_2018,Cervical Squamous Cell Carcinoma,"hg19,15:91337550-91337550, hg38,15:90794320-90794320","hg19,15:g.91337550A>G, hg38,15:g.90794320A>G",0.303,cervix,"carcinoma, squamous_cell_carcinoma",,
1708,1059,P,,,,,,,,,,,C,"USP7 binding motif, 1059-1063, ELM",,,,,,,,,,,
1709,1060,D,,,,,,,,,,,C,"USP7 binding motif, 1059-1063, ELM",,,,,,,,,,,
1710,1061,V,,,,,,,,,,,C,"USP7 binding motif, 1059-1063, ELM",,,,,,,,,,,
1711,1062,S,P,,,,,,,,,,C,"USP7 binding motif, 1059-1063, ELM",,COSMIC,,,"hg38,15:90794331-90794331","hg38,15:g.90794331T>C",0.194,breast,"carcinoma, carcinoma, ductal_carcinoma",,
1712,1063,C,Y,,,,,,,,,,C,"USP7 binding motif, 1059-1063, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1713,1064,D,G,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1714,1064,D,N,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1715,1065,N,,,,,,,,,,,C,,,,,,,,,,,,
1716,1066,C,,,,,,,,,,,C,,,,,,,,,,,,
1717,1067,C,F,,,,,,,,,,C,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91337577-91337577","hg19,15:g.91337577G>T",0.241,,,,
1718,1067,C,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1719,1067,C,Y,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",msk_ch_2020,Mixed Cancer Types,"hg19,15:91337577-91337577","hg19,15:g.91337577G>A",0.149,,,0.0000853489920284,
1720,1068,K,,,,,,,,,,,C,,,,,,,,,,,,
1721,1069,T,,,,,,,,,,,C,,,,,,,,,,,,
1722,1070,K,,,,,,,,,,,C,,,,,,,,,,,,
1723,1071,D,G,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",metastatic_solid_tumors_mich_2017,Mixed Cancer Types,"hg19,15:91341421-91341421","hg19,15:g.91341421A>G",0.401,,,,
1724,1071,D,N,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341420-91341420","hg19,15:g.91341420G>A",0.163,,,0.0000040081445497,
1725,1071,D,Y,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1726,1072,Y,C,,,,,,,,,,C,"FHA phosphopeptide ligands, 1072-1078, ELM",,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,15:91341424-91341424, hg38,15:90798194-90798194","hg19,15:g.91341424A>G, hg38,15:g.90798194A>G",0.284,"pancreas, ampulla_of_Vater","carcinoma, ductal_carcinoma",,
1727,1073,K,,,,,,,,,,,C,"FHA phosphopeptide ligands, 1072-1078, ELM",,,,,,,,,,,
1728,1074,T,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 1072-1078, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341429-91341429","hg19,15:g.91341429A>G",0.152,,,,
1729,1074,T,I,,,,,,,,,,C,"FHA phosphopeptide ligands, 1072-1078, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1730,1074,T,R,,,,,,,,,,C,"FHA phosphopeptide ligands, 1072-1078, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1731,1075,R,G,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91341432-91341432","hg19,15:g.91341432A>G",0.434,,,,
1732,1075,R,K,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1733,1075,R,T,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, msk_met_2021, tmb_mskcc_2018","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91341433-91341433, hg38,15:90798203-90798203","hg19,15:g.91341433G>C, hg38,15:g.90798203G>C",0.435,"upper_aerodigestive_tract, head_neck, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma",,
1734,1076,D,E,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1735,1076,D,G,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC","luad_tcga, luad_tcga_pan_can_atlas_2018, luad_tcga_pub, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91341436-91341436, hg38,15:90798206-90798206","hg19,15:g.91341436A>G, hg38,15:g.90798206A>G",0.675,lung,"carcinoma, adenocarcinoma",,
1736,1076,D,H,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC",msk_impact_2017,Mixed Cancer Types,"hg19,15:91341435-91341435, hg38,15:90798205-90798205","hg19,15:g.91341435G>C, hg38,15:g.90798205G>C",0.588,"haematopoietic_and_lymphoid_tissue, pelvis","lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",,
1737,1076,D,N,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1738,1076,D,V,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1739,1077,V,L,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1740,1077,V,M,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90798208-90798208","hg38,15:g.90798208G>A",0.240,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, diffuse_large_B_cell_lymphoma",0.0000319769765769,0.0001273479783508
1741,1078,T,I,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91341442-91341442, hg38,15:90798212-90798212","hg19,15:g.91341442C>T, hg38,15:g.90798212C>T",0.592,skin,"carcinoma, basal_cell_carcinoma",,
1742,1078,T,S,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1072-1078, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1743,1079,D,G,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1744,1079,D,H,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC","blca_nmibc_2017, msk_impact_2017, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91341444-91341444, hg38,15:90798214-90798214","hg19,15:g.91341444G>C, hg38,15:g.90798214G>C",0.155,"urinary_tract, bladder","carcinoma, transitional_cell_carcinoma",0.0000039957804558,
1745,1079,D,N,,,,,,,,,,C,"PCSK cleavage site, 1075-1079, ELM|FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga, blca_tcga_pan_can_atlas_2018, blca_tcga_pub, blca_tcga_pub_2017, pancan_pcawg_2020","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91341444-91341444, hg38,15:90798214-90798214","hg19,15:g.91341444G>A, hg38,15:g.90798214G>A",0.135,"urinary_tract, bladder",carcinoma,,
1746,1080,D,A,,,,,,,,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,,,,"central_nervous_system, frontal_lobe","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1747,1080,D,H,,,,,,,,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1748,1080,D,N,,,,,,,,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","coadread_dfci_2016, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91341447-91341447, hg38,15:90798217-90798217","hg19,15:g.91341447G>A, hg38,15:g.90798217G>A",0.409,"haematopoietic_and_lymphoid_tissue, large_intestine, prostate","carcinoma, carcinoma, adenocarcinoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0000279516994633,
1749,1080,D,V,,,,,,,,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1750,1080,D,Y,,,,,,,,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91341447-91341447","hg19,15:g.91341447G>T",0.299,,,,
1751,1081,V,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 1076-1082, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341451-91341451","hg19,15:g.91341451T>C",0.117,,,,
1752,1081,V,E,,,,,,,,,,S,"FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1753,1081,V,G,,,,,,,,,,S,"FHA phosphopeptide ligands, 1076-1082, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1754,1081,V,L,,,,,,,,,,S,"FHA phosphopeptide ligands, 1076-1082, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341450-91341450","hg19,15:g.91341450G>T",0.209,,,,
1755,1082,K,,,,Ubq,,,,Sumo,,,C,"FHA phosphopeptide ligands, 1076-1082, ELM",,,,,,,,,,,
1756,1083,S,R,P,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1757,1084,I,,,,,,,,,,,S,,,,,,,,,,,,
1758,1085,V,G,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1759,1085,V,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1760,1086,R,,,,,,,,,,,C,,,,,,,,,,,,
1761,1087,F,C,,,,,,,,,,C,,,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, pan_origimed_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91341469-91341469, hg38,15:90798239-90798239","hg19,15:g.91341469T>G, hg38,15:g.90798239T>G",0.292,"large_intestine, rectum","carcinoma, adenocarcinoma",,
1762,1087,F,L,,,,,,,,,,C,,,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,15:91341468-91341468","hg19,15:g.91341468T>C",0.240,,,,
1763,1088,V,F,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv","esca_tcga, esca_tcga_pan_can_atlas_2018",Esophageal Adenocarcinoma,"hg19,15:91341471-91341471","hg19,15:g.91341471G>T",0.578,,,,
1764,1088,V,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1765,1088,V,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1766,1089,Q,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1767,1089,Q,R,,,,,,,,,,C,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91341475-91341475, hg38,15:90798245-90798245","hg19,15:g.91341475A>G, hg38,15:g.90798245A>G",0.295,endometrium,"carcinoma, endometrioid_carcinoma",,
1768,1090,E,K,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91341477-91341477","hg19,15:g.91341477G>A",0.513,,,,
1769,1090,E,Q,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91341477-91341477","hg19,15:g.91341477G>C",0.327,,,,
1770,1091,H,N,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1771,1091,H,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1772,1091,H,Y,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1773,1092,S,,,,,,,,,,,C,,,,,,,,,,,,
1774,1093,S,L,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91341487-91341487","hg19,15:g.91341487C>T",0.344,,,0.0000119706957368,
1775,1094,S,A,,,,,,,,,,C,,,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91341489-91341489","hg19,15:g.91341489T>G",0.060,,,,
1776,1094,S,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1777,1095,Q,,,,,,,,,,,C,,,,,,,,,,,,
1778,1096,G,A,,,,,,,,,,C,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90798266-90798266","hg38,15:g.90798266G>C",0.192,prostate,carcinoma,,
1779,1096,G,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1780,1096,G,R,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91341495-91341495","hg19,15:g.91341495G>A",0.088,,,0.0000039921753363,
1781,1096,G,V,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1782,1097,M,I,,,,,,,,,,C,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341500-91341500","hg19,15:g.91341500G>A",0.021,,,,
1783,1098,R,K,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1784,1099,N,K,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1785,1100,I,L,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1786,1100,I,M,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,COSMIC,,,"hg38,15:90798279-90798279","hg38,15:g.90798279A>G",0.052,thyroid,"carcinoma, papillary_carcinoma",,
1787,1100,I,R,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1788,1100,I,V,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1789,1101,K,,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,,,,,,,,,,
1790,1102,H,L,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341514-91341514","hg19,15:g.91341514A>T",0.011,,,,
1791,1102,H,R,,,,,,,,,,C,"PCSK cleavage site, 1098-1102, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1792,1103,V,A,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1793,1103,V,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1794,1104,G,D,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","brca_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91341520-91341520, hg38,15:90798290-90798290","hg19,15:g.91341520G>A, hg38,15:g.90798290G>A",0.125,"breast, gastrointestinal_tract_(site_indeterminate)",carcinoma,0.0000199395433047,
1795,1104,G,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1796,1105,P,S,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1105-1109, ELM",,cBioPortal,"bcc_unige_2016, ccle_broad_2019","Basal Cell Carcinoma, Mixed Cancer Types","hg19,15:91341522-91341522","hg19,15:g.91341522C>T",0.013,,,,
1797,1106,S,C,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1105-1109, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1798,1106,S,F,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1105-1109, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1799,1107,G,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1105-1109, ELM",,,,,,,,,,,
1800,1108,R,K,,,,,,,,,,C,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|BRCT phosphopeptide ligands, 1105-1109, ELM|eh1 motif, 1108-1116, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91341532-91341532, hg38,15:90798302-90798302","hg19,15:g.91341532G>A, hg38,15:g.90798302G>A",0.188,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
1801,1108,R,S,,,,,,,,,,C,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|BRCT phosphopeptide ligands, 1105-1109, ELM|eh1 motif, 1108-1116, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1802,1108,R,T,,,,,,,,,,C,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|BRCT phosphopeptide ligands, 1105-1109, ELM|eh1 motif, 1108-1116, ELM",,"cBioPortal,COSMIC",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,15:91341532-91341532, hg38,15:90798302-90798302","hg19,15:g.91341532G>C, hg38,15:g.90798302G>C",0.645,breast,carcinoma,,
1803,1109,F,L,,,,,,,,,,C,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|BRCT phosphopeptide ligands, 1105-1109, ELM|eh1 motif, 1108-1116, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91341536-91341536","hg19,15:g.91341536T>G",0.044,,,,
1804,1109,F,Y,,,,,,,,,,C,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|BRCT phosphopeptide ligands, 1105-1109, ELM|eh1 motif, 1108-1116, ELM",,cBioPortal,dlbc_tcga,"Diffuse Large B-Cell Lymphoma, NOS","hg19,15:91341535-91341535","hg19,15:g.91341535T>A",0.089,,,,
1805,1110,T,I,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,cBioPortal,"ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91341538-91341538","hg19,15:g.91341538C>T",0.647,,,,
1806,1111,M,I,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91341542-91341542, hg38,15:90798312-90798312","hg19,15:g.91341542G>A, hg38,15:g.90798312G>A",0.059,breast,"carcinoma, ductal_carcinoma",,
1807,1111,M,V,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1808,1112,N,D,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1809,1112,N,H,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,cBioPortal,"msk_met_2021, prad_cdk12_mskcc_2020, prad_mcspc_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91341543-91341543","hg19,15:g.91341543A>C",0.264,,,0.0000079713033081,
1810,1112,N,S,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|14-3-3 binding phosphopeptide motif, 1108-1112, ELM|eh1 motif, 1108-1116, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1811,1113,M,L,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|eh1 motif, 1108-1116, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,cBioPortal,bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91341546-91341546","hg19,15:g.91341546A>T",0.225,,,,
1812,1114,L,P,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|eh1 motif, 1108-1116, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1813,1115,V,,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|eh1 motif, 1108-1116, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,,,,,,,,,,
1814,1116,D,H,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|eh1 motif, 1108-1116, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1815,1116,D,N,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|eh1 motif, 1108-1116, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91341555-91341555","hg19,15:g.91341555G>A",0.334,,,,
1816,1117,I,,,,,,,,,,,S,"MAPK docking motifs, 1108-1117, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,,,,,,,,,,
1817,1118,F,L,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,"cBioPortal,Manual annotations from clinvar.csv",rectal_msk_2022,Bowel,"hg19,15:91341563-91341563","hg19,15:g.91341563C>A",0.193,,,,
1818,1118,F,V,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1819,1119,L,F,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,"cBioPortal,COSMIC","gbc_msk_2018, luad_msk_npjpo_2021, luad_mskcc_2020, msk_impact_2017, msk_met_2021","Gallbladder Cancer, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91341566-91341566, hg38,15:90798336-90798336","hg19,15:g.91341566G>C, hg19,15:g.91341566G>T, hg38,15:g.90798336G>T",0.287,lung,"carcinoma, adenocarcinoma",,
1820,1120,G,E,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,cBioPortal,mixed_kunga_msk_2022,Mixed Cancer Types,"hg19,15:91346751-91346751","hg19,15:g.91346751G>A",0.940,,,0.0000039806064852,
1821,1120,G,R,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90798336-90798337","hg38,15:g.90798336_90798337delinsAA",,"skin, scalp",malignant_melanoma,,
1822,1121,S,I,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1823,1121,S,T,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1824,1122,K,T,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM|Binding motif for UBA3 adenylation domain, 1113-1122, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1825,1123,S,C,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1826,1123,S,G,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,COSMIC,,,"hg38,15:90803529-90803529","hg38,15:g.90803529A>G",0.175,large_intestine,"carcinoma, adenocarcinoma",,
1827,1123,S,R,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1828,1124,A,G,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1829,1124,A,T,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,"cBioPortal,COSMIC","glioma_msk_2018, glioma_mskcc_2019",Diffuse Glioma,"hg19,15:91346762-91346762, hg38,15:90803532-90803532","hg19,15:g.91346762G>A, hg38,15:g.90803532G>A",0.233,thyroid,carcinoma,,
1830,1124,A,V,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91346763-91346763","hg19,15:g.91346763C>T",0.238,,,0.0000039800995025,
1831,1125,K,,,,Ubq,,,,Sumo,,,C,"PCSK cleavage site, 1122-1126, ELM",,,,,,,,,,,
1832,1126,I,M,,,,,,,,,,C,"PCSK cleavage site, 1122-1126, ELM",,COSMIC,,,"hg38,15:90803540-90803540","hg38,15:g.90803540C>G",0.161,lung,"carcinoma, adenocarcinoma",,
1833,1127,Q,H,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub",Invasive Breast Carcinoma,"hg19,15:91346773-91346773, hg38,15:90803543-90803543","hg19,15:g.91346773G>T, hg38,15:g.90803543G>T",0.105,breast,carcinoma,,
1834,1128,S,,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,,,,,,,,,,
1835,1129,G,A,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1836,1129,G,D,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1837,1129,G,R,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,"cBioPortal,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad",Mixed Cancer Types,"hg19,15:91346777-91346777","hg19,15:g.91346777G>C",0.554,,,,
1838,1129,G,V,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90803548-90803548","hg38,15:g.90803548G>T",0.629,liver,"other, neoplasm",0.0000039793709410,
1839,1130,I,V,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1840,1131,F,,,,,,,,,,,S,"BRCT phosphopeptide ligands, 1127-1131, ELM|BRCT phosphopeptide ligands, 1127-1133, ELM",,,,,,,,,,,
1841,1132,G,E,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1133, ELM",,cBioPortal,"difg_glass_2019, pancan_pcawg_2020","Diffuse Glioma, Mixed Cancer Types","hg19,15:91346787-91346787","hg19,15:g.91346787G>A",0.830,,,,
1842,1132,G,V,,,,,,,,,,C,"BRCT phosphopeptide ligands, 1127-1133, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91346787-91346787, hg38,15:90803557-90803557","hg19,15:g.91346787G>T, hg38,15:g.90803557G>T",0.852,endometrium,"carcinoma, endometrioid_carcinoma",0.0000039797510268,
1843,1133,K,E,,,Ubq,,,,,,,S,"BRCT phosphopeptide ligands, 1127-1133, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1844,1134,G,E,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",brca_tcga_pan_can_atlas_2018,Invasive Breast Carcinoma,"hg19,15:91346793-91346793, hg38,15:90803563-90803563","hg19,15:g.91346793G>A, hg38,15:g.90803563G>A",0.744,breast,carcinoma,,
1845,1134,G,R,,,,,,,,,,S,,,"cBioPortal,Manual annotations from clinvar.csv",cfdna_msk_2019,Mixed Cancer Types,"hg19,15:91346792-91346792","hg19,15:g.91346792G>A",0.787,,,,
1846,1135,S,C,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346796-91346796","hg19,15:g.91346796C>G",0.171,,,,
1847,1136,A,F,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1848,1137,Y,,,,,,,,,,,S,,,,,,,,,,,,
1849,1138,S,,,,,,,,,,,S,,,,,,,,,,,,
1850,1139,R,L,,,,,,,,,,S,,,COSMIC,,,"hg38,15:90803578-90803578","hg38,15:g.90803578G>T",0.311,stomach,carcinoma,,
1851,1139,R,P,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1852,1139,R,Q,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, skcm_broad_brafresist_2012","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91346808-91346808, hg38,15:90803578-90803578","hg19,15:g.91346808G>A, hg38,15:g.90803578G>A",0.290,", stomach","carcinoma, adenocarcinoma, malignant_melanoma",0.0000119362128784,
1853,1140,H,L,,,,,,,,,,S,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346811-91346811","hg19,15:g.91346811A>T",0.386,,,,
1854,1140,H,Q,,,,,,,,,,S,,,"cBioPortal,COSMIC",kirc_tcga_pub,Renal Clear Cell Carcinoma,"hg19,15:91346812-91346812, hg38,15:90803582-90803582","hg19,15:g.91346812C>A, hg38,15:g.90803582C>A",0.183,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
1855,1140,H,R,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1856,1140,H,Y,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1857,1141,N,S,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91346814-91346814, hg38,15:90803584-90803584","hg19,15:g.91346814A>G, hg38,15:g.90803584A>G",0.255,"urinary_tract, upper_urinary_tract","carcinoma, transitional_cell_carcinoma",0.0000278493904962,
1858,1142,A,S,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91346816-91346816","hg19,15:g.91346816G>T",0.241,,,,
1859,1142,A,V,,,,,,,,,,S,,,cBioPortal,rectal_msk_2022,Bowel,"hg19,15:91346817-91346817","hg19,15:g.91346817C>T",0.141,,,,
1860,1143,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","acc_2019, crc_msk_2017, msk_impact_2017, msk_met_2021, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub, tmb_mskcc_2018","Adrenocortical Carcinoma, Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,15:91346819-91346819, hg38,15:90803589-90803589","hg19,15:g.91346819G>A, hg38,15:g.90803589G>A",0.337,"large_intestine, caecum, stomach","carcinoma, adenocarcinoma",0.0001074370299630,0.0000955414012739
1861,1144,R,I,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91346823-91346823, hg38,15:90803593-90803593","hg19,15:g.91346823G>T, hg38,15:g.90803593G>T",0.686,"large_intestine, caecum","carcinoma, adenocarcinoma",,
1862,1144,R,S,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM",,COSMIC,,,"hg38,15:90803594-90803594","hg38,15:g.90803594A>T",0.445,"biliary_tract, bile_duct",carcinoma,,
1863,1145,L,P,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1864,1145,L,R,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,cBioPortal,"paad_tcga, paad_tcga_pan_can_atlas_2018",Pancreatic Adenocarcinoma,"hg19,15:91346826-91346826","hg19,15:g.91346826T>G",0.772,,,,
1865,1146,F,,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,,,,,,,,,,
1866,1147,K,,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,,,,,,,,,,
1867,1148,K,E,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1868,1148,K,N,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, cfdna_msk_2019, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91346836-91346836, hg38,15:90803606-90803606","hg19,15:g.91346836G>T, hg38,15:g.90803606G>T",0.239,breast,"carcinoma, ductal_carcinoma",,
1869,1148,K,T,,,,,,,,,,S,"PCSK cleavage site, 1144-1148, ELM|PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1870,1149,L,M,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,"cBioPortal,COSMIC","gbm_tcga_pan_can_atlas_2018, msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Glioblastoma Multiforme, Mixed Cancer Types","hg19,15:91346837-91346837, hg38,15:90803607-90803607","hg19,15:g.91346837C>A, hg38,15:g.90803607C>A",0.333,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
1871,1150,I,L,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346840-91346840","hg19,15:g.91346840A>C",0.101,,,,
1872,1150,I,T,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1873,1151,L,F,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91346843-91346843","hg19,15:g.91346843C>T",0.254,,,0.0000079569687132,
1874,1151,L,R,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1875,1152,D,E,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1876,1152,D,Y,,,,,,,,,,S,"PCSK cleavage site, 1148-1152, ELM|Cyclin N-terminal Domain Docking Motifs, 1144-1152, ELM|Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1877,1153,K,E,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1878,1153,K,M,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1879,1153,K,N,,,,,,,,,,S,"Binding motif for UBA3 adenylation domain, 1145-1153, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91346851-91346851","hg19,15:g.91346851G>C",0.067,,,,
1880,1154,I,T,,,,,,,,,,C,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91346853-91346853, hg38,15:90803623-90803623","hg19,15:g.91346853T>C, hg38,15:g.90803623T>C",0.444,skin,"carcinoma, basal_cell_carcinoma",,
1881,1154,I,V,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1882,1155,L,,,,,,,,,,,S,,,,,,,,,,,,
1883,1156,D,E,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1884,1156,D,N,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91346858-91346858","hg19,15:g.91346858G>A",0.090,,,0.0000039778829707,
1885,1156,D,V,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1886,1157,E,K,,,,,,,,,,S,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017",Bladder Urothelial Carcinoma,"hg19,15:91346861-91346861, hg38,15:90803631-90803631","hg19,15:g.91346861G>A, hg38,15:g.90803631G>A",0.741,"urinary_tract, bladder",carcinoma,,
1887,1158,D,E,,,,,,,,,,C,,,cBioPortal,acc_2019,Adrenocortical Carcinoma,"hg19,15:91346866-91346866","hg19,15:g.91346866C>G",0.087,,,,
1888,1158,D,G,,,,,,,,,,C,,,"cBioPortal,COSMIC",lihc_tcga_pan_can_atlas_2018,Hepatocellular Carcinoma,"hg19,15:91346865-91346865, hg38,15:90803635-90803635","hg19,15:g.91346865A>G, hg38,15:g.90803635A>G",0.332,liver,"carcinoma, hepatocellular_carcinoma",,
1889,1158,D,H,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1890,1158,D,N,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1891,1159,L,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91346868-91346868, hg38,15:90803638-90803638","hg19,15:g.91346868T>C, hg38,15:g.90803638T>C",0.442,"skin, trunk","malignant_melanoma, superficial_spreading",,
1892,1160,Y,C,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,cBioPortal,"msk_met_2021, ucec_ccr_msk_2022","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91346871-91346871","hg19,15:g.91346871A>G",0.329,,,,
1893,1160,Y,F,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91346871-91346871","hg19,15:g.91346871A>T",0.164,,,,
1894,1160,Y,H,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,"cBioPortal,Manual annotations from clinvar.csv",mm_broad,Plasma Cell Myeloma,"hg19,15:91346870-91346870","hg19,15:g.91346870T>C",0.199,,,0.0000039774399605,
1895,1160,Y,N,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1896,1161,I,V,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1897,1162,N,D,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91346876-91346876","hg19,15:g.91346876A>G",0.264,,,,
1898,1162,N,I,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,COSMIC,,,"hg38,15:90803647-90803647","hg38,15:g.90803647A>T",0.317,skin,malignant_melanoma,,
1899,1162,N,S,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1900,1163,A,,,,,,,,,,,C,"Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM|Phosphotyrosine ligands bound by SH2 domains, 1160-1163, ELM",,,,,,,,,,,
1901,1164,N,D,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1902,1164,N,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1903,1165,D,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1904,1166,Q,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1905,1166,Q,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1906,1167,A,G,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
1907,1168,I,T,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 1168-1173, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346895-91346895","hg19,15:g.91346895T>C",0.173,,,,
1908,1169,A,T,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 1168-1173, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",luad_broad,Lung Adenocarcinoma,"hg19,15:91346897-91346897, hg38,15:90803667-90803667","hg19,15:g.91346897G>A, hg38,15:g.90803667G>A",0.244,lung,"carcinoma, adenocarcinoma",0.0000676175551083,
1909,1170,Y,C,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346901-91346901","hg19,15:g.91346901A>G",0.641,,,,
1910,1170,Y,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1911,1170,Y,S,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1912,1171,V,A,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,cBioPortal,msk_ch_2020,Mixed Cancer Types,"hg19,15:91346904-91346904","hg19,15:g.91346904T>C",0.257,,,,
1913,1171,V,M,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1914,1172,M,L,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1915,1173,L,F,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Phosphotyrosine ligands bound by SH2 domains, 1170-1173, ELM|Immunoreceptor tyrosine-based motif, 1168-1173, ELM|Y-based sorting signal, 1170-1173, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1916,1174,G,R,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1917,1175,N,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1918,1176,K,,,,,,,,,,,C,,,,,,,,,,,,
1919,1177,A,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1920,1178,Q,P,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1921,1179,T,A,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1922,1179,T,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1923,1180,V,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1924,1180,V,L,,,,,,,,,,C,,,cBioPortal,"luad_msk_npjpo_2021, luad_mskcc_2020, msk_met_2021","Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91346930-91346930","hg19,15:g.91346930G>T",0.069,,,,
1925,1181,L,V,,,,,,,,,,C,,,COSMIC,,,"hg38,15:90803703-90803703","hg38,15:g.90803703C>G",0.238,"oesophagus, middle_third","carcinoma, squamous_cell_carcinoma",,
1926,1182,N,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1927,1183,G,,,,,,,,,,,C,,,,,,,,,,,,
1928,1184,N,D,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1929,1184,N,S,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_ch_2020,Mixed Cancer Types,"hg19,15:91346943-91346943","hg19,15:g.91346943A>G",0.112,,,,
1930,1184,N,Y,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1931,1185,L,,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,,,,,,,,,,
1932,1186,K,E,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,"cBioPortal,Manual annotations from clinvar.csv",cellline_ccle_broad,Mixed Cancer Types,"hg19,15:91346948-91346948","hg19,15:g.91346948A>G",0.134,,,0.0001035229661719,
1933,1186,K,R,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1934,1186,K,T,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91346949-91346949","hg19,15:g.91346949A>C",0.188,,,,
1935,1187,V,I,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1936,1187,V,L,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91347397-91347397, hg38,15:90804167-90804167","hg19,15:g.91347397G>T, hg38,15:g.90804167G>T",0.277,endometrium,"carcinoma, endometrioid_carcinoma",,
1937,1188,D,G,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1938,1188,D,V,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","luad_broad, nsclc_tcga_broad_2016","Lung Adenocarcinoma, Non-Small Cell Lung Cancer","hg19,15:91347401-91347401, hg38,15:90804171-90804171","hg19,15:g.91347401A>T, hg38,15:g.90804171A>T",0.226,lung,"carcinoma, adenocarcinoma",,
1939,1189,F,,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,,,,,,,,,,
1940,1190,M,T,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1941,1190,M,V,,,,,,,,,,C,"PP1-docking motif RVXF, 1184-1190, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1942,1191,E,G,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1943,1191,E,K,,,,,,,,,,C,,,cBioPortal,"msk_access_2021, msk_met_2021",Mixed Cancer Types,"hg19,15:91347409-91347409","hg19,15:g.91347409G>A",0.205,,,,
1944,1192,T,I,,,,,,,,,,C,,,"cBioPortal,COSMIC",kirc_bgi,Renal Clear Cell Carcinoma,"hg19,15:91347413-91347413, hg38,15:90804183-90804183","hg19,15:g.91347413C>T, hg38,15:g.90804183C>T",0.322,kidney,"carcinoma, clear_cell_renal_cell_carcinoma",,
1945,1193,E,Q,,,,,,,,,,C,,,"cBioPortal,COSMIC","hnsc_tcga, hnsc_tcga_pan_can_atlas_2018, hnsc_tcga_pub, lung_msk_2017, msk_impact_2017, msk_met_2021, pan_origimed_2020","Head and Neck Squamous Cell Carcinoma, Lung Adenocarcinoma, Mixed Cancer Types","hg19,15:91347415-91347415, hg38,15:90804185-90804185","hg19,15:g.91347415G>C, hg38,15:g.90804185G>C",0.114,"lung, upper_aerodigestive_tract, head_neck","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",,
1946,1194,N,H,,,,,,,,,,C,,,"cBioPortal,COSMIC",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91347418-91347418, hg38,15:90804188-90804188","hg19,15:g.91347418A>C, hg38,15:g.90804188A>C",0.148,endometrium,"carcinoma, endometrioid_carcinoma",,
1947,1195,S,F,,,,,,,,,,C,,,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91347422-91347422","hg19,15:g.91347422C>T",0.050,,,,
1948,1196,S,R,,,,,,,,,,C,,,COSMIC,,,"hg38,15:90804196-90804196","hg38,15:g.90804196C>A",0.137,thyroid,carcinoma,,
1949,1197,S,C,P,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1950,1198,V,M,,,,,,,,,,C,,,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90804200-90804200","hg38,15:g.90804200G>A",0.056,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, Burkitt_lymphoma",0.0002269180547151,0.0007355292612728
1951,1199,K,,,,Ubq,,,,Sumo,,,C,,,,,,,,,,,,
1952,1200,K,,,,,,,,,,,C,,,,,,,,,,,,
1953,1201,Q,,,,,,,,,,,C,,,,,,,,,,,,
1954,1202,K,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1955,1202,K,N,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1956,1203,A,G,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1957,1203,A,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1958,1203,A,V,,,,,,,,,,C,,,"cBioPortal,Manual annotations from mutations_icope_sentieon.csv,Manual annotations from clinvar.csv","ccle_broad_2019, cellline_ccle_broad, msk_met_2021, prad_msk_stopsack_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91347446-91347446","hg19,15:g.91347446C>T",0.141,,,0.0000198984383706,0.0000318633698700
1959,1204,L,,,,,,,,,,,C,,,,,,,,,,,,
1960,1205,V,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1961,1205,V,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1962,1206,A,E,,,,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1963,1206,A,T,,,,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1964,1207,K,,,,Ubq,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,,,,,,,,,,
1965,1208,V,,,,,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,,,,,,,,,,
1966,1209,S,T,,,,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","acc_2019, brca_mskcc_2019, cellline_ccle_broad, utuc_pdx_msk_2019","Adrenocortical Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,15:91347463-91347463, hg38,15:90804233-90804233","hg19,15:g.91347463T>A, hg38,15:g.90804233T>A",0.089,"central_nervous_system, hypothalamus","glioma, astrocytoma",0.0003580436494991,0.0003184713375796
1967,1210,Q,H,,,,,,,,,,C,"USP7 binding motif, 1206-1210, ELM",,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, ccle_broad_2019","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91347468-91347468, hg38,15:90804238-90804238","hg19,15:g.91347468G>C, hg38,15:g.90804238G>C",0.151,"urinary_tract, bladder",carcinoma,,
1968,1211,R,M,,,,,,,,,,C,,,COSMIC,,,"hg38,15:90804240-90804240","hg38,15:g.90804240G>T",0.361,ovary,"carcinoma, serous_carcinoma",,
1969,1211,R,W,,,,,,,,,,C,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91347469-91347469","hg19,15:g.91347469A>T",0.210,,,,
1970,1212,E,D,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91347474-91347474, hg38,15:90804244-90804244","hg19,15:g.91347474A>C, hg38,15:g.90804244A>C",0.071,lung,"carcinoma, large_cell_neuroendocrine_carcinoma",,
1971,1212,E,Q,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1972,1213,E,D,,,,,,,,,,C,,,cBioPortal,nsclc_tracerx_2017,Non-Small Cell Lung Cancer,"hg19,15:91347477-91347477","hg19,15:g.91347477G>C",0.113,,,,
1973,1213,E,K,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1974,1213,E,Q,,,,,,,,,,C,,,cBioPortal,"blca_cornell_2016, msk_met_2021","Bladder Urothelial Carcinoma, Mixed Cancer Types","hg19,15:91347475-91347475","hg19,15:g.91347475G>C",0.153,,,,
1975,1214,M,I,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv","msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91347480-91347480","hg19,15:g.91347480G>T",0.093,,,,
1976,1214,M,K,,,,,,,,,,C,,,cBioPortal,mel_dfci_2019,Melanoma,"hg19,15:91347479-91347479","hg19,15:g.91347479T>A",0.120,,,,
1977,1214,M,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1978,1214,M,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1979,1215,V,,,,,,,,,,,C,,,,,,,,,,,,
1980,1216,K,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1981,1217,K,N,,,Ubq,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
1982,1218,C,,,,,,,,,,,C,,,,,,,,,,,,
1983,1219,L,I,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,cBioPortal,"msk_met_2021, pan_origimed_2020",Mixed Cancer Types,"hg19,15:91347493-91347493","hg19,15:g.91347493C>A",0.167,,,,
1984,1219,L,V,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1985,1220,G,A,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1986,1220,G,E,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,COSMIC,,,"hg38,15:90804267-90804267","hg38,15:g.90804267G>A",0.092,oesophagus,"carcinoma, squamous_cell_carcinoma",,
1987,1220,G,R,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1988,1221,E,,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,,,,,,,,,,
1989,1222,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,,,,,,,,,,
1990,1223,T,A,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91347505-91347505","hg19,15:g.91347505A>G",0.054,,,,
1991,1223,T,I,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1992,1223,T,K,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1993,1223,T,R,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1994,1224,E,A,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
1995,1224,E,D,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,"cBioPortal,COSMIC","gct_msk_2016, msk_impact_2017, msk_met_2021","Mixed Cancer Types, Testis","hg19,15:91347510-91347510, hg38,15:90804280-90804280","hg19,15:g.91347510A>C, hg38,15:g.90804280A>C",0.070,testis,"germ_cell_tumour, mixed",,
1996,1224,E,K,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,cBioPortal,"mixed_allen_2018, skcm_mskcc_2014","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91347508-91347508","hg19,15:g.91347508G>A",0.160,,,,
1997,1225,V,I,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1219-1225, ELM",,cBioPortal,glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91347511-91347511","hg19,15:g.91347511G>A",0.070,,,,
1998,1226,C,,,,,,,,,,,S,,,,,,,,,,,,
1999,1227,K,,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,,,,,,,,,,
2000,1228,S,C,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2001,1228,S,Y,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2002,1229,L,V,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2003,1230,G,W,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,cBioPortal,lusc_tcga_pub,Lung Squamous Cell Carcinoma,"hg19,15:91347526-91347526","hg19,15:g.91347526G>T",0.524,,,,
2004,1231,K,N,,,,,,,,,,S,"USP7 binding motif, 1227-1231, ELM",,COSMIC,,,"hg38,15:90804301-90804301","hg38,15:g.90804301A>T",0.182,"skin, head_neck","malignant_melanoma, nevoid",,
2005,1232,V,I,,,,,,,,,,S,,,Manual annotations from clinvar.csv,,,,,,,,,
2006,1233,F,,,,,,,,,,,S,,,,,,,,,,,,
2007,1234,G,S,,,,,,,,,,S,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91347538-91347538, hg38,15:90804308-90804308","hg19,15:g.91347538G>A, hg38,15:g.90804308G>A",0.192,pancreas,"carcinoma, ductal_carcinoma",,
2008,1235,V,,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 1235-1240, ELM",,,,,,,,,,,
2009,1236,H,R,,,,,,,,,,S,"Immunoreceptor tyrosine-based motif, 1235-1240, ELM",,"cBioPortal,COSMIC",ampca_bcm_2016,Ampullary Carcinoma,"hg19,15:91347545-91347545, hg38,15:90804315-90804315","hg19,15:g.91347545A>G, hg38,15:g.90804315A>G",0.347,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
2010,1237,Y,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Immunoreceptor tyrosine-based motif, 1235-1240, ELM|Y-based sorting signal, 1237-1240, ELM",,,,,,,,,,,
2011,1238,F,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Immunoreceptor tyrosine-based motif, 1235-1240, ELM|Y-based sorting signal, 1237-1240, ELM",,,,,,,,,,,
2012,1239,N,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Immunoreceptor tyrosine-based motif, 1235-1240, ELM|Y-based sorting signal, 1237-1240, ELM",,,,,,,,,,,
2013,1240,I,,,,,,,,,,,S,"Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Phosphotyrosine ligands bound by SH2 domains, 1237-1240, ELM|Immunoreceptor tyrosine-based motif, 1235-1240, ELM|Y-based sorting signal, 1237-1240, ELM",,,,,,,,,,,
2014,1241,F,,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,,,,,,,,,,
2015,1242,N,Y,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,COSMIC,,,"hg38,15:90804332-90804332","hg38,15:g.90804332A>T",0.365,"biliary_tract, bile_duct","carcinoma, adenocarcinoma",,
2016,1243,T,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,COSMIC,,,"hg38,15:90804335-90804335","hg38,15:g.90804335A>G",0.225,prostate,carcinoma,,
2017,1243,T,I,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,"cBioPortal,Manual annotations from clinvar.csv",acc_2019,Adrenocortical Carcinoma,"hg19,15:91347566-91347566","hg19,15:g.91347566C>T",0.243,,,,
2018,1244,V,A,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2019,1244,V,F,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2020,1244,V,G,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2021,1244,V,I,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_ch_2020, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91347568-91347568, hg38,15:90804338-90804338","hg19,15:g.91347568G>A, hg38,15:g.90804338G>A",0.120,"pancreas, prostate, upper_aerodigestive_tract, mouth","carcinoma, carcinoma, ductal_carcinoma, carcinoma, squamous_cell_carcinoma",0.0000039794026121,
2022,1245,T,S,,,,,,,,,,S,"FHA phosphopeptide ligands, 1241-1247, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2023,1246,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM|FHA phosphopeptide ligands, 1241-1247, ELM",,,,,,,,,,,
2024,1247,K,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM|FHA phosphopeptide ligands, 1241-1247, ELM",,,,,,,,,,,
2025,1248,K,M,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2026,1248,K,R,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2027,1249,L,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,,,,,,,,,,
2028,1250,A,,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,,,,,,,,,,
2029,1251,E,K,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2030,1251,E,Q,,,,,,,,,,S,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2031,1252,S,F,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,"cBioPortal,COSMIC","coadread_tcga, coadread_tcga_pan_can_atlas_2018, coadread_tcga_pub, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91352370-91352370, hg38,15:90809140-90809140","hg19,15:g.91352370C>T, hg38,15:g.90809140C>T",0.238,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
2032,1252,S,Y,,,,,,,,,,C,"PP2A holoenzyme B56-docking site, 1246-1252, ELM",,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, pan_origimed_2020, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91352370-91352370, hg38,15:90809140-90809140","hg19,15:g.91352370C>A, hg38,15:g.90809140C>A",0.169,"large_intestine, rectum","carcinoma, adenocarcinoma",,
2033,1253,L,S,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2034,1253,L,V,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91352372-91352372","hg19,15:g.91352372T>G",0.170,,,0.0000039767440011,
2035,1254,S,A,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2036,1255,S,C,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2037,1255,S,F,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91352379-91352379","hg19,15:g.91352379C>T",0.188,,,,
2038,1256,D,E,,,,,,,,,,C,,,"cBioPortal,COSMIC","skcm_tcga, skcm_tcga_pan_can_atlas_2018, skcm_tcga_pub_2015",Cutaneous Melanoma,"hg19,15:91352383-91352383, hg38,15:90809153-90809153","hg19,15:g.91352383T>G, hg38,15:g.90809153T>G",0.054,skin,malignant_melanoma,,
2039,1257,P,A,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",brca_mbcproject_2022,Invasive Breast Carcinoma,"hg19,15:91352384-91352384","hg19,15:g.91352384C>G",0.257,,,,
2040,1257,P,L,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2041,1257,P,S,,,,,,,,,,C,,,"cBioPortal,COSMIC",bcc_unige_2016,Basal Cell Carcinoma,"hg19,15:91352384-91352384, hg38,15:90809154-90809154","hg19,15:g.91352384C>T, hg38,15:g.90809154C>T",0.154,skin,"carcinoma, basal_cell_carcinoma",,
2042,1258,E,D,,,,,,,,,,C,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91352389-91352389, hg38,15:90809159-90809159","hg19,15:g.91352389G>T, hg38,15:g.90809159G>T",0.059,endometrium,"carcinoma, endometrioid_carcinoma",,
2043,1258,E,K,,,,,,,,,,C,,,"cBioPortal,COSMIC","blca_msk_tcga_2020, blca_tcga_pan_can_atlas_2018, blca_tcga_pub_2017, luad_oncosg_2020","Bladder Urothelial Carcinoma, Lung Adenocarcinoma","hg19,15:91352387-91352387, hg38,15:90809157-90809157","hg19,15:g.91352387G>A, hg38,15:g.90809157G>A",0.268,"skin, lower_leg, upper_aerodigestive_tract, pharynx, nasopharynx, urinary_tract, bladder","carcinoma, carcinoma, squamous_cell_carcinoma, malignant_melanoma",,
2044,1259,V,I,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2045,1260,L,V,,,,,,,,,,S,"Clathrin box, 1260-1264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2046,1261,L,F,,,,,,,,,,S,"Clathrin box, 1260-1264, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2047,1261,L,I,,,,,,,,,,S,"Clathrin box, 1260-1264, ELM",,COSMIC,,,"hg38,15:90809166-90809166","hg38,15:g.90809166C>A",0.202,"skin, mucosal, nasopharynx",malignant_melanoma,,
2048,1262,Q,,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM|Clathrin box, 1260-1264, ELM",,,,,,,,,,,
2049,1263,I,M,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM|Clathrin box, 1260-1264, ELM",,cBioPortal,lusc_cptac_2021,Lung Squamous Cell Carcinoma,"hg19,15:91352404-91352405",,,,,,
2050,1264,D,E,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM|Clathrin box, 1260-1264, ELM",,cBioPortal,nhl_bcgsc_2013,Non-Hodgkin Lymphoma,"hg19,15:91352407-91352407","hg19,15:g.91352407T>G",0.160,,,,
2051,1265,G,C,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM",,"cBioPortal,COSMIC",cscc_hgsc_bcm_2014,Cutaneous Squamous Cell Carcinoma,"hg19,15:91352408-91352408, hg38,15:90809178-90809178","hg19,15:g.91352408G>T, hg38,15:g.90809178G>T",0.597,"skin, head_neck","carcinoma, squamous_cell_carcinoma",,
2052,1266,V,,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM",,,,,,,,,,,
2053,1267,T,,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM",,,,,,,,,,,
2054,1268,E,K,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM",,cBioPortal,"gbc_mskcc_2022, msk_met_2021","Gallbladder Cancer, Mixed Cancer Types","hg19,15:91352417-91352417","hg19,15:g.91352417G>A",0.324,,,,
2055,1268,E,V,,,,,,,,,,S,"Taspase1 cleavage site, 1262-1268, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2056,1269,D,N,,,,,,,,,,S,,,"cBioPortal,COSMIC","breast_ink4_msk_2021, breast_msk_2018, msk_impact_2017, msk_met_2021","Breast, Mixed Cancer Types","hg19,15:91352420-91352420, hg38,15:90809190-90809190","hg19,15:g.91352420G>A, hg38,15:g.90809190G>A",0.198,breast,"carcinoma, ductal_carcinoma",,
2057,1270,K,R,,,,,,,,,,S,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91352424-91352424","hg19,15:g.91352424A>G",0.334,,,,
2058,1271,L,,,,,,,,,,,S,,,,,,,,,,,,
2059,1272,E,,,,,,,,,,,C,,,,,,,,,,,,
2060,1273,K,,,,Ubq,,,,Sumo,,,C,,,,,,,,,,,,
2061,1274,Y,,,,,,,,,,,C,,,,,,,,,,,,
2062,1275,G,,,,,,,,,,,C,,,,,,,,,,,,
2063,1276,A,E,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2064,1276,A,T,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2065,1276,A,V,,,,,,,,,,C,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91352442-91352442","hg19,15:g.91352442C>T",0.258,,,0.0000039766807441,
2066,1277,E,,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,,,,,,,,,,
2067,1278,V,,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,,,,,,,,,,
2068,1279,I,V,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,"cBioPortal,COSMIC","ov_tcga, ov_tcga_pan_can_atlas_2018, ov_tcga_pub",High-Grade Serous Ovarian Cancer,"hg19,15:91352450-91352450, hg38,15:90809220-90809220","hg19,15:g.91352450A>G, hg38,15:g.90809220A>G",0.135,ovary,"carcinoma, serous_carcinoma",,
2069,1280,S,L,P,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, pancan_pcawg_2020","Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91352454-91352454, hg38,15:90809224-90809224","hg19,15:g.91352454C>T, hg38,15:g.90809224C>T",0.075,breast,carcinoma,,
2070,1281,V,I,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2071,1282,L,,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,,,,,,,,,,
2072,1283,Q,H,,,,,,,,,,C,"SUMO interaction site, 1277-1283, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91352464-91352464, hg38,15:90809234-90809234","hg19,15:g.91352464G>T, hg38,15:g.90809234G>T",0.214,endometrium,"carcinoma, endometrioid_carcinoma",,
2073,1284,K,,,,,,,,,,,C,,,,,,,,,,,,
2074,1285,Y,,,,,,,,,,,C,,,,,,,,,,,,
2075,1286,S,C,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2076,1286,S,P,,,,,,,,,,C,,,Manual annotations from clinvar.csv,,,,,,,,,
2077,1287,E,,,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,,,,,,,,,,
2078,1288,W,R,,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2079,1289,T,S,,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90809250-90809250","hg38,15:g.90809250A>T",0.097,,malignant_melanoma,,
2080,1290,S,L,P,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021, ucec_ccr_msk_2022, ucec_msk_2018","Endometrial Carcinoma, Mixed Cancer Types","hg19,15:91352484-91352484, hg38,15:90809254-90809254","hg19,15:g.91352484C>T, hg38,15:g.90809254C>T",0.063,"endometrium, prostate","carcinoma, carcinoma, endometrioid_carcinoma",0.0000159059639412,
2081,1291,P,L,,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2082,1291,P,T,,,,,,,,,,C,"WW domain ligands, 1287-1292, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2083,1292,A,D,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1287-1292, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2084,1292,A,T,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1287-1292, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2085,1293,E,G,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2086,1294,D,E,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,cBioPortal,"msk_met_2021, prad_cdk12_mskcc_2020, prad_msk_stopsack_2021, prad_pik3r1_msk_2021","Mixed Cancer Types, Prostate Adenocarcinoma","hg19,15:91354442-91354442","hg19,15:g.91354442C>G",0.047,,,,
2087,1294,D,N,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2088,1294,D,Y,,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2089,1295,S,,P,,,,,,,,,C,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,,,,,,,,,,
2090,1296,S,F,P,,,,,,,,,D,"USP7 binding motif, 1292-1296, ELM|WW domain ligands, 1293-1298, ELM",,"cBioPortal,Manual annotations from clinvar.csv",brca_broad,Invasive Breast Carcinoma,"hg19,15:91354447-91354447","hg19,15:g.91354447C>T",0.144,,,,
2091,1297,P,Q,,,,,,,,,,D,"WW domain ligands, 1293-1298, ELM",,COSMIC,,,"hg38,15:90811220-90811220","hg38,15:g.90811220C>A",0.058,thyroid,carcinoma,,
2092,1298,G,R,,,,,,,,,,D,"WW domain ligands, 1293-1298, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2093,1298,G,V,,,,,,,,,,D,"WW domain ligands, 1293-1298, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91354453-91354453","hg19,15:g.91354453G>T",0.055,,,,
2094,1298,G,W,,,,,,,,,,D,"WW domain ligands, 1293-1298, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91354452-91354452","hg19,15:g.91354452G>T",0.057,,,,
2095,1299,I,M,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2096,1300,S,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2097,1300,S,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2098,1301,L,,,,,,,,,,,d,,,,,,,,,,,,
2099,1302,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021, utuc_msk_2019, utuc_pdx_msk_2019","Mixed Cancer Types, Upper Tract Urothelial Carcinoma","hg19,15:91354465-91354465, hg38,15:90811235-90811235","hg19,15:g.91354465C>T, hg38,15:g.90811235C>T",0.059,"urinary_tract, upper_urinary_tract","carcinoma, transitional_cell_carcinoma",,
2100,1303,S,R,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2101,1304,S,,P,,,,,,,,,d,,,,,,,,,,,,
2102,1305,R,,,,,,,,,,,d,,,,,,,,,,,,
2103,1306,G,D,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2104,1307,P,S,,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91354479-91354479","hg19,15:g.91354479C>T",0.062,,,,
2105,1308,G,E,,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2106,1308,G,R,,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021, stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Colorectal Adenocarcinoma, Esophagogastric Adenocarcinoma, Mixed Cancer Types, Stomach Adenocarcinoma","hg19,15:91354482-91354482, hg38,15:90811252-90811252","hg19,15:g.91354482G>A, hg38,15:g.90811252G>A",0.009,"large_intestine, colon, large_intestine, colon, ascending, skin, stomach","carcinoma, adenocarcinoma, carcinoma, squamous_cell_carcinoma",0.0000238625517022,0.0000318491623670
2107,1309,R,T,,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90811256-90811256","hg38,15:g.90811256G>C",0.028,lung,"carcinoma, non_small_cell_carcinoma",0.0000159079881963,
2108,1310,S,R,P,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2109,1311,A,,,,,,,,,,,d,"USP7 binding motif, 1307-1311, ELM|TRAF2 binding site, 1311-1314, ELM",,,,,,,,,,,
2110,1312,A,D,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,cBioPortal,lihc_tcga,Hepatocellular Carcinoma,"hg19,15:91354495-91354495","hg19,15:g.91354495C>A",0.052,,,,
2111,1312,A,T,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2112,1312,A,V,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2113,1313,E,A,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2114,1313,E,D,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,"cBioPortal,COSMIC",stad_tcga_pan_can_atlas_2018,Stomach Adenocarcinoma,"hg19,15:91354499-91354499, hg38,15:90811269-90811269","hg19,15:g.91354499G>T, hg38,15:g.90811269G>T",0.050,stomach,"carcinoma, adenocarcinoma",,
2115,1313,E,K,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,COSMIC,,,"hg38,15:90811267-90811267","hg38,15:g.90811267G>A",0.080,lung,"carcinoma, adenocarcinoma",,
2116,1314,E,D,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,cBioPortal,mixed_allen_2018,Mixed Cancer Types,"hg19,15:91354502-91354502","hg19,15:g.91354502G>T",0.033,,,,
2117,1314,E,K,,,,,,,,,,d,"TRAF2 binding site, 1311-1314, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91354500-91354500","hg19,15:g.91354500G>A",0.136,,,,
2118,1315,L,F,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91354503-91354503, hg38,15:90811273-90811273","hg19,15:g.91354503C>T, hg38,15:g.90811273C>T",0.023,"large_intestine, caecum","carcinoma, adenocarcinoma",0.0000039769654163,
2119,1315,L,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2120,1316,D,E,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2121,1316,D,H,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2122,1316,D,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2123,1317,E,D,,,,,,,,,,d,,,"cBioPortal,COSMIC","crc_msk_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91354511-91354511, hg38,15:90811281-90811281","hg19,15:g.91354511G>C, hg38,15:g.90811281G>C",0.085,"large_intestine, colon, transverse","carcinoma, adenocarcinoma",,
2124,1317,E,K,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","egc_msk_tp53_ccr_2022, egc_mskcc_2020, msk_impact_2017, summit_2018","Esophagogastric Adenocarcinoma, Esophagus/Stomach, Mixed Cancer Types","hg19,15:91354509-91354509, hg38,15:90811279-90811279","hg19,15:g.91354509G>A, hg38,15:g.90811279G>A",0.151,"soft_tissue, fat, soft_tissue, fat, mediastinum","liposarcoma, pleomorphic",0.0002107959336271,
2125,1318,E,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2126,1319,I,M,,,,,,,,,,d,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91354517-91354517","hg19,15:g.91354517A>G",0.054,,,,
2127,1320,P,H,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2128,1320,P,L,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,COSMIC,,,"hg38,15:90811289-90811289","hg38,15:g.90811289C>T",0.143,pancreas,"carcinoma, ductal_carcinoma",,
2129,1320,P,S,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,"cBioPortal,COSMIC","brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub2015",Invasive Breast Carcinoma,"hg19,15:91354518-91354518, hg38,15:90811288-90811288","hg19,15:g.91354518C>T, hg38,15:g.90811288C>T",0.016,breast,carcinoma,,
2130,1320,P,T,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2131,1321,V,I,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90811291-90811291","hg38,15:g.90811291G>A",0.089,"haematopoietic_and_lymphoid_tissue, prostate, soft_tissue, blood_vessel, central_nervous_system","carcinoma, carcinoma, adenocarcinoma, haemangioblastoma, lymphoid_neoplasm, plasma_cell_myeloma",0.0661130070241590,0.0856323669958585
2132,1321,V,L,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","msk_impact_2017, msk_met_2021, nsclc_pd1_msk_2018, tmb_mskcc_2018","Mixed Cancer Types, Non-Small Cell Lung Cancer","hg19,15:91354521-91354521, hg38,15:90811291-90811291","hg19,15:g.91354521G>C, hg38,15:g.90811291G>C, hg38,15:g.90811291G>T",0.063,"haematopoietic_and_lymphoid_tissue, lung","carcinoma, squamous_cell_carcinoma, haematopoietic_neoplasm, acute_myeloid_leukaemia",0.0000039774399605,
2133,1322,S,F,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM|BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2134,1323,S,F,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM|BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM",,cBioPortal,"mel_dfci_2019, mel_mskimpact_2020, msk_met_2021, tmb_mskcc_2018","Cutaneous Melanoma, Melanoma, Mixed Cancer Types","hg19,15:91354528-91354528","hg19,15:g.91354528C>T",0.309,,,0.0000039770286823,
2135,1324,H,N,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM|BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM",,cBioPortal,brca_broad,Invasive Breast Carcinoma,"hg19,15:91354530-91354530","hg19,15:g.91354530C>A",0.158,,,,
2136,1324,H,Y,,,,,,,,,,d,"USP7 binding motif, 1320-1324, ELM|BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2137,1325,Y,,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM|Phosphotyrosine ligands bound by SH2 domains, 1325-1328, ELM",,,,,,,,,,,
2138,1326,F,I,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1322-1326, ELM|MLH1 C-terminal Domain Ligand, 1322-1326, ELM|Phosphotyrosine ligands bound by SH2 domains, 1325-1328, ELM",,"cBioPortal,Manual annotations from clinvar.csv",glioma_mskcc_2019,Diffuse Glioma,"hg19,15:91354536-91354536","hg19,15:g.91354536T>A",0.255,,,0.0000039770603161,
2139,1327,A,E,,,,,,,,,,d,"Phosphotyrosine ligands bound by SH2 domains, 1325-1328, ELM",,COSMIC,,,"hg38,15:90811310-90811310","hg38,15:g.90811310C>A",0.119,"skin, scalp","carcinoma, squamous_cell_carcinoma",,
2140,1327,A,S,,,,,,,,,,d,"Phosphotyrosine ligands bound by SH2 domains, 1325-1328, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2141,1328,S,,,,,,,,,,,d,"FHA phosphopeptide ligands, 1328-1334, ELM|Phosphotyrosine ligands bound by SH2 domains, 1325-1328, ELM",,,,,,,,,,,
2142,1329,K,E,,,Ubq,,,,,,,d,"FHA phosphopeptide ligands, 1328-1334, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2143,1330,T,I,,,,,,,,,,d,"FHA phosphopeptide ligands, 1328-1334, ELM",,cBioPortal,difg_glass_2019,Diffuse Glioma,"hg19,15:91354549-91354549","hg19,15:g.91354549C>T",0.069,,,,
2144,1331,R,G,,,,,,,,,,d,"PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2145,1331,R,K,,,,,,,,,,d,"PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2146,1332,N,,,,,,,,,,,d,"PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM",,,,,,,,,,,
2147,1333,E,V,,,,,,,,,,d,"NRD cleavage site, 1333-1335, ELM|PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM",,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91354558-91354558","hg19,15:g.91354558A>T",0.225,,,,
2148,1334,R,M,,,,,,,,,,d,"NRD cleavage site, 1333-1335, ELM|PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM",,"cBioPortal,COSMIC","cfdna_msk_2019, msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91354561-91354561, hg38,15:90811331-90811331","hg19,15:g.91354561G>T, hg38,15:g.90811331G>T",0.149,lung,"carcinoma, adenocarcinoma",,
2149,1334,R,T,,,,,,,,,,d,"NRD cleavage site, 1333-1335, ELM|PCSK cleavage site, 1331-1337, ELM|FHA phosphopeptide ligands, 1328-1334, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91354561-91354561","hg19,15:g.91354561G>C",0.088,,,,
2150,1335,K,R,,,,,,,,,,d,"NRD cleavage site, 1333-1335, ELM|NRD cleavage site, 1335-1337, ELM|PCSK cleavage site, 1335-1337, ELM|PCSK cleavage site, 1331-1337, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,COSMIC,,,"hg38,15:90811334-90811334","hg38,15:g.90811334A>G",0.093,stomach,carcinoma,,
2151,1336,R,G,,,,,,,,,,d,"NRD cleavage site, 1335-1337, ELM|PCSK cleavage site, 1335-1337, ELM|PCSK cleavage site, 1331-1337, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2152,1337,K,E,,,,,,,,,,d,"NRD cleavage site, 1335-1337, ELM|PCSK cleavage site, 1335-1337, ELM|PCSK cleavage site, 1331-1337, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",coadread_dfci_2016,Colorectal Adenocarcinoma,"hg19,15:91354569-91354569, hg38,15:90811339-90811339","hg19,15:g.91354569A>G, hg38,15:g.90811339A>G",0.178,large_intestine,"carcinoma, adenocarcinoma",,
2153,1338,K,N,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,"cBioPortal,COSMIC","coadread_tcga_pan_can_atlas_2018, pancan_pcawg_2020","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91354574-91354574, hg38,15:90811344-90811344","hg19,15:g.91354574G>T, hg38,15:g.90811344G>T",0.045,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
2154,1339,M,I,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2155,1339,M,L,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,cBioPortal,"msk_met_2021, tmb_mskcc_2018",Mixed Cancer Types,"hg19,15:91354575-91354575","hg19,15:g.91354575A>T",0.030,,,,
2156,1339,M,R,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2157,1339,M,T,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1334-1339, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2158,1340,P,L,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90811349-90811349","hg38,15:g.90811349C>T",0.081,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing",0.0000159077351362,
2159,1340,P,S,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,"cBioPortal,COSMIC","ucec_tcga, ucec_tcga_pan_can_atlas_2018, ucec_tcga_pub",Endometrial Carcinoma,"hg19,15:91354578-91354578, hg38,15:90811348-90811348","hg19,15:g.91354578C>T, hg38,15:g.90811348C>T",0.045,endometrium,"carcinoma, endometrioid_carcinoma",,
2160,1340,P,T,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM|NLS classical Nuclear Localization Signals, 1334-1340, ELM|NLS classical Nuclear Localization Signals, 1335-1340, ELM",,"cBioPortal,COSMIC","stad_tcga_pan_can_atlas_2018, stad_tcga_pub",Stomach Adenocarcinoma,"hg19,15:91354578-91354578, hg38,15:90811348-90811348","hg19,15:g.91354578C>A, hg38,15:g.90811348C>A",0.038,stomach,"carcinoma, adenocarcinoma",,
2161,1341,A,S,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2162,1341,A,V,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91354582-91354582","hg19,15:g.91354582C>T",0.069,,,0.0000954494475863,0.0000955353162219
2163,1342,S,F,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2164,1342,S,P,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90811354-90811354","hg38,15:g.90811354T>C",0.029,large_intestine,"carcinoma, adenocarcinoma",,
2165,1343,Q,R,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2166,1344,R,,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,,,,,,,,,,
2167,1345,S,C,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,cBioPortal,breast_ink4_msk_2021,Breast,"hg19,15:91354594-91354594","hg19,15:g.91354594C>G",0.134,,,,
2168,1345,S,F,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,cBioPortal,"mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91354594-91354594","hg19,15:g.91354594C>T",0.130,,,,
2169,1345,S,Y,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,cBioPortal,ccle_broad_2019,Mixed Cancer Types,"hg19,15:91354594-91354594","hg19,15:g.91354594C>A",0.142,,,,
2170,1346,K,N,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|PCSK cleavage site, 1346-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,"cBioPortal,COSMIC",hccihch_pku_2019,Hepatocellular Carcinoma plus Intrahepatic Cholangiocarcinoma,"hg19,15:91354598-91354598, hg38,15:90811368-90811368","hg19,15:g.91354598G>T, hg38,15:g.90811368G>C",0.214,"upper_aerodigestive_tract, pharynx, nasopharynx","carcinoma, nasopharyngeal_carcinoma, non_keratinizing",,
2171,1346,K,R,,,,,,,,,,d,"PCSK cleavage site, 1344-1348, ELM|PCSK cleavage site, 1346-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2172,1347,R,G,,,,,,,,,,d,"NRD cleavage site, 1347-1349, ELM|PCSK cleavage site, 1344-1348, ELM|PCSK cleavage site, 1346-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,"cBioPortal,Manual annotations from clinvar.csv",pan_origimed_2020,Mixed Cancer Types,"hg19,15:91354599-91354599","hg19,15:g.91354599A>G",0.177,,,,
2173,1347,R,K,,,,,,,,,,d,"NRD cleavage site, 1347-1349, ELM|PCSK cleavage site, 1344-1348, ELM|PCSK cleavage site, 1346-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,"cBioPortal,COSMIC",skcm_tcga_pan_can_atlas_2018,Cutaneous Melanoma,"hg19,15:91354600-91354600, hg38,15:90811370-90811370","hg19,15:g.91354600G>A, hg38,15:g.90811370G>A",0.065,skin,malignant_melanoma,,
2174,1348,R,T,,,,,,,,,,d,"NRD cleavage site, 1347-1349, ELM|PCSK cleavage site, 1344-1348, ELM|PCSK cleavage site, 1346-1348, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,COSMIC,,,"hg38,15:90811373-90811373","hg38,15:g.90811373G>C",0.168,cervix,"carcinoma, squamous_cell_carcinoma",,
2175,1349,K,N,,,,,,,,,,d,"NRD cleavage site, 1347-1349, ELM|NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91354607-91354607, hg38,15:90811377-90811377","hg19,15:g.91354607A>C, hg38,15:g.90811377A>C",0.062,"large_intestine, colon, ascending","carcinoma, adenocarcinoma",,
2176,1350,T,,,,,,,,,,,d,"NLS classical Nuclear Localization Signals, 1334-1350, ELM|NLS classical Nuclear Localization Signals, 1335-1350, ELM|NLS classical Nuclear Localization Signals, 1336-1350, ELM|NLS classical Nuclear Localization Signals, 1345-1350, ELM|NLS classical Nuclear Localization Signals, 1344-1350, ELM",,,,,,,,,,,
2177,1351,A,,,,,,,,,,,d,,,,,,,,,,,,
2178,1352,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","bcc_unige_2016, brca_tcga, brca_tcga_pan_can_atlas_2018, brca_tcga_pub, brca_tcga_pub2015, msk_met_2021","Basal Cell Carcinoma, Invasive Breast Carcinoma, Mixed Cancer Types","hg19,15:91354615-91354615, hg38,15:90811385-90811385","hg19,15:g.91354615C>T, hg38,15:g.90811385C>T",0.045,"breast, skin","carcinoma, carcinoma, basal_cell_carcinoma",,
2179,1353,S,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2180,1353,S,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2181,1354,G,A,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2182,1354,G,D,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2183,1354,G,V,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91354621-91354621","hg19,15:g.91354621G>T",0.074,,,,
2184,1355,S,,,,,,,,,,,d,,,,,,,,,,,,
2185,1356,K,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2186,1356,K,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2187,1357,A,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2188,1358,K,,,,,,,,,,,d,,,,,,,,,,,,
2189,1359,G,E,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2190,1360,G,E,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2191,1360,G,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2192,1361,S,,,,,,,,,,,d,,,,,,,,,,,,
2193,1362,A,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2194,1362,A,P,,,,,,,,,,d,,,cBioPortal,brca_smc_2018,Invasive Breast Carcinoma,"hg19,15:91358339-91358339","hg19,15:g.91358339G>C",0.055,,,,
2195,1363,T,A,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2196,1363,T,I,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91358343-91358343","hg19,15:g.91358343C>T",0.114,,,,
2197,1364,C,R,,,,,,,,,,d,"NRD cleavage site, 1364-1366, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2198,1365,R,G,,,,,,,,,,d,"NRD cleavage site, 1364-1366, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2199,1365,R,K,,,,,,,,,,d,"NRD cleavage site, 1364-1366, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2200,1366,K,N,,,,,,,,,,d,"NRD cleavage site, 1364-1366, ELM|USP7 binding motif, 1366-1370, ELM",,"cBioPortal,COSMIC","gbc_msk_2018, gbc_mskcc_2022, msk_impact_2017, msk_met_2021, pan_origimed_2020","Gallbladder Cancer, Mixed Cancer Types","hg19,15:91358353-91358353, hg38,15:90815123-90815123","hg19,15:g.91358353G>C, hg38,15:g.90815123G>C",0.059,"biliary_tract, gallbladder","carcinoma, adenocarcinoma",,
2201,1367,I,M,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv",ccle_broad_2019,Mixed Cancer Types,"hg19,15:91358356-91358356, hg38,15:90815126-90815126","hg19,15:g.91358356A>G, hg38,15:g.90815126A>G",0.027,large_intestine,"carcinoma, adenocarcinoma",,
2202,1368,S,P,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,"COSMIC,Manual annotations from clinvar.csv",,,"hg38,15:90815127-90815127","hg38,15:g.90815127T>C",0.010,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",0.0000278358796536,
2203,1368,S,T,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2204,1368,S,Y,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,COSMIC,,,"hg38,15:90815128-90815128","hg38,15:g.90815128C>A",0.104,haematopoietic_and_lymphoid_tissue,"lymphoid_neoplasm, acute_lymphoblastic_B_cell_leukaemia",,
2205,1369,S,F,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91358361-91358361","hg19,15:g.91358361C>T",0.198,,,,
2206,1370,K,,,,,,,,,,,d,"USP7 binding motif, 1366-1370, ELM",,,,,,,,,,,
2207,1371,T,M,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","crc_msk_2017, msk_impact_2017, msk_met_2021, rectal_msk_2019","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91358367-91358367, hg38,15:90815137-90815137","hg19,15:g.91358367C>T, hg38,15:g.90815137C>T",0.046,"large_intestine, rectum","carcinoma, adenocarcinoma",0.0000238585664183,
2208,1372,K,N,,,Ubq,,,,Sumo,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2209,1373,S,F,,,,,,,,,,d,,,"cBioPortal,COSMIC",skcm_broad_brafresist_2012,Cutaneous Melanoma,"hg19,15:91358373-91358373, hg38,15:90815143-90815143","hg19,15:g.91358373C>T, hg38,15:g.90815143C>T",0.030,,malignant_melanoma,,
2210,1374,S,F,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2211,1375,S,G,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2212,1375,S,N,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2213,1375,S,R,P,,,,,,,,,d,,,cBioPortal,"nbl_ucologne_2015, pediatric_dkfz_2017","Mixed Cancer Types, Neuroblastoma","hg19,15:91358380-91358380","hg19,15:g.91358380C>A",0.082,,,,
2214,1376,I,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2215,1377,I,T,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2216,1378,G,,,,,,,,,,,d,,,,,,,,,,,,
2217,1379,S,C,,,,,,,,,,d,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91358391-91358391","hg19,15:g.91358391C>G",0.125,,,,
2218,1380,S,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2219,1380,S,R,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","es_dfarber_broad_2014, msk_ch_2020","Ewing Sarcoma, Mixed Cancer Types","hg19,15:91358395-91358395, hg38,15:90815165-90815165","hg19,15:g.91358395T>A, hg19,15:g.91358395T>G, hg38,15:g.90815165T>G",0.023,"bone, tibia",Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour,0.0000119289037337,
2220,1381,S,L,,,,,,,,,,d,,,"cBioPortal,Manual annotations from clinvar.csv","mel_mskimpact_2020, msk_met_2021","Cutaneous Melanoma, Mixed Cancer Types","hg19,15:91358397-91358397","hg19,15:g.91358397C>T",0.125,,,,
2221,1382,A,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2222,1382,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC","glioma_mskcc_2019, msk_impact_2017","Diffuse Glioma, Mixed Cancer Types","hg19,15:91358399-91358399, hg38,15:90815169-90815169","hg19,15:g.91358399G>A, hg38,15:g.90815169G>A",0.035,"central_nervous_system, brain","glioma, astrocytoma_Grade_IV, glioblastoma_multiforme",,
2223,1383,S,,P,,,,,,,,,d,,,,,,,,,,,,
2224,1384,H,D,,,,,,,,,,d,,,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91358405-91358405","hg19,15:g.91358405C>G",0.044,,,,
2225,1384,H,Q,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2226,1384,H,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2227,1385,T,A,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2228,1385,T,I,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2229,1386,S,,,,,,,,,,,d,,,,,,,,,,,,
2230,1387,Q,E,,,,,,,,,,d,,,"cBioPortal,COSMIC","blca_dfarber_mskcc_2014, blca_msk_tcga_2020, cesc_tcga_pan_can_atlas_2018","Bladder Urothelial Carcinoma, Cervical Squamous Cell Carcinoma","hg19,15:91358414-91358414, hg38,15:90815184-90815184","hg19,15:g.91358414C>G, hg38,15:g.90815184C>G",0.194,"cervix, urinary_tract, bladder","carcinoma, squamous_cell_carcinoma, carcinoma, transitional_cell_carcinoma",,
2231,1388,A,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2232,1388,A,P,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2233,1388,A,T,,,,,,,,,,d,,,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","cesc_tcga_pan_can_atlas_2018, msk_met_2021","Cervical Squamous Cell Carcinoma, Mixed Cancer Types","hg19,15:91358417-91358417, hg38,15:90815187-90815187","hg19,15:g.91358417G>A, hg38,15:g.90815187G>A",0.055,cervix,"carcinoma, squamous_cell_carcinoma",,
2234,1388,A,V,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2235,1389,T,,,,,,,,,,,d,,,,,,,,,,,,
2236,1390,S,A,,,,,,,,,,d,,,cBioPortal,pan_origimed_2020,Mixed Cancer Types,"hg19,15:91358423-91358423","hg19,15:g.91358423T>G",0.021,,,,
2237,1390,S,L,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2238,1391,G,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2239,1392,A,G,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2240,1393,N,D,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2241,1393,N,S,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2242,1394,S,N,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2243,1394,S,R,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2244,1395,K,I,,,,,,,,,,d,,,COSMIC,,,"hg38,15:90815209-90815209","hg38,15:g.90815209A>T",0.211,pancreas,pancreatic_intraepithelial_neoplasia_(PanIN),,
2245,1396,L,,,,,,,,,,,d,,,,,,,,,,,,
2246,1397,G,E,,,,,,,,,,d,,,"cBioPortal,COSMIC",pancan_pcawg_2020,Mixed Cancer Types,"hg19,15:91358445-91358445, hg38,15:90815215-90815215","hg19,15:g.91358445G>A, hg38,15:g.90815215G>A",0.341,"skin, trunk",malignant_melanoma,,
2247,1398,I,M,,,,,,,,,,d,"SH3 ligand, 1398-1404, ELM",,"cBioPortal,COSMIC","crc_msk_2017, msk_impact_2017","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91358449-91358449, hg38,15:90815219-90815219","hg19,15:g.91358449T>G, hg38,15:g.90815219T>G",0.135,"large_intestine, colon, sigmoid","carcinoma, adenocarcinoma",,
2248,1398,I,T,,,,,,,,,,d,"SH3 ligand, 1398-1404, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2249,1398,I,V,,,,,,,,,,d,"SH3 ligand, 1398-1404, ELM",,cBioPortal,msk_met_2021,Mixed Cancer Types,"hg19,15:91358447-91358447","hg19,15:g.91358447A>G",0.065,,,,
2250,1399,M,T,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1399-1402, ELM|SH3 ligand, 1398-1404, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2251,1399,M,V,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1399-1402, ELM|SH3 ligand, 1398-1404, ELM",,"cBioPortal,COSMIC","crc_apc_impact_2020, crc_msk_2017, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Mixed Cancer Types","hg19,15:91358450-91358450, hg38,15:90815220-90815220","hg19,15:g.91358450A>G, hg38,15:g.90815220A>G",0.149,"large_intestine, caecum","carcinoma, adenocarcinoma",,
2252,1400,A,T,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1399-1402, ELM|SH3 ligand, 1398-1404, ELM",,"cBioPortal,Manual annotations from clinvar.csv",rectal_msk_2022,Bowel,"hg19,15:91358453-91358453","hg19,15:g.91358453G>A",0.249,,,0.0000039767440011,
2253,1401,P,,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1399-1402, ELM|SH3 ligand, 1398-1404, ELM",,,,,,,,,,,
2254,1402,P,L,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1399-1402, ELM|SH3 ligand, 1398-1404, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91358460-91358460","hg19,15:g.91358460C>T",0.329,,,0.0000159059639412,0.0000318471337580
2255,1403,K,R,,,,,,,,,,d,"SH3 ligand, 1398-1404, ELM",,cBioPortal,nhl_bcgsc_2013,Non-Hodgkin Lymphoma,"hg19,15:91358463-91358463","hg19,15:g.91358463A>G",0.102,,,,
2256,1404,P,S,,,,,,,,,,d,"SH3 ligand, 1398-1404, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2257,1405,I,T,,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
2258,1406,N,S,,,,,,,,,,d,,,"cBioPortal,COSMIC","msk_impact_2017, msk_met_2021",Mixed Cancer Types,"hg19,15:91358472-91358472, hg38,15:90815242-90815242","hg19,15:g.91358472A>G, hg38,15:g.90815242A>G",0.183,lung,"carcinoma, squamous_cell_carcinoma",,
2259,1407,R,K,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM",,"cBioPortal,Manual annotations from clinvar.csv","gbc_mskcc_2022, msk_met_2021","Gallbladder Cancer, Mixed Cancer Types","hg19,15:91358475-91358475","hg19,15:g.91358475G>A",0.240,,,0.0000357898420475,0.0000318552497452
2260,1407,R,S,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2261,1407,R,T,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2262,1408,P,L,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|MYND domain binding motif., 1408-1412, ELM",,"cBioPortal,Manual annotations from clinvar.csv","glioma_mskcc_2019, msk_met_2021","Diffuse Glioma, Mixed Cancer Types","hg19,15:91358478-91358478","hg19,15:g.91358478C>T",0.139,,,0.0000039768388903,
2263,1408,P,R,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|MYND domain binding motif., 1408-1412, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2264,1408,P,S,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|MYND domain binding motif., 1408-1412, ELM",,cBioPortal,skcm_broad,Cutaneous Melanoma,"hg19,15:91358477-91358477","hg19,15:g.91358477C>T",0.102,,,,
2265,1409,F,,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,,,,,,,,,,
2266,1410,L,F,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,"cBioPortal,Manual annotations from clinvar.csv",msk_met_2021,Mixed Cancer Types,"hg19,15:91358483-91358483","hg19,15:g.91358483C>T",0.233,,,,
2267,1410,L,I,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,"cBioPortal,COSMIC","coadread_dfci_2016, lihc_tcga, lihc_tcga_pan_can_atlas_2018, mel_mskimpact_2020, msk_impact_2017, msk_met_2021","Colorectal Adenocarcinoma, Cutaneous Melanoma, Hepatocellular Carcinoma, Mixed Cancer Types","hg19,15:91358483-91358483, hg38,15:90815253-90815253","hg19,15:g.91358483C>A, hg38,15:g.90815253C>A",0.243,"large_intestine, liver, ovary, penis","carcinoma, adenocarcinoma, carcinoma, hepatocellular_carcinoma, carcinoma, mucinous_carcinoma, carcinoma, squamous_cell_carcinoma",,
2268,1410,L,R,,,,,,,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,"cBioPortal,COSMIC,Manual annotations from clinvar.csv","stad_tcga, stad_tcga_pan_can_atlas_2018, stad_tcga_pub, stes_tcga_pub","Esophagogastric Adenocarcinoma, Stomach Adenocarcinoma","hg19,15:91358484-91358484, hg38,15:90815254-90815254","hg19,15:g.91358484T>G, hg38,15:g.90815254T>G",0.333,stomach,"carcinoma, adenocarcinoma",,
2269,1411,K,M,,,,,,Ac,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2270,1411,K,R,,,,,,Ac,,,,d,"PCSK cleavage site, 1407-1411, ELM|PP4 EVH1-binding docking motifs, 1409-1412, ELM|MYND domain binding motif., 1408-1412, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2271,1412,P,A,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1409-1412, ELM|BRCT phosphopeptide ligands, 1412-1416, ELM|MYND domain binding motif., 1408-1412, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2272,1412,P,T,,,,,,,,,,d,"PP4 EVH1-binding docking motifs, 1409-1412, ELM|BRCT phosphopeptide ligands, 1412-1416, ELM|MYND domain binding motif., 1408-1412, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2273,1413,S,P,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1412-1416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2274,1414,Y,H,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1412-1416, ELM",,Manual annotations from clinvar.csv,,,,,,,,,
2275,1415,A,S,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1412-1416, ELM",,"cBioPortal,COSMIC",esca_broad,Esophageal Adenocarcinoma,"hg19,15:91358498-91358498, hg38,15:90815268-90815268","hg19,15:g.91358498G>T, hg38,15:g.90815268G>T",0.042,"stomach, gastroesophageal_junction","carcinoma, adenocarcinoma",,
2276,1416,F,L,,,,,,,,,,d,"BRCT phosphopeptide ligands, 1412-1416, ELM",,"cBioPortal,Manual annotations from clinvar.csv",ucec_tcga_pan_can_atlas_2018,Endometrial Carcinoma,"hg19,15:91358503-91358503","hg19,15:g.91358503C>A",0.013,,,,
2277,1417,S,L,P,,,,,,,,,d,,,Manual annotations from clinvar.csv,,,,,,,,,
